WO2009096855A1 - Blood clot removal device, system, and method - Google Patents
Blood clot removal device, system, and method Download PDFInfo
- Publication number
- WO2009096855A1 WO2009096855A1 PCT/SE2009/000040 SE2009000040W WO2009096855A1 WO 2009096855 A1 WO2009096855 A1 WO 2009096855A1 SE 2009000040 W SE2009000040 W SE 2009000040W WO 2009096855 A1 WO2009096855 A1 WO 2009096855A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- energy
- clot removal
- blood
- removal device
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/66—Regeneration of the filtering material or filter elements inside the filter
- B01D46/68—Regeneration of the filtering material or filter elements inside the filter by means acting on the cake side involving movement with regard to the filter elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/72—Cassettes forming partially or totally the fluid circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/79—Filters for solid matter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/80—Suction pumps
- A61M1/82—Membrane pumps, e.g. bulbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/857—Implantable blood tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/66—Regeneration of the filtering material or filter elements inside the filter
- B01D46/68—Regeneration of the filtering material or filter elements inside the filter by means acting on the cake side involving movement with regard to the filter elements
- B01D46/681—Regeneration of the filtering material or filter elements inside the filter by means acting on the cake side involving movement with regard to the filter elements by scrapers, brushes or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/48—Operating or control means, e.g. from outside the body, control of sphincters
- A61F2/482—Electrical means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/48—Operating or control means, e.g. from outside the body, control of sphincters
- A61F2/484—Fluid means, i.e. hydraulic or pneumatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0001—Means for transferring electromagnetic energy to implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0001—Means for transferring electromagnetic energy to implants
- A61F2250/0002—Means for transferring electromagnetic energy to implants for data transfer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M2027/004—Implant devices for drainage of body fluids from one part of the body to another with at least a part of the circuit outside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/10—General characteristics of the apparatus with powered movement mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3507—Communication with implanted devices, e.g. external control
- A61M2205/3523—Communication with implanted devices, e.g. external control using telemetric means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
- A61M2205/7554—General characteristics of the apparatus with filters with means for unclogging or regenerating filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1021—Abdominal cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/66—Regeneration of the filtering material or filter elements inside the filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/66—Regeneration of the filtering material or filter elements inside the filter
- B01D46/79—Regeneration of the filtering material or filter elements inside the filter by liquid process
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/66—Regeneration of the filtering material or filter elements inside the filter
- B01D46/86—Cleaning the filter surface by interrupting suction so that the filter cake falls by gravity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/88—Replacing filter elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/90—Devices for taking out of action one or more units of multi-unit filters, e.g. for regeneration or maintenance
Definitions
- the present invention relates generally to a device and a system implantable in a blood flow passageway of a human or mammal patient for removing blood clots, and more particularly to a system for removing blood clots in a vascular system of the patient, one example being a heart pump system.
- the invention also relates to a method of removing blood clots.
- BACKGROUND Today many implants are provided where the blood comes into contact with foreign material. All such implants have an associated risk of triggering blood clots. Such clots may become loose and may create severe damages at other parts of the body. Blood clots reaching the brain are the most dangerous ones and implants in the heart region may therefore be a first priority (although not limited to) of a blood clot removal system.
- One example of such implants and one example of use for the blood clot removal system may be heart help pumps. When a person has heart failure, his or her heart can't pump enough blood to meet the body's needs. In some cases, an advanced treatment such as a heart pump may be recommended.
- a heart pump takes over the function of one or both of the heart's lower chambers, with the potential to improve your symptoms and quality of life. Once considered a last resort for prolonging life until a donated heart became available, heart pumps have become a possible long-term treatment for selected people with heart failure.
- a heart pump either takes over or assists the pumping role of the left ventricle - the heart's main pumping chamber.
- Part of the device, such as an electronic pump is implanted in the heart and abdomen, and part, such as an electronic control unit, remains outside your body.
- An energy supply, such as a battery, can be provided either outside the body or be implanted.
- One tube carries blood from the left ventricle of the heart and into the pump. Another tube takes blood pumped from the device into the artery to be circulated throughout the body.
- a heart pump can be a lifesaving treatment.
- the potential risks are serious, including the risk of having blood clots in the arteries leading from the heart.
- An object of the present invention is to provide a device, a system, and a method for removing blood clots in the vascular system of a patient.
- the invention is based on the realization that a blood clot removal device can be implanted in a patient instead of being external of the patient.
- a blood clot removal device for removing blood clots from the vascular system of a patient, the blood clot removal device being implantable in the patient's body and comprising a blood flow passageway, a filter provided in the blood flow passageway for filtering blood clots, and a cleaning device for cleaning the filter.
- a blood flow passageway for filtering blood clots
- a cleaning device for cleaning the filter.
- One possibility is to clean the filter mechanically.
- the cleaning device preferably is adapted to move blood clots away from the blood flow passageway to a place free inside the patient's body, where the body itself will take care of the blood clots.
- a collecting volume such as a bag, is provided for collecting cleaned blood that has been mechanically cleaned from the filter. Most likely such a bag will then be placed inside the body.
- the cleaning device is adapted to slice, push or scratch away any clots from the filter, but the cleaning device can also suck away any clots from the filter.
- the cleaning device comprises a first piston, with preferably is provided with a first recess in an outer end portion thereof to collect blood clots removed from the filter.
- the first piston By providing the first piston with a plurality of channels for accommodating the filter in an extended position of the first piston, it can surround the filter, ensuring essentially complete removal of blood clots therefrom. This is preferably effected if the first piston is movable in a direction perpendicular to the direction of the blood flow passageway.
- the movement of the first piston can be controlled by a source of pressurized air, ensuring rapid acceleration of the first piston and thereby short cleaning cycles.
- the movement of the first piston can alternatively be controlled by an electric motor, a solenoid or the like.
- the filter is of biocompatible material in order to avoid unnecessary interference with the blood environment.
- the blood clot removal device is used in a system comprising a heart pump connected to the blood flow passageway, wherein a first tube preferably connects the heart pump to the left ventricle of the patient's heart and a second tube connects the heart pump connected to the patient's aorta.
- the filter preferably comprises a plurality of strips, which may be equally spaced to form a filter for blood clots.
- the distance between two adjacent strips is preferably less than 2 millimeters, and even more preferably less than 1.0 millimeter. The distance depends on which size blood clots you want to avoid.
- a second piston is provided across the blood flow passageway from the first piston, wherein the second piston is movable in a direction essentially perpendicular to the direction of the blood flow passageway and spring biased in the direction of the first piston. If an outer end portion of the second piston is provided with a second recess, the first piston and the second piston cooperate to catch blood clots for further removal. This further removal can be accomplished by means of a third piston, which is movable in a direction perpendicular to both the direction of the blood flow passageway and the direction of movement of the first piston and of the second piston.
- the blood flow passageway of the blood clot removal device has an essentially square cross-sectional shape, which provides for a laminated flow of the blood, particularly if the square shape is combined with a filter comprising parallel strips.
- the blood clot removal device is in a preferred embodiment insertable in a blood vessel of the patient, preferably via surgery.
- the blood clot removal device can be adapted to be placed in the patient's abdomen or thorax.
- the blood clot removal device is preferably comprised in a system for removing blood clots of a patient.
- This system can comprise a switch, preferably a subcutaneous switch being adapted to manually and non-invasively control any function of the blood clot removal device.
- the system for removing blood clots preferably comprises a hydraulic device having a hydraulic reservoir, wherein the blood clot removal device is adapted to non- invasively be regulated by manually pressing the hydraulic reservoir.
- a wireless remote control can non-invasively regulate any function of the blood clot removal device. Even more important any function of the device may be programmable by such a remote control.
- a wireless energy transmitter can non-invasively energize the blood clot removal device.
- An energy source is preferably adapted to power the blood clot removal device.
- the energy source can comprise an internal energy source, such as an internal energy source adapted to receive energy from an external energy source transmitting energy in a wireless mode. The internal energy source can then be charged from the energy in the wireless mode.
- the system preferably comprises a feedback device for sending information from inside the patient's body to the outside thereof to give feedback information related to at least one functional parameter of the device or a physical parameter of the patient, thereby optimizing the performance of the system.
- One preferred functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
- the system preferably comprises an operation device for operating the blood clot removal device.
- This operation device can comprise a motor or a pump, an electrically powered operation device, a hydraulic operation device, or an electric motor.
- a physical parameter sensor such as a pressure sensor
- An internal control unit can act in response to the physical parameter sensed by the sensor.
- a functional parameter sensor sensing a functional parameter of the blood clot removal device can also be provided.
- An internal control unit acting in response to the functional parameter sensed by the sensor can also be provided.
- a method of using the system for removing blood clots is also provided, wherein at least one function of the blood clot removal device is regulated from outside the patient's body.
- the regulation is in a preferred embodiment non-invasively by manually pressing a subcutaneous switch.
- non- invasively regulation are performed by manually pressing a hydraulic reservoir connected to the blood clot removal device.
- the system for removing blood clots comprises a wireless remote " control, wherein non-invasively regulation is performed using said remote control.
- the system for removing blood clots comprises a wireless energy transmitter, wherein non-invasively regulation is performed using said energy transmitter.
- an energy source is used for powering and adjusting any function of the blood clot removal device.
- the energy source may comprise an internal energy source, which preferably is associated with an external energy source adapted to transmit wireless energy. Energy is preferably transmitted from the external energy source to charge the internal energy source. Feedback information is preferably sent from inside the body to the outside thereof to give feed back related to the functional parameters of the device or physical parameters of the patient. The functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
- wireless energy is transmitted for powering the operation device.
- the method of using a system for removing blood clots comprises the steps of: implanting an implantable source of energy in the patient, providing an external source of energy, controlling the external source of energy to release wireless energy, charging non-invasively the implantable source of energy with the wireless energy, controlling the implantable source of energy from outside the patient's body, and releasing energy for use in connection with operation of the blood clot removal device.
- the wireless energy is preferably stored in the implantable source of energy.
- the method of using a system for removing blood clots comprises the steps of: providing an external source of energy outside the patient's body, and controlling the external source of energy from outside the patient's body to release wireless energy, and using released wireless energy for operating the operation device.
- the wireless energy is preferably transformed into electrical energy inside the patient's body using an implanted energy-transforming device and using the electrical energy when operating the blood clot removal device.
- the electrical energy is used directly in connection with operation of the blood clot removal device, as a transforming device transforms the wireless energy into the electrical energy.
- the external source of energy is controlling from outside the patient's body to release non-magnetic wireless energy, and released non-magnetic wireless energy is used for operating the blood clot removal device.
- the external source of energy is controlled from outside the patient's body to release electromagnetic wireless energy, and released electromagnetic wireless energy is used for operating the blood clot removal device.
- a method for placing a blood clot removal device comprising a surgical method via a laparoscopic abdominal approach, comprises the steps of: inserting a needle or tube like instrument into the abdomen of the patient's body, using the needle or tube like instrument to fill the patient's abdomen with gas thereby expanding the patient's abdominal cavity, placing at least two laparoscopic trocars in the patient's body, inserting a camera through one of the trocars into the patient's abdomen, inserting at least one dissecting tool through a trocar and dissecting the intended placement area of the patient, placing at least one blood clot removal device in any part of the vascular system in the abdomen, moving blood clots away from the vascular system post operatively to a different part of the body, and powering the device with a source of energy.
- the blood clots can be moved either to a place that is free in the abdomen, to a place that is free in the abdomen, or to a place that is encapsulated in a closed bag in the abdomen
- the blood clot removal device is preferably programmable from outside the patients body. By adding the steps of sensing a physical parameter of the patient or a functional parameter of the device, and sending sensing information to an internal control unit adapted for regulating said blood clot removal device, performance is improved.
- a method of placing a blood clot removal device comprising a surgical method via a laparoscopic thoraxial approach, comprises the steps of: inserting a needle or tube like instrument into the thorax of the patients body, using the needle or tube like instrument to fill the thorax with gas thereby expanding the thoraxical cavity, placing at least two laparoscopic trocars in the patient's body, inserting a camera through one of the trocars into the thorax, inserting at least one dissecting tool through a trocar and dissecting the intended area of the patient, placing at least one blood clot removal device in any part of the vascular system in the thorax, moving blood clots away from vascular system post operatively to a different part of the body, and powering the device with a source of energy.
- the blood clots can be moved either to a place that is free in the thorax, to a place that is free in the abdomen, or to a place that is encapsulated in
- the device is preferably programmed from outside the body of the patient.
- a method for surgically treating a patient needing a blood clot removal device in the vascular system in the patient's abdomen comprises the steps of: cutting an opening in the patient's abdominal wall, dissecting an area of the vascular system, placing a blood clot removal device inside the vascular system, and suturing said abdominal wall.
- blood clots are moved away from the vascular system into an encapsulated closed bag in the patient's abdomen by means of the blood clot removal device.
- blood clots are moved to the free abdomen.
- a method for surgically treating a patient needing a blood clot removal device in the vascular system in the thorax comprises the steps of: cutting an opening in the thorax wall, dissecting the area of the vascular system, placing a blood clot removal device inside the vascular system, and suturing said thorax wall.
- a step of moving blood clots away from the vascular system can comprise moving blood clots either to a place that is free in the thorax, to a place that is free in the abdomen, or to a place that is encapsulated in a closed bag in the thorax
- a method using an system for removing blood clots, for postoperatively and non- invasively regulating the blood clot removal device comprises the steps of: moving any blood clots, which have been accumulated in the vascular system of the patient's body, away from the vascular system, and placing the blood clots outside the vascular system. This can be accomplished by an energy source, preferably repeatedly according to a pre-programmed time-schedule.
- the steps of moving any blood clots away from the vascular system and placing the blood clots outside the vascular system are preferably repeated and at least partly controlled by an internal control unit getting input from a sensor sensing any physical parameter of the patient or any functional parameter of the device.
- An operation method for surgically placing a blood clot removal device comprises the steps of: cutting the patient's skin, dissecting a placement area where to place the blood clot removal device inside the vascular system in the abdomen or thorax or retroperitoneal or subcutaneously or any limb of the patient, placing the blood clot removal device in the placement area, removing, postoperatively and non-invasively without penetrating the patent's skin, any blood clots from the vascular system to outside thereof, and using energy from an energy source without any penetration through the patient's skin to power the blood clot removal device.
- Fig. 1 is an overview of the body of a patient having an implanted heart pump.
- Fig. 2 is a sectional view of a clot removal device according to the invention.
- Fig. 3 is a cross sectional view of the clot removal device of Fig. 2 taken along the line III-III before a cleaning operation.
- Fig. 4 is a sectional view of the clot removal device of Fig. 2 taken along the line IV-IV.
- Fig. 5 is a sectional view similar to that of Fig. 2 showing blood clots before a clot removal operation.
- Fig. 6 is a sectional view similar to that of Fig. 2 during a first step of a clot removal operation.
- Fig. 7 is a sectional view similar to that of Fig. 2 during a second step of a clot removal operation.
- Fig. 8 is a sectional view similar to that of Fig. 2 during a third step of a clot removal operation.
- Fig. 9 is a cross sectional view similar to that of Fig. 3 but during a cleaning operation.
- Fig. 10 is a sectional view of the clot removal device of Fig. 8 taken along the line X-X showing a clot ejection piston before ejection of clots.
- Fig. 11 is a view similar to that of Fig. 9 but after ejection of clots.
- Fig. 12 is an overall view of a clot removal system according to the invention.
- Fig. 13 is a schematic diagram of the system of Fig. 12.
- Figs. 14-29 show various embodiments based on the system of Fig. 13.
- Figs. 30a and 30b are views of a filter cassette.
- Figs. 31a and 3 Ib are views of a filter cassette.
- Fig.l shows a patient 1 having an implanted heart pump 2.
- the implanted heart pump 2 is connected to the left ventricle 3a of the patient's heart 3 by means of a first tube 2a.
- the heart pump 2 is also connected to the aorta, generally designated 4, of the patient 1 by means of a second tube 2b. In this way, during operation the heart pump supplements or replaces the blood pumping operation of the patient's heart 3.
- a blood clot removal device 10 is shown provided in the second tube 2b of the heart pump 2, i.e., in the tube leading to the aorta 4 of the patient 1. This means that part of the blood flow passageway provided by the second tube 2b is replaced by a blood flow passageway in the blood clot removal device 10.
- the blood clot removal device 10 is thus an artificial device insertable in an artificial blood vessel of the patient.
- the function of the clot removal device is to remove any blood clots in the blood transported by the second tube 2b. These blood clots are preferably moved to a place free inside the body of the patient.
- a collecting volume such as a bag 10a connected to the blood clot removal device 10 for subsequent removal or storage.
- a preferred storage capacity of the bag 10a can be more than 100 milliliters, for example.
- the blood clot removal device is an artificial device but could be inserted directly into a blood vessel of the patient or connected between two ends of a blood vessel.
- the clot removal device is preferably insertable in a blood flow passageway of the patient via surgery and is placed in the patient's abdomen or thorax or cephalic or neck region or retroperitoneal or any limb of the patient.
- Fig. 2 shows a sectional view wherein the blood clot removal device 10 is provided in the blood flow passageway provided by the second tube 2b.
- a filter 12 is provided across the blood flow passageway 14 formed in a housing 11 with the function of stopping potential blood clots brought forward in the second tube 2b by the blood flow, indicated by arrows in the figure.
- the filter 12 comprises a plurality of preferably equally spaced strips 12a of some suitable material, such as biocompatible metal or plastic. These strips 12a are preferably arranged mutual parallel.
- the distance between two adjacent strips is small enough to stop any blood clots.
- the distance is preferably less than 2 millimeters, and even more preferably less than 1.0 millimeters, but if the goal is to protect the brain from larger clots only the distance could be larger.
- the blood flow passageway 14 in the preferred embodiment has an essentially square cross-sectional shape, it will be realized that it can take any suitable shape, such as rectangular or circular.
- a laminar blood flow is achieved downstream of the filter, which is advantageous in a blood clot preventing perspective.
- the blood flow configuration can be further enhanced by giving the plurality of strips 12a a desired cross-sectional shape, although the rectangular shape shown in Fig. 4 will be adequate for most purposes.
- a first piston 16 is provided movable in a direction essentially perpendicular to the direction of the blood flow passageway 14, i.e., essentially perpendicular to the direction of the blood flow.
- This first piston 16 is driven by some suitable actuator means, such as pressurized air, a solenoid arrangement, an electrical servo motor or the like.
- a motor could be used to build up a stored power that could be released very fast, one example being a spring.
- pressurized air acts as the actuator means, since by latching the piston by means of a suitable latching means for the piston, building up the air pressure, and subsequently releasing the piston, very high speed of the piston is achieved, with enables short cleaning times of the filter.
- the outer end portion of the first piston 16, i.e., the end portion facing the blood flow passageway 14, is essentially flush with the wall of the blood flow passageway in a non-active state of the blood clot removal device 10. Also, the outer end portion is provided with a concave portion or recess 16a (exaggerated in the figures) in order to act as a blood clot capturing means, as will be explained below.
- the strike range of the first piston 16 is such that it extends all way across the blood flow passageway 14, as will be explained below with reference to Figs. 5-8.
- a number of channels 16b corresponding to the number of strips 12a is provided in the first piston 16 to accommodate the strips when the first piston is in an extended position.
- the first piston 16 is also provided with a plurality of through holes 17 in the direction of the blood flow passageway. These through holes will allow blood to flow through the blood flow passageway also during a cleaning operation, as will be explained below with reference to Fig. 9.
- a second piston 18 is provided across the blood flow passageway 14 from the first piston 16. Also this second piston 18 is movable in a direction essentially perpendicular to the direction of the blood flow passageway 14 and is biased in the direction thereof by means of a spring 18a, for example. Likewise, the outer end portion of the second piston is provided with a recess 18b similar to the recess 16a of the first piston 16.
- the first and second pistons 16, 18, are sealed to the housing 11 by means of a respective sealing 20, such as an O sealing.
- FIG. 5 is a view similar to that of Fig. 2. However, this figures shows the blood clot removal device 10 during operation, wherein blood clots, generally designated 22, have assembled on the filter 12.
- the first piston 16 has moved linearly from the retracted starting position shown Fig. 5 to an extended position, wherein the outer end portion thereof is in contact with the second piston 18. Due to the recess 16a in the outer end of the first piston 16, the blood clots 22 have been assembled in the recess 16a, whereby they have been brought with the first piston 16 during the movement thereof. In the step shown in Fig. 6, the blood clots are confined in the recess 16a between the first and second pistons 16, 18.
- the second piston 18 By moving the first piston 16 an additional distance from the position shown in Fig. 6, the second piston 18 is pushed against the force of the spring 18a to a fully retracted position, see Fig. 7.
- the plurality of strips 12a is in this position fully received in a respective channel 16b in the first piston. It is seen that the outer ends of the first and second pistons define an unobstructed cavity in which the blood clots are confined. It is thereby possible to remove these by some suitable means.
- One such means could be a third piston 24, which is movable in a direction perpendicular to both the direction of the blood flow passageway 14 and the direction of movement of the first and second pistons 16, 18.
- This third piston scrapes off the blood clots collected by the first piston 16 and moves them to a place outside of the blood clot removal device 10 and the blood flow passageway 14.
- Fig. 9 shows a side view of the first piston 16 in a fully extended position, i.e., corresponding to the view of Fig. 8. It is here seen that in this position the through holes 17 will be aligned with the blood flow passageway 14, thereby allowing blood to flow therethrough also during cleaning of the filter 12.
- Fig. 10 shows a cross-sectional view taken along line X-X of Fig. 8. It is here seen that the third piston 24 collects the blood clots 22 during a downward movement, indicated by an arrow in the figure. The clots are ejected from the blood clot removal device 10 when the third piston 24 has reached its lower end position, shown in Fig. 11.
- pressurized air can be used for ejecting the collected blood clots from the cavity formed by the first piston 16 and the second piston 18.
- a clot removal system generally designated 28 and comprising a clot removal device as described above will now be described with reference to Figs. 12-25.
- the system of Fig. 12 comprises a blood clot removal device 10 placed in the abdomen of the patient.
- An internal energy source in the form of an implanted energy transforming device 30 is adapted to supply energy consuming components of the blood clot removal device 10 with energy via a power supply line 32.
- An external energy transmission device 34 includes a wireless remote control transmitting a wireless signal, which is received by a signal receiver incorporated in the implanted energy transforming device 30.
- the implanted energy transforming device 30 transforms energy from the signal into electric energy which is supplied via the power supply line 32.
- Fig. 12 The system of Fig. 12 is shown in a more generalized block diagram form in Fig. 13, wherein the patient's skin 36, generally shown by a vertical line, separates the interior of the patient to the right of the line from the exterior to the left of the line.
- Fig. 14 shows an embodiment of the invention identical to that of Fig. 13, except that a reversing device in the form of an electric switch 38 operable by polarized energy also is implanted in the patient for reversing the blood clot removal device 10.
- the wireless remote control of the external energy transmission device 34 transmits a wireless signal that carries polarized energy and the implanted energy transforming device 30 transforms the wireless polarized energy into a polarized current for operating the electric switch 38.
- the electric switch 38 reverses the function performed by the blood clot removal device 10.
- Fig. 15 shows an embodiment of the invention identical to that of Fig. 13, except that an operation device 40 implanted in the patient for regulating the blood clot removal device 10 is provided between the implanted energy transforming device 30 and the blood clot removal device 10.
- This operation device can be in the form of a motor 40, such as an electric servo motor.
- the motor 40 is powered with energy from the implanted energy transforming device 30, as the remote control of the external energy transmission device 34 transmits a wireless signal to the receiver of the implanted energy transforming device 30.
- Fig. 16 shows an embodiment of the invention identical to that of Fig. 13, except that it also comprises an operation device is in the form of an assembly 42 including a motor/pump unit 78 and a fluid reservoir 46 is implanted in the patient.
- the blood clot removal device 10 is hydraulically operated, i.e. hydraulic fluid is pumped by the motor/pump unit 44 from the fluid reservoir 46 through a conduit 48 to the blood clot removal device 10 to operate the clot removal device, and hydraulic fluid is pumped by the motor/pump unit 44 back from the blood clot removal device 10 to the fluid reservoir 46 to return the clot removal device to a starting position.
- the implanted energy transforming device 30 transforms wireless energy into a current, for example a polarized current, for powering the motor/pump unit 44 via an electric power supply line 50.
- the operation device comprises a pneumatic operation device.
- pressurized air can be used for regulation and the fluid reservoir is replaced by an air chamber and the fluid is replaced by air.
- Fig. 17 shows an embodiment of the invention comprising the external energy transmission device 34 with its wireless remote control, the blood clot removal device 10, in this case hydraulically operated, and the implanted energy transforming device 30, and further comprising a hydraulic fluid reservoir 52, a motor/pump unit 44 and an reversing device in the form of a hydraulic valve shifting device 54, all implanted in the patient.
- the motor of the motor/pump unit 44 is an electric motor.
- the implanted energy transforming device 30 powers the motor/pump unit 44 with energy from the energy carried by the control signal, whereby the motor/pump unit 44 distributes hydraulic fluid between the hydraulic fluid reservoir 52 and the blood clot removal device 10.
- the remote control of the external energy transmission device 34 controls the hydraulic valve shifting device 54 to shift the hydraulic fluid flow direction between one direction in which the fluid is pumped by the motor/pump unit 44 from the hydraulic fluid reservoir 52 to the blood clot removal device 10 to operate the clot removal device, and another opposite direction in which the fluid is pumped by the motor/pump unit 44 back from the blood clot removal device 10 to the hydraulic fluid reservoir 52 to return the clot removal device to a starting position.
- Fig. 18 shows an embodiment of the invention identical to that of Fig. 13, except that an internal control unit 56 controlled by the wireless remote control of the external energy transmission device 34, an accumulator 58 and a capacitor 60 also are implanted in the patient.
- the internal control unit 56 arranges storage of electric energy received from the implanted energy transforming device 30 in the accumulator 58, which supplies energy to the blood clot removal device 10.
- the internal control unit 56 In response to a control signal from the wireless remote control of the external energy transmission device 34, the internal control unit 56 either releases electric energy from the accumulator 58 and transforms the released energy via power lines 62 and 64, or directly transforms electric energy from the implanted energy transforming device 30 via a power line 66, the capacitor 60, which stabilizes the electric current, a power line 68 and the power line 64, for the operation of the blood clot removal device 10.
- the internal control unit is preferably programmable from outside the patient's body. In a preferred embodiment, the internal control unit is programmed to regulate the blood clot removal device 10 to remove any blood clots from the vascular system and place the blood clots outside the vascular system repeatedly according to a pre- programmed time-schedule.
- the capacitor 60 in the embodiment of Fig. 18 may be omitted.
- the accumulator 58 in this embodiment may be omitted.
- Fig. 19 shows an embodiment of the invention identical to that of Fig. 13, except that a battery 70 for supplying energy for the operation of the blood clot removal device 10 and an electric switch 72 for switching the operation of the blood clot removal device 10 also are implanted in the patient.
- the electric switch 72 is operated by the energy supplied by the implanted energy transforming device 30 to switch from an off mode, in which the battery 70 is not in use, to an on mode, in which the battery 70 supplies energy for the operation of the blood clot removal device 10.
- Fig. 20 shows an embodiment of the invention identical to that of Fig. 19, except that an internal control unit 56 controllable by the wireless remote control of the external energy transmission device 34 also is implanted in the patient.
- the electric switch 72 is operated by the energy supplied by the implanted energy transforming device 30 to switch from an off mode, in which the wireless remote control is prevented from controlling the internal control unit 56 and the battery is not in use, to a standby mode, in which the remote control is permitted to control the internal control unit 56 to release electric energy from the battery 70 for the operation of the blood clot removal device 10.
- Fig. 21 shows an embodiment of the invention identical to that of Fig. 20, except that an accumulator 58 is substituted for the battery 70 and the implanted components are interconnected differently.
- the accumulator 58 stores energy from the implanted energy transforming device 30.
- the internal control unit 56 controls the electric switch 72 to switch from an off mode, in which the accumulator 58 is not in use, to an on mode, in which the accumulator 58 supplies energy for the operation of the blood clot removal device 10.
- Fig. 22 shows an embodiment of the invention identical to that of Fig. 21, except that a battery 70 also is implanted in the patient and the implanted components are interconnected differently.
- the internal control unit 56 controls the accumulator 58 to deliver energy for operating the electric switch 72 to switch from an off mode, in which the battery 70 is not in use, to an on mode, in which the battery 70 supplies electric energy for the operation of the blood clot removal device 10.
- the electric switch 72 may be operated by energy supplied by the accumulator 58 to switch from an off mode, in which the wireless remote control is prevented from controlling the battery 70 to supply electric energy and is not in use, to a standby mode, in which the wireless remote control is permitted to control the battery 70 to supply electric energy for the operation of the blood clot removal device 10.
- Fig. 23 shows an embodiment of the invention identical to that of Fig. 19, except that a motor 40, a mechanical reversing device in the form of a gear box 74, and an internal control unit 56 for controlling the gear box 74 also are implanted in the patient.
- the internal control unit 56 controls the gear box 74 to reverse the function performed by the blood clot removal device 10 (mechanically operated).
- Fig. 24 shows an embodiment of the invention identical to that of Fig. 22 except that the implanted components are interconnected differently.
- the internal control unit 56 is powered by the battery 70 when the accumulator 58, suitably a capacitor, activates the electric switch 72 to switch to an on mode.
- the electric switch 72 is in its on mode the internal control unit 56 is permitted to control the battery 70 to supply, or not supply, energy for the operation of the blood clot removal device 10.
- Fig. 25 schematically shows conceivable combinations of implanted components of the apparatus for achieving various communication options. Basically, there are the blood clot removal device 10, the internal control unit 56, motor/pump unit 44, and the external energy transmission device 34 including the external wireless remote control. As already described above the wireless remote control transmits a control signal which is received by the internal control unit 56, which in turn controls the various implanted components of the apparatus.
- a feedback device preferably in the form of a sensor 76, may be implanted in the patient for sensing a physical parameter of the patient, such as the pressure in a blood vessel.
- the internal control unit 56 or alternatively the external wireless remote control of the external energy transmission device 34, may control the blood clot removal device 10 in response to signals from the sensor 76.
- a transceiver may be combined with the sensor 76 for sending information on the sensed physical parameter to the external wireless remote control.
- the wireless remote control may comprise a signal transmitter or transceiver and the internal control unit 56 may comprise a signal receiver or transceiver.
- the wireless remote control may comprise a signal receiver or transceiver and the internal control unit 56 may comprise a signal transmitter or transceiver.
- the above transceivers, transmitters and receivers may be used for sending information or data related to the blood clot removal device 10 from inside the patient's body to the outside thereof.
- the senor 76 may be arranged to sense a functional parameter of the blood clot removal device 10.
- the battery 70 may be equipped with a transceiver for sending information on the condition of the battery 70.
- Fig. 26 shows an alternative embodiment wherein the blood clot removal device 10 is regulated from outside the patient's body.
- the clot removal system 28 comprises a blood clot removal device 10 connected to a battery 70 via a subcutaneous switch 80.
- the regulation of the blood clot removal device 10 is performed non-invasively by manually pressing the subcutaneous switch, whereby the operation of the blood clot removal device 10 is switched on and off.
- the shown embodiment is a simplification and that additional components, such as an internal control unit, can be added to the clot removal system.
- Fig. 27 shows an alternative embodiment, wherein the clot removal system 28 comprises a blood clot removal device 10 in fluid connection with a hydraulic fluid reservoir 52.
- Non-invasive regulation is performed by manually pressing the hydraulic reservoir connected to the blood clot removal device 10.
- a further embodiment of a system according to the invention comprises a feedback device for sending information from inside the patient's body to the outside thereof to give feedback information related to at least one functional parameter of the clot removal device or system or a physical parameter of the patient, thereby optimizing the performance of the system.
- One preferred functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
- FIG. 28 an arrangement is schematically illustrated for supplying an accurate amount of energy to a clot removal system 28 implanted in a patient, whose skin 36 is indicated by a vertical line.
- a blood clot removal device 10 is connected to an implanted energy transforming device 30, likewise located inside the patient, preferably just beneath the patient's skin 36.
- the implanted energy transforming device 30 may be placed in the abdomen, thorax, muscle fascia (e.g. in the abdominal wall), subcutaneously, or at any other suitable location.
- the the implanted energy transforming device 30 is adapted to receive wireless energy E transmitted from an external energy source 34a provided in the external energy transmission device 34 located outside the patient's skin 36 in the vicinity of the implanted energy transforming device 30.
- the wireless energy E may generally be transferred by means of any suitable Transcutaneous Energy Transfer (TET) device, such as a device including a primary coil arranged in the external energy source 34a and an adjacent secondary coil arranged in the implanted energy transforming device 30.
- TET Transcutaneous Energy Transfer
- a clot removal device e.g. after storing the incoming energy in an energy storing device or accumulator, such as a battery or a capacitor.
- the present invention is generally not limited to any particular energy transfer technique, TET devices or energy storing devices, and any kind of wireless energy may be used.
- the amount of transferred energy can be regulated by means of an external control unit 34b controlling the external energy source 34a based on the determined energy balance, as described above.
- the energy balance and the required amount of energy can be determined by means of an internal control unit 56 connected to the blood clot removal device 10.
- the internal control unit 56 may thus be arranged to receive various measurements obtained by suitable sensors or the like, not shown, measuring certain characteristics of the blood clot removal device 10, somehow reflecting the required amount of energy needed for proper operation of the blood clot removal device 10.
- the current condition of the patient may also be detected by means of suitable measuring devices or sensors, in order to provide parameters reflecting the patient's condition.
- Such characteristics and/or parameters may be related to the current state of the blood clot removal device 10, such as power consumption, operational mode and temperature, as well as the patient's condition reflected by, e.g., body temperature, blood pressure, heartbeats and breathing.
- an energy storing device or accumulator 58 may optionally be connected to the implanted energy transforming device 30 for accumulating received energy for later use by the blood clot removal device 10.
- characteristics of such an accumulator also reflecting the required amount of energy, may be measured as well.
- the accumulator may be replaced by a battery, and the measured characteristics may be related to the current state of the battery, such as voltage, temperature, etc. In order to provide sufficient voltage and current to the blood clot removal device 10, and also to avoid excessive heating, it is clearly understood that the battery should be charged optimally by receiving a correct amount of energy from the implanted energy transforming device 30, i.e. not too little or too much.
- the accumulator may also be a capacitor with corresponding characteristics.
- battery characteristics may be measured on a regular basis to determine the current state of the battery, which then may be stored as state information in a suitable storage means in the internal control unit 56.
- state information in a suitable storage means in the internal control unit 56.
- the internal control unit 56 is adapted to determine the energy balance and/or the currently required amount of energy, (either energy per time unit or accumulated energy) based on measurements made by the above-mentioned sensors or measuring devices on the blood clot removal device 10, or the patient, or an energy storing device if used, or any combination thereof.
- the internal control unit 56 is further connected to an internal signal transmitter 82, arranged to transmit a control signal reflecting the determined required amount of energy, to an external signal receiver 34c connected to the external control unit 34b. The amount of energy transmitted from the external energy source 34a may then be regulated in response to the received control signal.
- sensor measurements can be transmitted directly to the external control unit 34b wherein the energy balance and/or the currently required amount of energy can be determined by the external control unit 34b, thus integrating the above- described function of the internal control unit 56 in the external control unit 34b.
- the internal control unit 56 can be omitted and the sensor measurements are supplied directly to the internal signal transmitter 82 which sends the measurements over to the external signal receiver 34c and the external control unit 34b. The energy balance and the currently required amount of energy can then be determined by the external control unit 34b based on those sensor measurements.
- the present solution employs the feed back of information indicating the required energy, which is more efficient than previous solutions because it is based on the actual use of energy that is compared to the received energy, e.g. with respect to the amount of energy, the energy difference, or the energy receiving rate as compared to the energy rate used by the clot removal device.
- the clot removal device may use the received energy either for consuming or for storing the energy in an energy storage device or the like.
- the different parameters discussed above would thus be used if relevant and needed and then as a tool for determining the actual energy balance. However, such parameters may also be needed per se for any actions taken internally to specifically operate the clot removal device.
- the internal signal transmitter 82 and the external signal receiver 34c may be implemented as separate units using suitable signal transfer means, such as radio, IR (Infrared) or ultrasonic signals.
- suitable signal transfer means such as radio, IR (Infrared) or ultrasonic signals.
- the internal signal transmitter 82 and the external signal receiver 34c may be integrated in the implanted energy transforming device 30 and the external energy source 34a, respectively, so as to convey control signals in a reverse direction relative to the energy transfer, basically using the same transmission technique.
- the control signals may be modulated with respect to frequency, phase or amplitude.
- the energy supply arrangement illustrated in Fig. 28 may operate basically in the following manner.
- the energy balance is first determined by the internal control unit 56.
- a control signal reflecting the required amount of energy is also created by the internal control unit 56, and the control signal is transmitted from the internal signal transmitter 82 to the external signal receiver 34c.
- the energy balance can be determined by the external control unit 34b instead depending on the implementation, as mentioned above.
- the control signal may carry measurement results from various sensors.
- the amount of energy emitted from the external energy source 34a can then be regulated by the external control unit 34b, based on the determined energy balance, e.g. in response to the received control signal. This process may be repeated intermittently at certain intervals during ongoing energy transfer, or may be executed on a more or less continuous basis during the energy transfer.
- the amount of transferred energy can generally be regulated by adjusting various transmission parameters in the external energy source 34a, such as voltage, current, amplitude, wave frequency and pulse characteristics.
- a method is thus provided for controlling transmission of wireless energy supplied to an electrically operable clot removal device implanted in a patient.
- the wireless energy E is transmitted from an external energy source located outside the patient and is received by an internal energy receiver located inside the patient, the internal energy receiver being connected to the clot removal device for directly or indirectly supplying received energy thereto.
- An energy balance is determined between the energy received by the internal energy receiver and the energy used for the clot removal device.
- the transmission of wireless energy E from the external energy source is then controlled based on the determined energy balance.
- a system for controlling transmission of wireless energy supplied to an electrically operable clot removal device implanted in a patient.
- the system is adapted to transmit the wireless energy E from an external energy source located outside the patient which is received by an implanted energy transforming device located inside the patient, the implanted energy transforming device being connected to the clot removal device for directly or indirectly supplying received energy thereto.
- the system is further adapted to determine an energy balance between the energy received by the implanted energy transforming device and the energy used for the clot removal device, and control the transmission of wireless energy E from the external energy source, based on the determined energy balance.
- the functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
- the external source of energy is controlled from outside the patient's body to release electromagnetic wireless energy, and released electromagnetic wireless energy is used for operating the blood clot removal device.
- the external source of energy is controlling from outside the patient's body to release non-magnetic wireless energy, and released non-magnetic wireless energy is used for operating the blood clot removal device.
- Figs. 13-29 could be combined in many different ways.
- the electric switch 38 operated polarized energy could be incorporated in any of the embodiments of Figs. 15, 18-24
- the hydraulic valve shifting device 54 could be incorporated in the embodiment of Fig. 16
- the gear box 74 could be incorporated in the embodiment of Fig. 15.
- FIG. 29 wherein an external switch 84 is interconnected between the external energy source 34a and an operation device, such as an electric motor regulating the blood clot removal device 10, by means of power lines 86 and 88.
- An external control unit 34b controls the operation of the external switch to effect proper operation of the blood clot removal device 10.
- the clot removal device can be placed surgically in the patient via a laparoscopic abdominal approach.
- a tube is inserted into the abdomen of the patient's body and this tube is used to fill the patient's abdomen with gas, thereby expanding the patient's abdominal cavity.
- At least two laparoscopic trocars are then placed in the patient's body, where after a camera is inserted through one of the trocars into the patient's abdomen.
- At least one dissecting tool is inserted through a trocar and dissection is performed at two intended areas of the patient.
- a clot removal device is placed in any part of the vascular system in the abdomen.
- the clot removal device can be placed in the patient's thorax.
- a tube is inserted into the thorax of the patient's body and this tube is used to fill the patient's thorax with gas, thereby expanding the patient's thoraxical cavity.
- At least two laparoscopic trocars are then placed in the patient's body, where after a camera is inserted through one of the trocars into the patient's thorax.
- At least one dissecting tool is inserted through a trocar and dissection is performed at two intended areas of the patient.
- a clot removal device is placed in any part of the vascular system in the thorax.
- An operation method for surgically placing a clot removal device starts with cutting the patient's skin and dissecting a placement area where to place the clot removal device inside the vascular system in the abdomen or thorax or retroperitoneal or subcutaneously or any limb of the patient. When a suitable place has been found, the clot removal device is placed in the placement area.
- the clot removal device can then be used postoperatively and non-invasively without penetrating the patent's skin for removing any blood clots from the vascular system to outside thereof, while using energy from an energy source without any penetration through the patient's skin to power the blood clot removal device.
- a method for surgically treating a patient needing a blood clot removal device in the vascular system in the patient's abdomen preferably comprises cutting an opening in the patient's abdominal wall and then dissecting an area of the vascular system.
- a clot removal device is placed inside the vascular system, and the abdominal wall is sutured.
- blood clots are moved away from the vascular system into an encapsulated closed bag in the patient's abdomen by means of the blood clot removal device.
- blood clots are moved to the free abdomen.
- a method for surgically treating a patient needing a blood clot removal device in the vascular system in the thorax comprises cutting an opening in the thorax wall and then dissecting the area of the vascular system.
- a clot removal device is placed inside the vascular system, and the thorax wall is sutured.
- a step of moving blood clots away from the vascular system can comprise moving blood clots either to a place that is free in the thorax, to a place that is free in the abdomen, or to a place that is encapsulated in a closed bag in the thorax.
- a method of using a system for removing blood clots comprises implanting an implantable source of energy, such as an implanted energy transforming device 30 and an accumulator 58, in the patient.
- An external source of energy such as an external energy transmission device 34, is provided for providing energy to the system.
- This external source of energy is operated to release wireless energy, thereby non-invasively charging the implantable source of energy with the wireless energy, while controlling the implantable source of energy from outside the patient's body.
- energy is releasing.
- the wireless energy is preferably stored in the implantable source of energy.
- the system for removing blood clots postoperatively and non- invasively regulates the clot removal device.
- Any blood clots which have been accumulated in the vascular system of the patient's body, are moved away from the vascular system and are then placed outside the vascular system. This can be accomplished by an energy source, preferably repeatedly according to a preprogrammed time-schedule.
- the movement of any blood clots away from the vascular system and placement of the blood clots outside the vascular system are preferably repeated and at least partly controlled by an internal control unit getting input from a sensor sensing any physical parameter of the patient or any functional parameter of the device.
- the blood clot removal device has been described as an artificial device insertable in an artificial blood vessel of the patient.
- the blood clot removal device is an artificial device adapted to be placed between two open ends of a blood vessel of the patient or be placed inside or attached to a blood vessel via surgery.
- the blood clot removal device has been described to be placed in the patient's abdomen or thorax. It could also be adapted to be placed in the patient's retroperitoneal region or cephalic or neck region or any limb of the patient.
- the filter in the blood clot removal device may be exchanged and replaced with a new fresh filter when it becomes dirty.
- a new fresh filter when it becomes dirty.
- a cassette 127 for holding filters is shown.
- the cassette 27 comprises a revolving cylinder 129 having segments 130 each holding a filter.
- the cylinder 129 is tightly sealed between two supports 131 holding the cylinder 129 in place and providing a tight sealing.
- Preferable are the contacting surfaces made of ceramics to seal the surfaces with fine tolerances.
- the blood flow passageway of an implantable blood clot removal apparatus passes through the cassette 127.
- the cassette is driven by a motor 133 causing the cylinder 129 to revolve at suitable times.
- the filter is designed to move any collected blood clots out from the blood flow passageway together with revolving filter, when the filter leaves the blood flow passageway to be replaced with a new filter.
- the filter may be any kind of filter preferable with a space for the collected blood clots or blood clots adherent to the filter itself. Such a space to both the sealing plates when rotating, should preferable be larger before the filter seen in the blood flow passageway.
- the motor is powered by a power supply 123b.
- the power supply can be a power supply like the power supplies 123 or 123 a.
- the power supplies 123, 123 a and 123b is the one and same power supply.
- the power supply 123b can receive wireless energy in a suitable form, including but not limited to inductive energy ultrasonic energy, light energy or any other form of wireless energy set out above.
- the energy is supplied by an external wireless energy transmitter 6 adapted to transmit energy through the skin 5 of a patient having the cassette 127 implanted.
- the power supply 132b can also comprise a control unit as described above for controlling the revolving cassette 127.
- the control unit can provide feedback to the outside and receive input data from an external transceiver 7 in a manner similar to the control unit used in conjunction with control of the pump.
- Fig. 30b the cassette 127 is shown from the side with the supports 131 and the revolving cylinder spaced apart is a disassembled view.
- Fig. 31a an alternative embodiment of the cassette 127 is shown.
- the view in Fig. 30a is similar to the view in Fig. 31a.
- a magazine 135 having a number of cylinders 129 stored therein is provided.
- a cylinder 129 can by replaced by shifting the cylinders in the magazine 135.
- the cylinders are shifted by pressurized air or a motor.
- the filter is then first replaced in the blood flow passageway and thereafter in a position outside the blood flow passageway replaced in the cassette.
- Such a replacement could preferable take place by having a number of filters in the cylinder 135 on one side of the cassette marked with 135 and moving the dirty filters out from the cassette into the cylinder on the other side of the cassette.
- the cylinder 135 is instead a cleaning device adapted to clean the filter at a position outside the blood flow passageway.
- Fig. 31b the cassette 127 is shown from the side with the supports 131 and the revolving cylinder spaced apart is a disassembled view.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- External Artificial Organs (AREA)
Abstract
A blood clot removal device for removing blood clots from the vascular system of a patient is implantable in the patient's body. The blood clot removal device comprises a blood flow passageway, a filter provided in the blood flow passageway for filtering blood clots, and a cleaning device for cleaning the filter. By means of such blood clot removal device and system, the risk of blood clots reaching sensitive areas of the patient's body, such as the brain, is reduced.
Description
BLOOD CLOT REMOVAL DEVICE, SYSTEM, AND METHOD
FIELD OF INVENTION
The present invention relates generally to a device and a system implantable in a blood flow passageway of a human or mammal patient for removing blood clots, and more particularly to a system for removing blood clots in a vascular system of the patient, one example being a heart pump system. The invention also relates to a method of removing blood clots.
BACKGROUND Today many implants are provided where the blood comes into contact with foreign material. All such implants have an associated risk of triggering blood clots. Such clots may become loose and may create severe damages at other parts of the body. Blood clots reaching the brain are the most dangerous ones and implants in the heart region may therefore be a first priority (although not limited to) of a blood clot removal system. One example of such implants and one example of use for the blood clot removal system may be heart help pumps. When a person has heart failure, his or her heart can't pump enough blood to meet the body's needs. In some cases, an advanced treatment such as a heart pump may be recommended. A heart pump takes over the function of one or both of the heart's lower chambers, with the potential to improve your symptoms and quality of life. Once considered a last resort for prolonging life until a donated heart became available, heart pumps have become a possible long-term treatment for selected people with heart failure.
A heart pump either takes over or assists the pumping role of the left ventricle - the heart's main pumping chamber. Part of the device, such as an electronic pump, is implanted in the heart and abdomen, and part, such as an electronic control unit, remains outside your body. An energy supply, such as a battery, can be provided either outside the body or be implanted.
One tube carries blood from the left ventricle of the heart and into the pump. Another tube takes blood pumped from the device into the artery to be circulated throughout the body.
A heart pump can be a lifesaving treatment. However, the potential risks are serious, including the risk of having blood clots in the arteries leading from the heart.
Many other implants may be used together with the blood clot removal system. Basically any implant in contact with blood may be targets for the invention.
SUMMARY OF THE INVENTION
An object of the present invention is to provide a device, a system, and a method for removing blood clots in the vascular system of a patient.
The invention is based on the realization that a blood clot removal device can be implanted in a patient instead of being external of the patient.
According to a first aspect of the present invention there is provided a blood clot removal device for removing blood clots from the vascular system of a patient, the blood clot removal device being implantable in the patient's body and comprising a blood flow passageway, a filter provided in the blood flow passageway for filtering blood clots, and a cleaning device for cleaning the filter. One possibility is to clean the filter mechanically.
The cleaning device preferably is adapted to move blood clots away from the blood flow passageway to a place free inside the patient's body, where the body itself will take care of the blood clots. Alternatively, a collecting volume, such as a bag, is provided for collecting cleaned blood that has been mechanically cleaned from the filter. Most likely such a bag will then be placed inside the body.
In a preferred embodiment, the cleaning device is adapted to slice, push or scratch away any clots from the filter, but the cleaning device can also suck away any clots from the filter.
In one embodiment, the cleaning device comprises a first piston, with preferably is provided with a first recess in an outer end portion thereof to collect blood clots removed from the filter. By providing the first piston with a plurality of channels for accommodating the filter in an extended position of the first piston, it can surround the filter, ensuring essentially complete removal of blood clots therefrom. This is
preferably effected if the first piston is movable in a direction perpendicular to the direction of the blood flow passageway.
The movement of the first piston can be controlled by a source of pressurized air, ensuring rapid acceleration of the first piston and thereby short cleaning cycles. The movement of the first piston can alternatively be controlled by an electric motor, a solenoid or the like.
The filter is of biocompatible material in order to avoid unnecessary interference with the blood environment.
In one embodiment, the blood clot removal device is used in a system comprising a heart pump connected to the blood flow passageway, wherein a first tube preferably connects the heart pump to the left ventricle of the patient's heart and a second tube connects the heart pump connected to the patient's aorta.
The filter preferably comprises a plurality of strips, which may be equally spaced to form a filter for blood clots. In order to achieve a filtering function, the distance between two adjacent strips is preferably less than 2 millimeters, and even more preferably less than 1.0 millimeter. The distance depends on which size blood clots you want to avoid.
In one embodiment, a second piston is provided across the blood flow passageway from the first piston, wherein the second piston is movable in a direction essentially perpendicular to the direction of the blood flow passageway and spring biased in the direction of the first piston. If an outer end portion of the second piston is provided with a second recess, the first piston and the second piston cooperate to catch blood clots for further removal. This further removal can be accomplished by means of a third piston, which is movable in a direction perpendicular to both the direction of the blood flow passageway and the direction of movement of the first piston and of the second piston.
In a preferred embodiment, the blood flow passageway of the blood clot removal device has an essentially square cross-sectional shape, which provides for a
laminated flow of the blood, particularly if the square shape is combined with a filter comprising parallel strips.
The blood clot removal device is in a preferred embodiment insertable in a blood vessel of the patient, preferably via surgery.
The blood clot removal device can be adapted to be placed in the patient's abdomen or thorax.
The blood clot removal device is preferably comprised in a system for removing blood clots of a patient. This system can comprise a switch, preferably a subcutaneous switch being adapted to manually and non-invasively control any function of the blood clot removal device.
The system for removing blood clots preferably comprises a hydraulic device having a hydraulic reservoir, wherein the blood clot removal device is adapted to non- invasively be regulated by manually pressing the hydraulic reservoir.
A wireless remote control can non-invasively regulate any function of the blood clot removal device. Even more important any function of the device may be programmable by such a remote control.
Also, a wireless energy transmitter can non-invasively energize the blood clot removal device.
An energy source is preferably adapted to power the blood clot removal device. The energy source can comprise an internal energy source, such as an internal energy source adapted to receive energy from an external energy source transmitting energy in a wireless mode. The internal energy source can then be charged from the energy in the wireless mode.
The system preferably comprises a feedback device for sending information from inside the patient's body to the outside thereof to give feedback information related to at least one functional parameter of the device or a physical parameter of the patient, thereby optimizing the performance of the system. One preferred functional
parameter of the device is correlated to the transfer of energy for charging the internal energy source.
The system preferably comprises an operation device for operating the blood clot removal device. This operation device can comprise a motor or a pump, an electrically powered operation device, a hydraulic operation device, or an electric motor.
To improve the performance of the system for removing blood clots, a physical parameter sensor, such as a pressure sensor, is provided for sensing a physical parameter of the patient. An internal control unit can act in response to the physical parameter sensed by the sensor.
A functional parameter sensor sensing a functional parameter of the blood clot removal device can also be provided. An internal control unit acting in response to the functional parameter sensed by the sensor can also be provided.
A method of using the system for removing blood clots is also provided, wherein at least one function of the blood clot removal device is regulated from outside the patient's body. The regulation is in a preferred embodiment non-invasively by manually pressing a subcutaneous switch. In an alternative embodiment, non- invasively regulation are performed by manually pressing a hydraulic reservoir connected to the blood clot removal device.
Alternatively, the system for removing blood clots comprises a wireless remote " control, wherein non-invasively regulation is performed using said remote control.
In a preferred embodiment, the system for removing blood clots comprises a wireless energy transmitter, wherein non-invasively regulation is performed using said energy transmitter.
Preferably, an energy source is used for powering and adjusting any function of the blood clot removal device. The energy source may comprise an internal energy source, which preferably is associated with an external energy source adapted to transmit wireless energy. Energy is preferably transmitted from the external energy
source to charge the internal energy source. Feedback information is preferably sent from inside the body to the outside thereof to give feed back related to the functional parameters of the device or physical parameters of the patient. The functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
In one embodiment, wireless energy is transmitted for powering the operation device.
In a preferred embodiment, the method of using a system for removing blood clots comprises the steps of: implanting an implantable source of energy in the patient, providing an external source of energy, controlling the external source of energy to release wireless energy, charging non-invasively the implantable source of energy with the wireless energy, controlling the implantable source of energy from outside the patient's body, and releasing energy for use in connection with operation of the blood clot removal device. The wireless energy is preferably stored in the implantable source of energy.
In another preferred embodiment, the method of using a system for removing blood clots comprises the steps of: providing an external source of energy outside the patient's body, and controlling the external source of energy from outside the patient's body to release wireless energy, and using released wireless energy for operating the operation device. The wireless energy is preferably transformed into electrical energy inside the patient's body using an implanted energy-transforming device and using the electrical energy when operating the blood clot removal device.
In one embodiment, the electrical energy is used directly in connection with operation of the blood clot removal device, as a transforming device transforms the wireless energy into the electrical energy.
In another embodiment, the external source of energy is controlling from outside the patient's body to release non-magnetic wireless energy, and released non-magnetic wireless energy is used for operating the blood clot removal device.
In yet an alternative embodiment, the external source of energy is controlled from outside the patient's body to release electromagnetic wireless energy, and released electromagnetic wireless energy is used for operating the blood clot removal device.
A method for placing a blood clot removal device, comprising a surgical method via a laparoscopic abdominal approach, comprises the steps of: inserting a needle or tube like instrument into the abdomen of the patient's body, using the needle or tube like instrument to fill the patient's abdomen with gas thereby expanding the patient's abdominal cavity, placing at least two laparoscopic trocars in the patient's body, inserting a camera through one of the trocars into the patient's abdomen, inserting at least one dissecting tool through a trocar and dissecting the intended placement area of the patient, placing at least one blood clot removal device in any part of the vascular system in the abdomen, moving blood clots away from the vascular system post operatively to a different part of the body, and powering the device with a source of energy. The blood clots can be moved either to a place that is free in the abdomen, to a place that is free in the abdomen, or to a place that is encapsulated in a closed bag in the abdomen
The blood clot removal device is preferably programmable from outside the patients body. By adding the steps of sensing a physical parameter of the patient or a functional parameter of the device, and sending sensing information to an internal control unit adapted for regulating said blood clot removal device, performance is improved.
A method of placing a blood clot removal device, comprising a surgical method via a laparoscopic thoraxial approach, comprises the steps of: inserting a needle or tube like instrument into the thorax of the patients body, using the needle or tube like instrument to fill the thorax with gas thereby expanding the thoraxical cavity, placing at least two laparoscopic trocars in the patient's body, inserting a camera through one of the trocars into the thorax, inserting at least one dissecting tool through a trocar and dissecting the intended area of the patient, placing at least one blood clot removal device in any part of the vascular system in the thorax, moving blood clots away from vascular system post operatively to a different part of the body, and powering the device with a source of energy. The blood clots can be moved either to
a place that is free in the thorax, to a place that is free in the abdomen, or to a place that is encapsulated in a closed bag in the thorax
The device is preferably programmed from outside the body of the patient.
A method for surgically treating a patient needing a blood clot removal device in the vascular system in the patient's abdomen comprises the steps of: cutting an opening in the patient's abdominal wall, dissecting an area of the vascular system, placing a blood clot removal device inside the vascular system, and suturing said abdominal wall. In one embodiment, blood clots are moved away from the vascular system into an encapsulated closed bag in the patient's abdomen by means of the blood clot removal device. In another embodiment, blood clots are moved to the free abdomen.
A method for surgically treating a patient needing a blood clot removal device in the vascular system in the thorax comprises the steps of: cutting an opening in the thorax wall, dissecting the area of the vascular system, placing a blood clot removal device inside the vascular system, and suturing said thorax wall. A step of moving blood clots away from the vascular system can comprise moving blood clots either to a place that is free in the thorax, to a place that is free in the abdomen, or to a place that is encapsulated in a closed bag in the thorax
A method using an system for removing blood clots, for postoperatively and non- invasively regulating the blood clot removal device, comprises the steps of: moving any blood clots, which have been accumulated in the vascular system of the patient's body, away from the vascular system, and placing the blood clots outside the vascular system. This can be accomplished by an energy source, preferably repeatedly according to a pre-programmed time-schedule. The steps of moving any blood clots away from the vascular system and placing the blood clots outside the vascular system are preferably repeated and at least partly controlled by an internal control unit getting input from a sensor sensing any physical parameter of the patient or any functional parameter of the device. The accumulation of blood clots in the filter may be visualized with light sensors, sensors measuring any electrical parameter, any blood flow measurement, pressure difference before and after the filter or any other kind of sensor.
An operation method for surgically placing a blood clot removal device comprises the steps of: cutting the patient's skin, dissecting a placement area where to place the blood clot removal device inside the vascular system in the abdomen or thorax or retroperitoneal or subcutaneously or any limb of the patient, placing the blood clot removal device in the placement area, removing, postoperatively and non-invasively without penetrating the patent's skin, any blood clots from the vascular system to outside thereof, and using energy from an energy source without any penetration through the patient's skin to power the blood clot removal device.
Further preferred embodiments are defined by the dependent claims.
BRIEF DESCRIPTION OF DRAWINGS
The invention is now described, by way of example, with reference to the accompanying drawings, in which:
Fig. 1 is an overview of the body of a patient having an implanted heart pump.
Fig. 2 is a sectional view of a clot removal device according to the invention.
Fig. 3 is a cross sectional view of the clot removal device of Fig. 2 taken along the line III-III before a cleaning operation.
Fig. 4 is a sectional view of the clot removal device of Fig. 2 taken along the line IV-IV.
Fig. 5 is a sectional view similar to that of Fig. 2 showing blood clots before a clot removal operation.
Fig. 6 is a sectional view similar to that of Fig. 2 during a first step of a clot removal operation.
Fig. 7 is a sectional view similar to that of Fig. 2 during a second step of a clot removal operation.
Fig. 8 is a sectional view similar to that of Fig. 2 during a third step of a clot removal operation.
Fig. 9 is a cross sectional view similar to that of Fig. 3 but during a cleaning operation.
Fig. 10 is a sectional view of the clot removal device of Fig. 8 taken along the line X-X showing a clot ejection piston before ejection of clots.
Fig. 11 is a view similar to that of Fig. 9 but after ejection of clots.
Fig. 12 is an overall view of a clot removal system according to the invention.
Fig. 13 is a schematic diagram of the system of Fig. 12.
Figs. 14-29 show various embodiments based on the system of Fig. 13.
Figs. 30a and 30b are views of a filter cassette.
Figs. 31a and 3 Ib are views of a filter cassette.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
In the following a detailed description of preferred embodiments of the present invention will be given. In the drawing figures, like reference numerals designate identical or corresponding elements throughout the several figures. It will be appreciated that these figures are for illustration only and are not in any way restricting the scope of the invention. Thus, any references to direction, such as "up" or "down", are only referring to the directions shown in the figures. Also, any dimensions etc. shown in the figures are for illustration purposes.
Fig.l shows a patient 1 having an implanted heart pump 2. The implanted heart pump 2 is connected to the left ventricle 3a of the patient's heart 3 by means of a first tube 2a. The heart pump 2 is also connected to the aorta, generally designated 4, of the patient 1 by means of a second tube 2b. In this way, during operation the heart pump supplements or replaces the blood pumping operation of the patient's heart 3.
A blood clot removal device 10 according to the invention is shown provided in the second tube 2b of the heart pump 2, i.e., in the tube leading to the aorta 4 of the patient 1. This means that part of the blood flow passageway provided by the second
tube 2b is replaced by a blood flow passageway in the blood clot removal device 10. The blood clot removal device 10 is thus an artificial device insertable in an artificial blood vessel of the patient. The function of the clot removal device is to remove any blood clots in the blood transported by the second tube 2b. These blood clots are preferably moved to a place free inside the body of the patient. However, they could alternatively be collected in a collecting volume, such as a bag 10a connected to the blood clot removal device 10 for subsequent removal or storage. A preferred storage capacity of the bag 10a can be more than 100 milliliters, for example. The blood clot removal device is an artificial device but could be inserted directly into a blood vessel of the patient or connected between two ends of a blood vessel.
The clot removal device is preferably insertable in a blood flow passageway of the patient via surgery and is placed in the patient's abdomen or thorax or cephalic or neck region or retroperitoneal or any limb of the patient.
The design of a first preferred embodiment of the blood clot removal device 10 will now be described in detail, with reference to Figs. 2-4. Fig. 2 shows a sectional view wherein the blood clot removal device 10 is provided in the blood flow passageway provided by the second tube 2b. A filter 12 is provided across the blood flow passageway 14 formed in a housing 11 with the function of stopping potential blood clots brought forward in the second tube 2b by the blood flow, indicated by arrows in the figure. In this preferred embodiment, the filter 12 comprises a plurality of preferably equally spaced strips 12a of some suitable material, such as biocompatible metal or plastic. These strips 12a are preferably arranged mutual parallel.
The distance between two adjacent strips is small enough to stop any blood clots. Thus, the distance is preferably less than 2 millimeters, and even more preferably less than 1.0 millimeters, but if the goal is to protect the brain from larger clots only the distance could be larger. Although the blood flow passageway 14 in the preferred embodiment has an essentially square cross-sectional shape, it will be realized that it can take any suitable shape, such as rectangular or circular.
By providing a plurality of strips 12a as a filter across the blood flow passageway 14, a laminar blood flow is achieved downstream of the filter, which is advantageous in a
blood clot preventing perspective. The blood flow configuration can be further enhanced by giving the plurality of strips 12a a desired cross-sectional shape, although the rectangular shape shown in Fig. 4 will be adequate for most purposes.
A first piston 16 is provided movable in a direction essentially perpendicular to the direction of the blood flow passageway 14, i.e., essentially perpendicular to the direction of the blood flow. This first piston 16 is driven by some suitable actuator means, such as pressurized air, a solenoid arrangement, an electrical servo motor or the like. A motor could be used to build up a stored power that could be released very fast, one example being a spring. In the preferred embodiment, pressurized air acts as the actuator means, since by latching the piston by means of a suitable latching means for the piston, building up the air pressure, and subsequently releasing the piston, very high speed of the piston is achieved, with enables short cleaning times of the filter.
The outer end portion of the first piston 16, i.e., the end portion facing the blood flow passageway 14, is essentially flush with the wall of the blood flow passageway in a non-active state of the blood clot removal device 10. Also, the outer end portion is provided with a concave portion or recess 16a (exaggerated in the figures) in order to act as a blood clot capturing means, as will be explained below.
The strike range of the first piston 16 is such that it extends all way across the blood flow passageway 14, as will be explained below with reference to Figs. 5-8. A number of channels 16b corresponding to the number of strips 12a is provided in the first piston 16 to accommodate the strips when the first piston is in an extended position.
The first piston 16 is also provided with a plurality of through holes 17 in the direction of the blood flow passageway. These through holes will allow blood to flow through the blood flow passageway also during a cleaning operation, as will be explained below with reference to Fig. 9.
A second piston 18 is provided across the blood flow passageway 14 from the first piston 16. Also this second piston 18 is movable in a direction essentially
perpendicular to the direction of the blood flow passageway 14 and is biased in the direction thereof by means of a spring 18a, for example. Likewise, the outer end portion of the second piston is provided with a recess 18b similar to the recess 16a of the first piston 16.
The first and second pistons 16, 18, are sealed to the housing 11 by means of a respective sealing 20, such as an O sealing.
A preferred embodiment of the method according to the invention will now be described with reference to Figs. 5-8, showing different operational steps of the above-described device. Fig. 5 is a view similar to that of Fig. 2. However, this figures shows the blood clot removal device 10 during operation, wherein blood clots, generally designated 22, have assembled on the filter 12.
In Fig. 6, the first piston 16 has moved linearly from the retracted starting position shown Fig. 5 to an extended position, wherein the outer end portion thereof is in contact with the second piston 18. Due to the recess 16a in the outer end of the first piston 16, the blood clots 22 have been assembled in the recess 16a, whereby they have been brought with the first piston 16 during the movement thereof. In the step shown in Fig. 6, the blood clots are confined in the recess 16a between the first and second pistons 16, 18.
By moving the first piston 16 an additional distance from the position shown in Fig. 6, the second piston 18 is pushed against the force of the spring 18a to a fully retracted position, see Fig. 7. The plurality of strips 12a is in this position fully received in a respective channel 16b in the first piston. It is seen that the outer ends of the first and second pistons define an unobstructed cavity in which the blood clots are confined. It is thereby possible to remove these by some suitable means. One such means could be a third piston 24, which is movable in a direction perpendicular to both the direction of the blood flow passageway 14 and the direction of movement of the first and second pistons 16, 18. This third piston, the movement of which could be controlled by means of pressurized air, a solenoid, an electric motor etc., scrapes off the blood clots collected by the first piston 16 and moves them to a place outside of the blood clot removal device 10 and the blood flow passageway 14.
Fig. 9 shows a side view of the first piston 16 in a fully extended position, i.e., corresponding to the view of Fig. 8. It is here seen that in this position the through holes 17 will be aligned with the blood flow passageway 14, thereby allowing blood to flow therethrough also during cleaning of the filter 12.
Fig. 10 shows a cross-sectional view taken along line X-X of Fig. 8. It is here seen that the third piston 24 collects the blood clots 22 during a downward movement, indicated by an arrow in the figure. The clots are ejected from the blood clot removal device 10 when the third piston 24 has reached its lower end position, shown in Fig. 11.
Again with reference to Fig. 7, it will be realized that pressurized air can be used for ejecting the collected blood clots from the cavity formed by the first piston 16 and the second piston 18.
A clot removal system, generally designated 28 and comprising a clot removal device as described above will now be described with reference to Figs. 12-25.
The system of Fig. 12 comprises a blood clot removal device 10 placed in the abdomen of the patient. An internal energy source in the form of an implanted energy transforming device 30 is adapted to supply energy consuming components of the blood clot removal device 10 with energy via a power supply line 32. An external energy transmission device 34 includes a wireless remote control transmitting a wireless signal, which is received by a signal receiver incorporated in the implanted energy transforming device 30. The implanted energy transforming device 30 transforms energy from the signal into electric energy which is supplied via the power supply line 32.
The system of Fig. 12 is shown in a more generalized block diagram form in Fig. 13, wherein the patient's skin 36, generally shown by a vertical line, separates the interior of the patient to the right of the line from the exterior to the left of the line.
Fig. 14 shows an embodiment of the invention identical to that of Fig. 13, except that a reversing device in the form of an electric switch 38 operable by polarized energy also is implanted in the patient for reversing the blood clot removal device 10. The
wireless remote control of the external energy transmission device 34 transmits a wireless signal that carries polarized energy and the implanted energy transforming device 30 transforms the wireless polarized energy into a polarized current for operating the electric switch 38. When the polarity of the current is shifted by the implanted energy transforming device 30 the electric switch 38 reverses the function performed by the blood clot removal device 10.
Fig. 15 shows an embodiment of the invention identical to that of Fig. 13, except that an operation device 40 implanted in the patient for regulating the blood clot removal device 10 is provided between the implanted energy transforming device 30 and the blood clot removal device 10. This operation device can be in the form of a motor 40, such as an electric servo motor. The motor 40 is powered with energy from the implanted energy transforming device 30, as the remote control of the external energy transmission device 34 transmits a wireless signal to the receiver of the implanted energy transforming device 30.
Fig. 16 shows an embodiment of the invention identical to that of Fig. 13, except that it also comprises an operation device is in the form of an assembly 42 including a motor/pump unit 78 and a fluid reservoir 46 is implanted in the patient. In this case the blood clot removal device 10 is hydraulically operated, i.e. hydraulic fluid is pumped by the motor/pump unit 44 from the fluid reservoir 46 through a conduit 48 to the blood clot removal device 10 to operate the clot removal device, and hydraulic fluid is pumped by the motor/pump unit 44 back from the blood clot removal device 10 to the fluid reservoir 46 to return the clot removal device to a starting position. The implanted energy transforming device 30 transforms wireless energy into a current, for example a polarized current, for powering the motor/pump unit 44 via an electric power supply line 50.
Instead of a hydraulically operated blood clot removal device 10, it is also envisaged that the operation device comprises a pneumatic operation device. In this case, pressurized air can be used for regulation and the fluid reservoir is replaced by an air chamber and the fluid is replaced by air.
Fig. 17 shows an embodiment of the invention comprising the external energy transmission device 34 with its wireless remote control, the blood clot removal device 10, in this case hydraulically operated, and the implanted energy transforming device 30, and further comprising a hydraulic fluid reservoir 52, a motor/pump unit 44 and an reversing device in the form of a hydraulic valve shifting device 54, all implanted in the patient. The motor of the motor/pump unit 44 is an electric motor. In response to a control signal from the wireless remote control of the external energy transmission device 34, the implanted energy transforming device 30 powers the motor/pump unit 44 with energy from the energy carried by the control signal, whereby the motor/pump unit 44 distributes hydraulic fluid between the hydraulic fluid reservoir 52 and the blood clot removal device 10. The remote control of the external energy transmission device 34 controls the hydraulic valve shifting device 54 to shift the hydraulic fluid flow direction between one direction in which the fluid is pumped by the motor/pump unit 44 from the hydraulic fluid reservoir 52 to the blood clot removal device 10 to operate the clot removal device, and another opposite direction in which the fluid is pumped by the motor/pump unit 44 back from the blood clot removal device 10 to the hydraulic fluid reservoir 52 to return the clot removal device to a starting position.
Fig. 18 shows an embodiment of the invention identical to that of Fig. 13, except that an internal control unit 56 controlled by the wireless remote control of the external energy transmission device 34, an accumulator 58 and a capacitor 60 also are implanted in the patient. The internal control unit 56 arranges storage of electric energy received from the implanted energy transforming device 30 in the accumulator 58, which supplies energy to the blood clot removal device 10. In response to a control signal from the wireless remote control of the external energy transmission device 34, the internal control unit 56 either releases electric energy from the accumulator 58 and transforms the released energy via power lines 62 and 64, or directly transforms electric energy from the implanted energy transforming device 30 via a power line 66, the capacitor 60, which stabilizes the electric current, a power line 68 and the power line 64, for the operation of the blood clot removal device 10.
The internal control unit is preferably programmable from outside the patient's body. In a preferred embodiment, the internal control unit is programmed to regulate the blood clot removal device 10 to remove any blood clots from the vascular system and place the blood clots outside the vascular system repeatedly according to a pre- programmed time-schedule.
In accordance with an alternative, the capacitor 60 in the embodiment of Fig. 18 may be omitted. In accordance with another alternative, the accumulator 58 in this embodiment may be omitted.
Fig. 19 shows an embodiment of the invention identical to that of Fig. 13, except that a battery 70 for supplying energy for the operation of the blood clot removal device 10 and an electric switch 72 for switching the operation of the blood clot removal device 10 also are implanted in the patient. The electric switch 72 is operated by the energy supplied by the implanted energy transforming device 30 to switch from an off mode, in which the battery 70 is not in use, to an on mode, in which the battery 70 supplies energy for the operation of the blood clot removal device 10.
Fig. 20 shows an embodiment of the invention identical to that of Fig. 19, except that an internal control unit 56 controllable by the wireless remote control of the external energy transmission device 34 also is implanted in the patient. In this case, the electric switch 72 is operated by the energy supplied by the implanted energy transforming device 30 to switch from an off mode, in which the wireless remote control is prevented from controlling the internal control unit 56 and the battery is not in use, to a standby mode, in which the remote control is permitted to control the internal control unit 56 to release electric energy from the battery 70 for the operation of the blood clot removal device 10.
Fig. 21 shows an embodiment of the invention identical to that of Fig. 20, except that an accumulator 58 is substituted for the battery 70 and the implanted components are interconnected differently. In this case, the accumulator 58 stores energy from the implanted energy transforming device 30. In response to a control signal from the wireless remote control of the external energy transmission device 34, the internal control unit 56 controls the electric switch 72 to switch from an off mode, in which
the accumulator 58 is not in use, to an on mode, in which the accumulator 58 supplies energy for the operation of the blood clot removal device 10.
Fig. 22 shows an embodiment of the invention identical to that of Fig. 21, except that a battery 70 also is implanted in the patient and the implanted components are interconnected differently. In response to a control signal from the wireless remote control of the external energy transmission device 34, the internal control unit 56 controls the accumulator 58 to deliver energy for operating the electric switch 72 to switch from an off mode, in which the battery 70 is not in use, to an on mode, in which the battery 70 supplies electric energy for the operation of the blood clot removal device 10.
Alternatively, the electric switch 72 may be operated by energy supplied by the accumulator 58 to switch from an off mode, in which the wireless remote control is prevented from controlling the battery 70 to supply electric energy and is not in use, to a standby mode, in which the wireless remote control is permitted to control the battery 70 to supply electric energy for the operation of the blood clot removal device 10.
Fig. 23 shows an embodiment of the invention identical to that of Fig. 19, except that a motor 40, a mechanical reversing device in the form of a gear box 74, and an internal control unit 56 for controlling the gear box 74 also are implanted in the patient. The internal control unit 56 controls the gear box 74 to reverse the function performed by the blood clot removal device 10 (mechanically operated).
Fig. 24 shows an embodiment of the invention identical to that of Fig. 22 except that the implanted components are interconnected differently. Thus, in this case the internal control unit 56 is powered by the battery 70 when the accumulator 58, suitably a capacitor, activates the electric switch 72 to switch to an on mode. When the electric switch 72 is in its on mode the internal control unit 56 is permitted to control the battery 70 to supply, or not supply, energy for the operation of the blood clot removal device 10.
Fig. 25 schematically shows conceivable combinations of implanted components of the apparatus for achieving various communication options. Basically, there are the blood clot removal device 10, the internal control unit 56, motor/pump unit 44, and the external energy transmission device 34 including the external wireless remote control. As already described above the wireless remote control transmits a control signal which is received by the internal control unit 56, which in turn controls the various implanted components of the apparatus.
A feedback device, preferably in the form of a sensor 76, may be implanted in the patient for sensing a physical parameter of the patient, such as the pressure in a blood vessel. The internal control unit 56, or alternatively the external wireless remote control of the external energy transmission device 34, may control the blood clot removal device 10 in response to signals from the sensor 76. A transceiver may be combined with the sensor 76 for sending information on the sensed physical parameter to the external wireless remote control. The wireless remote control may comprise a signal transmitter or transceiver and the internal control unit 56 may comprise a signal receiver or transceiver. Alternatively, the wireless remote control may comprise a signal receiver or transceiver and the internal control unit 56 may comprise a signal transmitter or transceiver. The above transceivers, transmitters and receivers may be used for sending information or data related to the blood clot removal device 10 from inside the patient's body to the outside thereof.
Alternatively, the sensor 76 may be arranged to sense a functional parameter of the blood clot removal device 10.
Where the motor/pump unit 44 and battery 70 for powering the motor/pump unit 44 are implanted, the battery 70 may be equipped with a transceiver for sending information on the condition of the battery 70.
Fig. 26 shows an alternative embodiment wherein the blood clot removal device 10 is regulated from outside the patient's body. The clot removal system 28 comprises a blood clot removal device 10 connected to a battery 70 via a subcutaneous switch 80. Thus, the regulation of the blood clot removal device 10 is performed non-invasively by manually pressing the subcutaneous switch, whereby the operation of the blood
clot removal device 10 is switched on and off. It will be appreciated that the shown embodiment is a simplification and that additional components, such as an internal control unit, can be added to the clot removal system.
Fig. 27 shows an alternative embodiment, wherein the clot removal system 28 comprises a blood clot removal device 10 in fluid connection with a hydraulic fluid reservoir 52. Non-invasive regulation is performed by manually pressing the hydraulic reservoir connected to the blood clot removal device 10.
A further embodiment of a system according to the invention comprises a feedback device for sending information from inside the patient's body to the outside thereof to give feedback information related to at least one functional parameter of the clot removal device or system or a physical parameter of the patient, thereby optimizing the performance of the system.
One preferred functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
In Fig. 28, an arrangement is schematically illustrated for supplying an accurate amount of energy to a clot removal system 28 implanted in a patient, whose skin 36 is indicated by a vertical line. A blood clot removal device 10 is connected to an implanted energy transforming device 30, likewise located inside the patient, preferably just beneath the patient's skin 36. Generally speaking, the implanted energy transforming device 30 may be placed in the abdomen, thorax, muscle fascia (e.g. in the abdominal wall), subcutaneously, or at any other suitable location. The the implanted energy transforming device 30 is adapted to receive wireless energy E transmitted from an external energy source 34a provided in the external energy transmission device 34 located outside the patient's skin 36 in the vicinity of the implanted energy transforming device 30.
As is well known in the art, the wireless energy E may generally be transferred by means of any suitable Transcutaneous Energy Transfer (TET) device, such as a device including a primary coil arranged in the external energy source 34a and an adjacent secondary coil arranged in the implanted energy transforming device 30.
When an electric current is fed through the primary coil, energy in the form of a voltage is induced in the secondary coil which can be used to operate a clot removal device, e.g. after storing the incoming energy in an energy storing device or accumulator, such as a battery or a capacitor. However, the present invention is generally not limited to any particular energy transfer technique, TET devices or energy storing devices, and any kind of wireless energy may be used.
The amount of transferred energy can be regulated by means of an external control unit 34b controlling the external energy source 34a based on the determined energy balance, as described above. In order to transfer the correct amount of energy, the energy balance and the required amount of energy can be determined by means of an internal control unit 56 connected to the blood clot removal device 10. The internal control unit 56 may thus be arranged to receive various measurements obtained by suitable sensors or the like, not shown, measuring certain characteristics of the blood clot removal device 10, somehow reflecting the required amount of energy needed for proper operation of the blood clot removal device 10. Moreover, the current condition of the patient may also be detected by means of suitable measuring devices or sensors, in order to provide parameters reflecting the patient's condition. Hence, such characteristics and/or parameters may be related to the current state of the blood clot removal device 10, such as power consumption, operational mode and temperature, as well as the patient's condition reflected by, e.g., body temperature, blood pressure, heartbeats and breathing.
Furthermore, an energy storing device or accumulator 58 may optionally be connected to the implanted energy transforming device 30 for accumulating received energy for later use by the blood clot removal device 10. Alternatively or additionally, characteristics of such an accumulator, also reflecting the required amount of energy, may be measured as well. The accumulator may be replaced by a battery, and the measured characteristics may be related to the current state of the battery, such as voltage, temperature, etc. In order to provide sufficient voltage and current to the blood clot removal device 10, and also to avoid excessive heating, it is clearly understood that the battery should be charged optimally by receiving a correct amount of energy from the implanted energy transforming device 30, i.e. not too
little or too much. The accumulator may also be a capacitor with corresponding characteristics.
For example, battery characteristics may be measured on a regular basis to determine the current state of the battery, which then may be stored as state information in a suitable storage means in the internal control unit 56. Thus, whenever new measurements are made, the stored battery state information can be updated accordingly. In this way, the state of the battery can be "calibrated" by transferring a correct amount of energy, so as to maintain the battery in an optimal condition.
Thus, the internal control unit 56 is adapted to determine the energy balance and/or the currently required amount of energy, (either energy per time unit or accumulated energy) based on measurements made by the above-mentioned sensors or measuring devices on the blood clot removal device 10, or the patient, or an energy storing device if used, or any combination thereof. The internal control unit 56 is further connected to an internal signal transmitter 82, arranged to transmit a control signal reflecting the determined required amount of energy, to an external signal receiver 34c connected to the external control unit 34b. The amount of energy transmitted from the external energy source 34a may then be regulated in response to the received control signal.
Alternatively, sensor measurements can be transmitted directly to the external control unit 34b wherein the energy balance and/or the currently required amount of energy can be determined by the external control unit 34b, thus integrating the above- described function of the internal control unit 56 in the external control unit 34b. In that case, the internal control unit 56 can be omitted and the sensor measurements are supplied directly to the internal signal transmitter 82 which sends the measurements over to the external signal receiver 34c and the external control unit 34b. The energy balance and the currently required amount of energy can then be determined by the external control unit 34b based on those sensor measurements.
Hence, the present solution employs the feed back of information indicating the required energy, which is more efficient than previous solutions because it is based on the actual use of energy that is compared to the received energy, e.g. with respect
to the amount of energy, the energy difference, or the energy receiving rate as compared to the energy rate used by the clot removal device. The clot removal device may use the received energy either for consuming or for storing the energy in an energy storage device or the like. The different parameters discussed above would thus be used if relevant and needed and then as a tool for determining the actual energy balance. However, such parameters may also be needed per se for any actions taken internally to specifically operate the clot removal device.
The internal signal transmitter 82 and the external signal receiver 34c may be implemented as separate units using suitable signal transfer means, such as radio, IR (Infrared) or ultrasonic signals. Alternatively, the internal signal transmitter 82 and the external signal receiver 34c may be integrated in the implanted energy transforming device 30 and the external energy source 34a, respectively, so as to convey control signals in a reverse direction relative to the energy transfer, basically using the same transmission technique. The control signals may be modulated with respect to frequency, phase or amplitude.
To conclude, the energy supply arrangement illustrated in Fig. 28 may operate basically in the following manner. The energy balance is first determined by the internal control unit 56. A control signal reflecting the required amount of energy is also created by the internal control unit 56, and the control signal is transmitted from the internal signal transmitter 82 to the external signal receiver 34c. Alternatively, the energy balance can be determined by the external control unit 34b instead depending on the implementation, as mentioned above. In that case, the control signal may carry measurement results from various sensors. The amount of energy emitted from the external energy source 34a can then be regulated by the external control unit 34b, based on the determined energy balance, e.g. in response to the received control signal. This process may be repeated intermittently at certain intervals during ongoing energy transfer, or may be executed on a more or less continuous basis during the energy transfer.
The amount of transferred energy can generally be regulated by adjusting various transmission parameters in the external energy source 34a, such as voltage, current, amplitude, wave frequency and pulse characteristics.
A method is thus provided for controlling transmission of wireless energy supplied to an electrically operable clot removal device implanted in a patient. The wireless energy E is transmitted from an external energy source located outside the patient and is received by an internal energy receiver located inside the patient, the internal energy receiver being connected to the clot removal device for directly or indirectly supplying received energy thereto. An energy balance is determined between the energy received by the internal energy receiver and the energy used for the clot removal device. The transmission of wireless energy E from the external energy source is then controlled based on the determined energy balance.
A system is also provided for controlling transmission of wireless energy supplied to an electrically operable clot removal device implanted in a patient. The system is adapted to transmit the wireless energy E from an external energy source located outside the patient which is received by an implanted energy transforming device located inside the patient, the implanted energy transforming device being connected to the clot removal device for directly or indirectly supplying received energy thereto. The system is further adapted to determine an energy balance between the energy received by the implanted energy transforming device and the energy used for the clot removal device, and control the transmission of wireless energy E from the external energy source, based on the determined energy balance.
The functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
In yet an alternative embodiment, the external source of energy is controlled from outside the patient's body to release electromagnetic wireless energy, and released electromagnetic wireless energy is used for operating the blood clot removal device.
In another embodiment, the external source of energy is controlling from outside the patient's body to release non-magnetic wireless energy, and released non-magnetic wireless energy is used for operating the blood clot removal device.
Those skilled in the art will realize that the above various embodiments according to Figs. 13-29 could be combined in many different ways. For example, the electric
switch 38 operated polarized energy could be incorporated in any of the embodiments of Figs. 15, 18-24, the hydraulic valve shifting device 54 could be incorporated in the embodiment of Fig. 16, and the gear box 74 could be incorporated in the embodiment of Fig. 15.
Wireless transfer of energy for operating the clot removal device has been described to enable non-invasive operation. It will be appreciated that the clot removal device can be operated with wire bound energy as well. On such example is shown in Fig. 29, wherein an external switch 84 is interconnected between the external energy source 34a and an operation device, such as an electric motor regulating the blood clot removal device 10, by means of power lines 86 and 88. An external control unit 34b controls the operation of the external switch to effect proper operation of the blood clot removal device 10.
Methods relating to the above described clot removal device and system will now be described in detail.
The clot removal device can be placed surgically in the patient via a laparoscopic abdominal approach. First, a tube is inserted into the abdomen of the patient's body and this tube is used to fill the patient's abdomen with gas, thereby expanding the patient's abdominal cavity. At least two laparoscopic trocars are then placed in the patient's body, where after a camera is inserted through one of the trocars into the patient's abdomen. At least one dissecting tool is inserted through a trocar and dissection is performed at two intended areas of the patient. A clot removal device is placed in any part of the vascular system in the abdomen.
Alternatively, the clot removal device can be placed in the patient's thorax. Thus, a tube is inserted into the thorax of the patient's body and this tube is used to fill the patient's thorax with gas, thereby expanding the patient's thoraxical cavity. At least two laparoscopic trocars are then placed in the patient's body, where after a camera is inserted through one of the trocars into the patient's thorax. At least one dissecting tool is inserted through a trocar and dissection is performed at two intended areas of the patient. A clot removal device is placed in any part of the vascular system in the thorax.
An operation method for surgically placing a clot removal device starts with cutting the patient's skin and dissecting a placement area where to place the clot removal device inside the vascular system in the abdomen or thorax or retroperitoneal or subcutaneously or any limb of the patient. When a suitable place has been found, the clot removal device is placed in the placement area. The clot removal device can then be used postoperatively and non-invasively without penetrating the patent's skin for removing any blood clots from the vascular system to outside thereof, while using energy from an energy source without any penetration through the patient's skin to power the blood clot removal device.
A method for surgically treating a patient needing a blood clot removal device in the vascular system in the patient's abdomen preferably comprises cutting an opening in the patient's abdominal wall and then dissecting an area of the vascular system. A clot removal device is placed inside the vascular system, and the abdominal wall is sutured. In one embodiment, blood clots are moved away from the vascular system into an encapsulated closed bag in the patient's abdomen by means of the blood clot removal device. In another embodiment, blood clots are moved to the free abdomen.
Alternatively, a method for surgically treating a patient needing a blood clot removal device in the vascular system in the thorax comprises cutting an opening in the thorax wall and then dissecting the area of the vascular system. A clot removal device is placed inside the vascular system, and the thorax wall is sutured. A step of moving blood clots away from the vascular system can comprise moving blood clots either to a place that is free in the thorax, to a place that is free in the abdomen, or to a place that is encapsulated in a closed bag in the thorax.
In one embodiment, a method of using a system for removing blood clots comprises implanting an implantable source of energy, such as an implanted energy transforming device 30 and an accumulator 58, in the patient. An external source of energy, such as an external energy transmission device 34, is provided for providing energy to the system. This external source of energy is operated to release wireless energy, thereby non-invasively charging the implantable source of energy with the wireless energy, while controlling the implantable source of energy from outside the patient's body. In connection with operation of the clot removal device, energy is
releasing. The wireless energy is preferably stored in the implantable source of energy.
During operation, the system for removing blood clots postoperatively and non- invasively regulates the clot removal device. Any blood clots, which have been accumulated in the vascular system of the patient's body, are moved away from the vascular system and are then placed outside the vascular system. This can be accomplished by an energy source, preferably repeatedly according to a preprogrammed time-schedule. The movement of any blood clots away from the vascular system and placement of the blood clots outside the vascular system are preferably repeated and at least partly controlled by an internal control unit getting input from a sensor sensing any physical parameter of the patient or any functional parameter of the device.
Preferred embodiments of a clot removal device, a system comprising a clot removal device, and a method according to the invention have been described. A person skilled in the art realizes that these could be varied within the scope of the appended claims.
The blood clot removal device has been described as an artificial device insertable in an artificial blood vessel of the patient. Alternatively, the blood clot removal device is an artificial device adapted to be placed between two open ends of a blood vessel of the patient or be placed inside or attached to a blood vessel via surgery.
The blood clot removal device has been described to be placed in the patient's abdomen or thorax. It could also be adapted to be placed in the patient's retroperitoneal region or cephalic or neck region or any limb of the patient.
The filter in the blood clot removal device may be exchanged and replaced with a new fresh filter when it becomes dirty. One embodiment of such a solution is described below in fig 30 and 31. There are obvious many different solutions to solve the same problems.
In Fig. 30a a cassette 127 for holding filters is shown. The cassette 27 comprises a revolving cylinder 129 having segments 130 each holding a filter. The cylinder 129
is tightly sealed between two supports 131 holding the cylinder 129 in place and providing a tight sealing. Preferable are the contacting surfaces made of ceramics to seal the surfaces with fine tolerances. The blood flow passageway of an implantable blood clot removal apparatus passes through the cassette 127. The cassette is driven by a motor 133 causing the cylinder 129 to revolve at suitable times. Preferable the filter is designed to move any collected blood clots out from the blood flow passageway together with revolving filter, when the filter leaves the blood flow passageway to be replaced with a new filter. The filter may be any kind of filter preferable with a space for the collected blood clots or blood clots adherent to the filter itself. Such a space to both the sealing plates when rotating, should preferable be larger before the filter seen in the blood flow passageway. The motor is powered by a power supply 123b. The power supply can be a power supply like the power supplies 123 or 123 a. In accordance with one embodiment the power supplies 123, 123 a and 123b is the one and same power supply. As with the power supplies 123 and 123a, the power supply 123b can receive wireless energy in a suitable form, including but not limited to inductive energy ultrasonic energy, light energy or any other form of wireless energy set out above. The energy is supplied by an external wireless energy transmitter 6 adapted to transmit energy through the skin 5 of a patient having the cassette 127 implanted. The power supply 132b can also comprise a control unit as described above for controlling the revolving cassette 127. The control unit can provide feedback to the outside and receive input data from an external transceiver 7 in a manner similar to the control unit used in conjunction with control of the pump.
In Fig. 30b the cassette 127 is shown from the side with the supports 131 and the revolving cylinder spaced apart is a disassembled view.
In Fig. 31a an alternative embodiment of the cassette 127 is shown. The view in Fig. 30a is similar to the view in Fig. 31a. In the embodiment in Fig. 31a a magazine 135 having a number of cylinders 129 stored therein is provided. Hereby a cylinder 129 can by replaced by shifting the cylinders in the magazine 135. In one embodiment the cylinders are shifted by pressurized air or a motor. The filter is then first replaced in the blood flow passageway and thereafter in a position outside the blood flow
passageway replaced in the cassette. Such a replacement could preferable take place by having a number of filters in the cylinder 135 on one side of the cassette marked with 135 and moving the dirty filters out from the cassette into the cylinder on the other side of the cassette.
In an alternative embodiment the cylinder 135 is instead a cleaning device adapted to clean the filter at a position outside the blood flow passageway.
In Fig. 31b the cassette 127 is shown from the side with the supports 131 and the revolving cylinder spaced apart is a disassembled view.
Please note that any embodiment or part of embodiment or feature or method or associated system or part of system described herein may be combined in any combination.
Claims
1. A blood clot removal device for removing blood clots from the vascular system of a patient, the blood clot removal device being implantable in the patient's body and comprising:
a blood flow passageway,
a filter provided in the blood flow passageway for filtering blood clots, and
a cleaning device for cleaning the filter.
2. The device according to claim 1, wherein the cleaning device is adapted to move blood clots away from the blood flow passageway.
3. The device according to claim 2, wherein the cleaning device is adapted to move blood clots to a place free inside the patient' body.
4. The device according to claim 1 , comprising a collecting volume adapted to collect cleaned blood that has been cleaned from the filter.
5. The device according to claim 4, wherein the collecting volume comprises a bag.
6. The device according to claim 5, wherein the bag has a storage capacity of more than 100ml.
7. The device according to claim 1, wherein the cleaning device is adapted to slice, push or scratch away any clots from the filter.
8. The device according to claim 1 , wherein the cleaning device is adapted to suck away any clots from the filter.
9. The device according to claim 1 , wherein the cleaning device comprises a first piston.
10. The device according to claim 9, wherein an outer end portion of the first piston is provided with a first recess.
11. The device according to claim 9, wherein the first piston is provided with a plurality of channels for accommodating the filter in an extended position of said first piston.
12. The device according to claim 9, wherein the first piston is movable in a direction perpendicular to the direction of the blood flow passageway.
13. The device according to claim 12, wherein the first piston during movement is arranged to take away any clots from the filter.
14. The device according to claim 9, comprising a source of pressurized air controlling the movement of the first piston.
15. The device according to claim 9, comprising an electric motor controlling the movement of the first piston.
16. The device according to claim 9, comprising a solenoid controlling the movement of the first piston.
17. The device according to claim 9, comprising a second piston provided across the blood flow passageway from the first piston.
18. The device according to claim 17, wherein the second piston is movable in a direction essentially perpendicular to the direction of the blood flow passageway
19. The device according to claim 17, wherein the second piston is spring biased in the direction of the first piston.
20. The device according to claim 17, wherein an outer end portion of the second piston is provided with a second recess.
21. The device according to claim 17, comprising a third piston, which is movable in a direction perpendicular to both the direction of the blood flow passageway and the direction of movement of the first piston and of the second piston.
22. The device according to claim 1, wherein the filter is of biocompatible material.
23. The device according to claim 1 , wherein the filter comprises a plurality of strips.
24. The device according to claim 23, wherein the plurality of strips are equally spaced.
25. The device according to claim 23, wherein the plurality of strips has essentially rectangular cross-sectional shape.
26. The device according to claim 23, wherein the distance between two adjacent strips is less than 2 millimeters.
27. The device according to claim 26, wherein the distance between two adjacent strips is less than 1 millimeter.
28. The device according to claim 1 , wherein the blood flow passageway has an essentially square cross-sectional shape.
29. The device according to claim 1 , wherein the blood clot removal device is an artificial device insertable in or attached to a blood vessel of the patient.
30. The device according to claim 1 , wherein the blood clot removal device is adapted to be placed in a blood vessel via surgery.
31. The device according to claim 1 , wherein the blood clot removal device is adapted to be placed in the patient's abdomen.
32. The device according to claim 1 , wherein the blood clot removal device is adapted to be placed in the patient's thorax.
33. A blood clot removal system for removing blood clots of a patient, comprising a blood clot removal device according to claim 1 implanted in the patient.
34. The system according to claim 33, comprising a heart pump connected to the blood flow passageway.
35. The system according to claim 34, comprising a tube connecting the heart pump to the left ventricle of the patient's heart.
36. The system according to claim 34, comprising a tube for connecting the heart pump connected to the patient's aorta.
37. The system according to claim 33, comprising a switch, the switch being adapted to manually and non-invasively control a function of the blood clot removal device.
38. The system according to claim 37, wherein the switch is a subcutaneous switch.
39. The system according to claim 37, wherein the switch is an electric switch.
40. The system according to claim 33, comprising a hydraulic device for hydralically operating the blood clot removal device and having a hydraulic reservoir, wherein the blood clot removal device is adapted to non-invasively be regulated by manually pressing said hydraulic reservoir.
41. The system according to claim 33, comprising a wireless remote control for non-invasively regulating a function of the blood clot removal device.
42. The system according to claim 33, comprising a wireless energy transmitter for non-invasively energising the blood clot removal device.
43. The system according to claim 33, comprising an energy source adapted to power the blood clot removal device.
44. The system according to claim 43, wherein the energy source comprises an internal energy source.
45. The system according to claim 43, wherein the energy source is an internal energy source adapted to receive energy from an external energy source transmitting energy in a wireless mode.
46. The system according to claim 45, wherein the internal energy source is charged by the energy in the wireless mode.
47. The system according to claim 33, comprising a sensor sensing a parameter.
48. The system according to claim 47, wherein the sensor is a functional parameter sensor sensing a functional parameter of the blood clot removal system.
49. The system according to claim 47, wherein the functional parameter of the system is correlated to the transfer of energy for charging an internal energy source.
50. The system according to claim 3347, comprising a feedback device for sending information from inside the patient's body to the outside thereof to give feedback information related to a functional parameter of the blood clot removal device.
51. The system according to claim 47, comprising an internal control unit acting in response to a functional parameter sensed by the sensor.
52. The system according to claim 47, wherein the sensor is a physical parameter sensor sensing a physical parameter of the patient.
53. The system according to claim 52, wherein the physical parameter is one of body temperature, blood pressure, blood flow, heartbeats and breathing.
54. The system according to claim 52, wherein the physical parameter sensor is a pressure sensor.
55. The system according to claim 52, further comprising an internal control unit acting in response to the physical parameter sensed by the physical parameter sensor.
56. The system according to claim 33, comprising an operation device for operating the blood clot removal device.
57. The system according to claim 56, wherein the operation device comprises a motor or a pump.
58. The system according to claim 57, wherein the operation device comprises an electric motor.
59. The system according to claim 56, wherein the operation device is electrically powered.
60. The system according to claim 56, wherein the operation device comprises a hydraulic operation device.
61. The system according to claim 56, wherein the operation device comprises a pneumatic operation device.
62. A method of using the blood clot removal system according to claim 33, comprising the step of non-invasively regulating at least one function of the blood clot removal device from outside the patient's body.
63. The method according to claim 62, wherein the step of non-invasively regulating is performed by manually pressing a subcutaneous switch.
64. The method according to claim 62, wherein the system comprises a hydraulic reservoir connected to the blood clot removal device, and wherein the step of non- invasively regulating is performed by manually pressing said hydraulic reservoir.
65. The method according to claim 62, wherein the system comprises a wireless remote control, and wherein the step of non-invasively regulating is performed using said wireless remote control.
66. The method according to claim 62, wherein the system comprises a wireless energy transmitter, and wherein the step of non-invasively regulating is performed using said wireless energy transmitter.
67. The method according to claim 62, wherein an energy source is used for powering and adjusting a function of the blood clot removal device.
68. The method according to claim 67, wherein the energy source used comprises an internal energy source.
69. The method according to claim 68, wherein the internal energy source is associated with an external energy source adapted to transmit wireless energy.
70. The method according to claim 69, further comprising the step of transmitting energy from the external energy source to charge the internal energy source.
71. The method according to claim 70, further comprising the step of sending feedback information from inside the patient' s body to the outside thereof to give feed back related to a functional parameter of the device or physical parameter of the patient.
72. The method according to claim 71 , wherein the functional parameter of the device is correlated to the transfer of energy for charging the internal energy source.
73. A method of using the blood clot removal system according to claim 33, wherein wireless energy is transmitted for powering an operation device.
74. A method of using the blood clot removal system according to claim 33, comprising the steps of:
implanting an implantable source of energy in the patient,
- providing an external source of energy,
controlling the external source of energy to release wireless energy,
charging non-invasively the implantable source of energy with said wireless energy,
controlling the implantable source of energy from outside the patient's body, and releasing energy for use in connection with operation of the blood clot removal device.
75. The method according to claim 74, wherein the wireless energy is stored in the implantable source of energy.
76. The method of using the blood clot removal system according to claim 33, comprising the steps of:
providing an external source of energy outside the patient's body,
providing an operation device for operating the blood clot removal device,
controlling the external source of energy from outside the patient's body to release wireless energy, and
using said released wireless energy for operating the operation device.
77. The method according to claim 76, comprising the steps of transforming the wireless energy into electrical energy inside the patient's body using an implanted energy-transforming device and using said electrical energy when operating the blood clot removal device.
78. The method according to claim 77, further comprising directly using the electrical energy in connection with operation of the blood clot removal device, as a transforming device transforms the wireless energy into the electrical energy.
79. The method according to claim 76, further comprising the steps of:
- controlling the external source of energy from outside the patient's body to release non-magnetic wireless energy, and
using direct or indirect released non-magnetic wireless energy for operating the blood clot removal device.
80. The method according to claim 76, further comprising the steps of: controlling the external source of energy from outside the patient's body to release electromagnetic wireless energy, and
using direct or indirect released electromagnetic wireless energy for operating the blood clot removal device.
81. A method using an system according to claim 33, for postoperatively and non-invasively regulating the blood clot removal device, the method comprising the steps of:
moving any blood clots, which have been accumulated in the vascular system of the patient's body, away from the vascular system by means of the blood clot removal device, and
placing the blood clots outside the vascular system.
82. The method according to claim 81 , wherein the steps of moving any blood clots away from the vascular system and placing the blood clots outside the vascular system are powered by an energy source.
83. The method according to claim 81 , wherein the steps of moving any blood clots away from the vascular system and placing the blood clots outside the vascular system are repeated according to a pre-programmed time-schedule.
84 The method according to claim 81, wherein the steps of moving any blood clots away from the vascular system and placing the blood clots outside the vascular system are repeated and at least partly controlled by an internal control unit getting input from a sensor sensing any physical parameter of the patient or any functional parameter of the device.
85. A method for surgically placing a blood clot removal device in a patient via a laparoscopic abdominal approach, the method comprising the steps of:
- inserting a needle or a tube like instrument into the abdomen of the patient's body, using the needle or a tube like instrument to fill the patient's abdomen with gas thereby expanding the patient's abdominal cavity,
placing at least two laparoscopic trocars in the patient's body,
inserting a camera through one of the laparoscopic trocars into the patient's abdomen,
inserting at least one dissecting tool through one of said at least two laparoscopic trocars and dissecting an intended placement area of the patient,
placing a blood clot removal device in any part of the vascular system in the abdomen,
- moving blood clots away from vascular system post operatively, and
powering the device with a source of energy.
86. A method of surgically placing a blood clot removal device in a patient via a laparoscopic thoraxial approach, the method comprising the steps of:
inserting a needle or a tube like instrument into the thorax of the patient's body,
using the needle or a tube like instrument to fill the thorax with gas thereby expanding the thoraxical cavity,
placing at least two laparoscopic trocars in the patient's body,
inserting a camera through one of the laparoscopic trocars into the thorax,
- inserting at least one dissecting tool through one of said at least two laparoscopic trocars and dissecting an intended placement area of the patient,
placing a blood clot removal device in any part of the vascular system in the thorax,
moving blood clots away from vascular system post operatively, and powering the device with a source of energy,
87. The method according to claim 85 or 86, wherein the device is programmed from outside the body of the patient.
88. The method according to claim 85 or 86, wherein the step of moving blood clots away from vascular system post operatively to another a different part of the body comprises moving blood clots to a place that is free in the thorax.
89. The method according to claim 85 or 86, wherein the step of moving blood clots away from vascular system post operatively to another a different part of the body comprises moving blood clots to a place that is free in the abdomen.
90. The method according to claim 85 or 86, wherein the step of moving blood clots away from vascular system post operatively to another a different part of the body comprises moving blood clots to a place that is encapsulated in a closed bag in the thorax.
91. An operation method for surgically placing a blood clot removal device in a patient, the method comprising the steps of:
cutting the patient's skin,
dissecting a placement area where to place the blood clot removal device inside the vascular system in the abdomen or thorax or cephalic region retroperitoneal or subcutaneously or any limb of the patient,
- placing the blood clot removal device in the placement area,
removing, postoperatively and non-invasively, without penetrating the patent's skin, any blood clots from the vascular system to outside thereof, and
using energy from an energy source without any penetration through the patient's skin to power the blood clot removal device.
92. A method for surgically treating a patient needing a blood clot removal device in the vascular system in the patient's abdomen, the method comprising the steps of:
cutting an opening in the abdominal wall,
- dissecting an area of the vascular system,
placing the blood clot removal device inside the vascular system, and
suturing the abdominal wall.
93. A method for surgically treating a patient needing a blood clot removal device in the vascular system in the thorax, the method comprising the steps of:
- cutting an opening in the thorax wall,
dissecting an area of the vascular system,
placing the blood clot removal device inside the vascular system, and
suturing the thorax wall.
94. The method according to claim 92 or 93, comprising the step of moving blood clots away from the vascular system into an encapsulated closed bag in the patient's abdomen by means of the blood clot removal device.
95. The method according to claim 92 or 93, comprising the step of moving blood clots away from the vascular system into the free abdomen of the patient by means of the blood clot removal device.
96. The device according to claim 1 , wherein the blood clot removal device is an artificial device adapted to be placed between two open ends of a blood vessel of the patient.
97. The device according to claim 1, wherein the blood clot removal device is adapted to be placed attached to a blood vessel via surgery.
98. The device according to claim 1, wherein the blood clot removal device is adapted to be placed in any of the patient's limbs.
99. The device according to claim 1 , wherein the blood clot removal device is adapted to be placed in the patient's retroperitoneal region or cephalic or neck region of the patient.
100. The device according to claim 51 or 55, further comprising an operation device for operating the cleaning device, wherein the internal control unit controls the operation device to operate the cleaning device in response to the sensor sensing aparameter.
101. The device according to claim 1 , wherein the cleaning device is adapted to mechanically clean said filter.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21199129.4A EP3964243A1 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device, system, and method |
US12/864,828 US10729894B2 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device, system, and method |
EP09706196.4A EP2244662B1 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device and system |
ES09706196T ES2901553T3 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device and system |
US16/984,368 US11839848B2 (en) | 2008-01-28 | 2020-08-04 | Blood clot removal device, system, and method |
US18/499,253 US20240058736A1 (en) | 2008-01-28 | 2023-11-01 | Blood clot removal device, system, and method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US671108P | 2008-01-28 | 2008-01-28 | |
US61/006,711 | 2008-01-28 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/864,828 A-371-Of-International US10729894B2 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device, system, and method |
US16/984,368 Continuation US11839848B2 (en) | 2008-01-28 | 2020-08-04 | Blood clot removal device, system, and method |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009096855A1 true WO2009096855A1 (en) | 2009-08-06 |
Family
ID=40913032
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2009/000036 WO2009096851A1 (en) | 2008-01-28 | 2009-01-28 | A drainage device comprising a filter cleaning device |
PCT/SE2009/000040 WO2009096855A1 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device, system, and method |
PCT/SE2009/000041 WO2009096856A1 (en) | 2008-01-28 | 2009-01-28 | A drainage device comprising an active filter |
PCT/SE2009/000038 WO2009096853A1 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device, system, and method |
PCT/SE2009/000037 WO2009096852A1 (en) | 2008-01-28 | 2009-01-28 | An implantable drainage device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2009/000036 WO2009096851A1 (en) | 2008-01-28 | 2009-01-28 | A drainage device comprising a filter cleaning device |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2009/000041 WO2009096856A1 (en) | 2008-01-28 | 2009-01-28 | A drainage device comprising an active filter |
PCT/SE2009/000038 WO2009096853A1 (en) | 2008-01-28 | 2009-01-28 | Blood clot removal device, system, and method |
PCT/SE2009/000037 WO2009096852A1 (en) | 2008-01-28 | 2009-01-28 | An implantable drainage device |
Country Status (7)
Country | Link |
---|---|
US (19) | US8961448B2 (en) |
EP (8) | EP2244662B1 (en) |
JP (1) | JP5643113B2 (en) |
AU (3) | AU2009209515A1 (en) |
CA (6) | CA2749771C (en) |
ES (2) | ES2901553T3 (en) |
WO (5) | WO2009096851A1 (en) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6482145B1 (en) | 2000-02-14 | 2002-11-19 | Obtech Medical Ag | Hydraulic anal incontinence treatment |
US6464628B1 (en) | 1999-08-12 | 2002-10-15 | Obtech Medical Ag | Mechanical anal incontinence |
US6461292B1 (en) | 1999-08-12 | 2002-10-08 | Obtech Medical Ag | Anal incontinence treatment with wireless energy supply |
US6471635B1 (en) | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Anal incontinence disease treatment with controlled wireless energy supply |
CN1698552B (en) | 2000-02-10 | 2010-05-12 | 厄罗洛吉卡股份公司 | Controlled urinary incontinence treatment |
MXPA02007649A (en) * | 2000-02-10 | 2004-08-23 | Potencia Medical Ag | Urinary incontinence treatment with wireless energy supply. |
BR0108223B1 (en) | 2000-02-10 | 2009-08-11 | mechanical apparatus for the treatment of impotence. | |
MX340163B (en) | 2000-02-11 | 2016-06-29 | Potentica Ag | Impotence treatment apparatus with energy transforming means. |
ATE380006T1 (en) | 2000-02-11 | 2007-12-15 | Potencia Medical Ag | CONTROLLED IMPOTENCY TREATMENT |
DE60111019T2 (en) | 2000-02-14 | 2006-05-11 | Potencia Medical Ag | PROSTHESIS |
US20030100929A1 (en) * | 2000-02-14 | 2003-05-29 | Peter Forsell | Controlled penile prosthesis |
BR0108307B1 (en) | 2000-02-14 | 2009-12-01 | Prosthesis apparatus for the treatment of male sexual impotence with wireless power supply device. | |
US8202248B2 (en) | 2004-08-18 | 2012-06-19 | Sequana Medical Ag | Dialysis implant and methods of use |
CA2650570C (en) * | 2006-04-26 | 2017-06-06 | Eastern Virginia Medical School | Systems and methods for monitoring and controlling internal pressure of an eye or body part |
GB0623395D0 (en) | 2006-11-23 | 2007-01-03 | Renishaw Plc | Port |
US20080207983A1 (en) | 2007-02-22 | 2008-08-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Coded-sequence activation of surgical implants |
US8961448B2 (en) * | 2008-01-28 | 2015-02-24 | Peter Forsell | Implantable drainage device |
EP3970664A1 (en) * | 2008-01-28 | 2022-03-23 | Implantica Patent Ltd. | A fluid movement device |
US9060771B2 (en) | 2008-01-29 | 2015-06-23 | Peter Forsell | Method and instrument for treating obesity |
WO2009140202A1 (en) * | 2008-05-12 | 2009-11-19 | Cardionephrx, Inc. | Implantable fluid separation system |
EP3689318A1 (en) | 2008-10-10 | 2020-08-05 | MedicalTree Patent Ltd. | Heart help device and system |
EP2349096B1 (en) | 2008-10-10 | 2021-01-27 | MedicalTree Patent Ltd. | An improved artificial valve |
US20110196484A1 (en) | 2008-10-10 | 2011-08-11 | Milux Holding Sa | Heart help method |
EP2349170B1 (en) | 2008-10-10 | 2023-09-27 | Implantica Patent Ltd. | Apparatus for the treatment of female sexual dysfunction |
EP3120896A1 (en) | 2008-10-10 | 2017-01-25 | Kirk Promotion LTD. | A system, an apparatus, and a method for treating a sexual dysfunctional female patient |
WO2010042032A1 (en) | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | Fastening means for implantable medcial control assembly |
US9095436B2 (en) * | 2009-04-14 | 2015-08-04 | The Invention Science Fund I, Llc | Adjustable orthopedic implant and method for treating an orthopedic condition in a subject |
US9949812B2 (en) | 2009-07-17 | 2018-04-24 | Peter Forsell | Vaginal operation method for the treatment of anal incontinence in women |
US10952836B2 (en) | 2009-07-17 | 2021-03-23 | Peter Forsell | Vaginal operation method for the treatment of urinary incontinence in women |
GB201002370D0 (en) | 2010-02-12 | 2010-03-31 | Renishaw Ireland Ltd | Percutaneous drug delivery apparatus |
AU2012217696B2 (en) | 2011-02-16 | 2015-11-12 | Sequana Medical Nv | Apparatus and methods for treating intracorporeal fluid accumulation |
US8585635B2 (en) | 2012-02-15 | 2013-11-19 | Sequana Medical Ag | Systems and methods for treating chronic liver failure based on peritoneal dialysis |
GB201217606D0 (en) | 2012-10-02 | 2012-11-14 | Renishaw Plc | Neurosurgical device and method |
GB2510166B (en) | 2013-01-28 | 2015-05-20 | Cook Medical Technologies Llc | Thrombus removal apparatus |
US9126009B2 (en) | 2013-03-12 | 2015-09-08 | DePuy Synthes Products, Inc. | System and method for determining position and pressure of an implantable shunt |
WO2014150288A2 (en) | 2013-03-15 | 2014-09-25 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
DE102013106352A1 (en) * | 2013-06-18 | 2014-12-18 | Universität Zu Lübeck | Cardiac support system and cardiac assistive procedure |
WO2015200797A2 (en) * | 2014-06-26 | 2015-12-30 | The Trustees Of The University Of Pennsylvania | Devices and methods for alleviating lymphatic system congestion |
CA2906099C (en) | 2014-09-30 | 2022-10-11 | DePuy Synthes Products, Inc. | Optical reading of an implantable valve |
GB201417623D0 (en) | 2014-10-06 | 2014-11-19 | Ecole Polytech | Medical fluid drainage system and method |
CN108697423A (en) | 2016-02-16 | 2018-10-23 | 伊瑟拉医疗公司 | The part flow arrangement of suction unit and anchoring |
US10716922B2 (en) | 2016-08-26 | 2020-07-21 | Sequana Medical Nv | Implantable fluid management system having clog resistant catheters, and methods of using same |
US10769244B2 (en) | 2016-08-26 | 2020-09-08 | Sequana Medical Nv | Systems and methods for managing and analyzing data generated by an implantable device |
US11253683B2 (en) * | 2017-02-07 | 2022-02-22 | ewimed | Method and apparatus for treating ascites |
WO2018170064A1 (en) | 2017-03-15 | 2018-09-20 | Merit Medical Systems, Inc. | Transluminal stents and related methods |
US10898631B2 (en) | 2017-05-24 | 2021-01-26 | Sequana Medical Nv | Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients |
US11559618B2 (en) | 2017-05-24 | 2023-01-24 | Sequana Medical Nv | Formulations and methods for direct sodium removal in patients having severe renal dysfunction |
US10687676B2 (en) * | 2017-06-09 | 2020-06-23 | Hamilton Sundstrand Corporation | Microgravity urine collection and storage |
EP3672677A1 (en) * | 2017-08-25 | 2020-07-01 | Strataca Systems Limited | Indwelling pump for facilitating removal of urine from the urinary tract |
US10696906B2 (en) | 2017-09-29 | 2020-06-30 | Marathon Petroleum Company Lp | Tower bottoms coke catching device |
KR102082503B1 (en) * | 2017-10-31 | 2020-04-23 | 재단법인 아산사회복지재단 | Drainage bag assembly |
USD847864S1 (en) | 2018-01-22 | 2019-05-07 | Insera Therapeutics, Inc. | Pump |
US12000720B2 (en) | 2018-09-10 | 2024-06-04 | Marathon Petroleum Company Lp | Product inventory monitoring |
WO2020163380A1 (en) * | 2019-02-05 | 2020-08-13 | Merit Medical Systems, Inc. | Vacuum assisted drainage reservoir and systems |
US12031676B2 (en) | 2019-03-25 | 2024-07-09 | Marathon Petroleum Company Lp | Insulation securement system and associated methods |
US11975316B2 (en) | 2019-05-09 | 2024-05-07 | Marathon Petroleum Company Lp | Methods and reforming systems for re-dispersing platinum on reforming catalyst |
US11124714B2 (en) | 2020-02-19 | 2021-09-21 | Marathon Petroleum Company Lp | Low sulfur fuel oil blends for stability enhancement and associated methods |
KR20210127836A (en) * | 2020-04-14 | 2021-10-25 | 삼성전자주식회사 | Wireless power receiver and object stimulator |
US20210361840A1 (en) * | 2020-05-22 | 2021-11-25 | Fenwal, Inc. | Systems and methods for pumping saline through a sterilizing filter |
CN111558246B (en) * | 2020-05-28 | 2021-11-09 | 林汉斌 | Refining frame with high-precision screening function for medical reagent processing |
US11702600B2 (en) | 2021-02-25 | 2023-07-18 | Marathon Petroleum Company Lp | Assemblies and methods for enhancing fluid catalytic cracking (FCC) processes during the FCC process using spectroscopic analyzers |
US11898109B2 (en) | 2021-02-25 | 2024-02-13 | Marathon Petroleum Company Lp | Assemblies and methods for enhancing control of hydrotreating and fluid catalytic cracking (FCC) processes using spectroscopic analyzers |
US11905468B2 (en) | 2021-02-25 | 2024-02-20 | Marathon Petroleum Company Lp | Assemblies and methods for enhancing control of fluid catalytic cracking (FCC) processes using spectroscopic analyzers |
US20220268694A1 (en) | 2021-02-25 | 2022-08-25 | Marathon Petroleum Company Lp | Methods and assemblies for determining and using standardized spectral responses for calibration of spectroscopic analyzers |
US12037548B2 (en) | 2021-10-10 | 2024-07-16 | Marathon Petroleum Company Lp | Methods and systems for enhancing processing of hydrocarbons in a fluid catalytic cracking unit using a renewable additive |
US12018216B2 (en) | 2021-10-10 | 2024-06-25 | Marathon Petroleum Company Lp | Methods and systems for enhancing processing of hydrocarbons in a fluid catalytic cracking unit using plastic |
US11692141B2 (en) | 2021-10-10 | 2023-07-04 | Marathon Petroleum Company Lp | Methods and systems for enhancing processing of hydrocarbons in a fluid catalytic cracking unit using a renewable additive |
US11802257B2 (en) | 2022-01-31 | 2023-10-31 | Marathon Petroleum Company Lp | Systems and methods for reducing rendered fats pour point |
KR20230172060A (en) * | 2022-06-14 | 2023-12-22 | 주식회사 유메드 | Bladder continuous irrigation apparatus and method thereof |
WO2024035645A1 (en) * | 2022-08-08 | 2024-02-15 | The Children's Hospital Of Philadelphia | Expandable flow detection system for alleviating lymphatic system congestion |
US20240189753A1 (en) * | 2022-12-08 | 2024-06-13 | Marathon Petroleum Company Lp | Removable flue gas strainer and associated methods |
CN116899338B (en) * | 2023-05-31 | 2024-06-04 | 山东兆鼎瓷业有限公司 | Flue gas treatment process and device for foamed ceramic production |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001012108A1 (en) * | 1999-08-12 | 2001-02-22 | Potencia Medical Ag | Medical implant apparatus with wireless energy transmission |
WO2001045590A2 (en) * | 1999-12-23 | 2001-06-28 | Percusurge, Inc. | Strut design for an occlusion device |
US20020151922A1 (en) * | 1998-05-13 | 2002-10-17 | Michael Hogendijk | Apparatus and methods for removing emboli during a surgical procedure |
US20020165575A1 (en) * | 2001-05-07 | 2002-11-07 | Saleh Fathy M.A. | Vascular filtration device |
WO2005072169A2 (en) * | 2004-01-20 | 2005-08-11 | Massachusetts General Hospital | Permanent thrombus filtering stent |
US20050266042A1 (en) * | 2004-05-27 | 2005-12-01 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
US20060224177A1 (en) * | 2005-04-01 | 2006-10-05 | Stephanos Finitsis | Thrombus removal system and process |
Family Cites Families (866)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2734649A (en) * | 1956-02-14 | Moistureproof vial closure | ||
US2060913A (en) * | 1934-07-07 | 1936-11-17 | Western Electric Co | Electrical conductor |
US2279834A (en) * | 1941-04-14 | 1942-04-14 | Howard H Mcgee | Valve |
US2795641A (en) | 1953-12-03 | 1957-06-11 | Rowell Ross Fredrick | Cord supporting coil |
US2776055A (en) * | 1954-08-13 | 1957-01-01 | Medical Plastics Inc | Blood filter with clot remover |
US3017050A (en) * | 1955-01-10 | 1962-01-16 | Sr Courtland H Barr | Blood sample collection apparatus |
US2869543A (en) * | 1957-08-23 | 1959-01-20 | Iowa Cooperative Ass | Injector |
GB885674A (en) | 1959-07-20 | 1961-12-28 | Interscience Res Corp | Improvements in or relating to mechanical hearts |
US3127892A (en) * | 1960-07-13 | 1964-04-07 | Baxter Laboratories Inc | Blood handling apparatus |
US3209081A (en) | 1961-10-02 | 1965-09-28 | Behrman A Ducote | Subcutaneously implanted electronic device |
US3429314A (en) * | 1965-07-26 | 1969-02-25 | Kendall & Co | Self-venting drainage system for body fluids |
GB1194358A (en) | 1967-11-22 | 1970-06-10 | Dana Christopher Mears | Fluid Flow Control Valve. |
US3662758A (en) | 1969-06-30 | 1972-05-16 | Mentor Corp | Stimulator apparatus for muscular organs with external transmitter and implantable receiver |
US3598287A (en) | 1969-08-01 | 1971-08-10 | Heiko T De Man | Liquid dispenser with level control |
US3705575A (en) | 1969-09-26 | 1972-12-12 | Lynn Euryl Edwards | Incontinence device for female use |
US4141361A (en) * | 1970-02-09 | 1979-02-27 | Snyder Manufacturing Co., Incorporated | Evacuator |
US3731681A (en) | 1970-05-18 | 1973-05-08 | Univ Minnesota | Implantable indusion pump |
US3683926A (en) * | 1970-07-09 | 1972-08-15 | Dainippon Pharmaceutical Co | Tube for connecting blood vessels |
US3731679A (en) | 1970-10-19 | 1973-05-08 | Sherwood Medical Ind Inc | Infusion system |
US3683929A (en) * | 1970-12-28 | 1972-08-15 | Extracorporeal Med Spec | Device for draining cerebrospinal fluid in cases of hydrocephalus |
US3677242A (en) * | 1971-01-11 | 1972-07-18 | Baxter Laboratories Inc | Air block prevention system |
US3750194A (en) | 1971-03-16 | 1973-08-07 | Fairchild Industries | Apparatus and method for reversibly closing a natural or implanted body passage |
US3788327A (en) * | 1971-03-30 | 1974-01-29 | H Donowitz | Surgical implant device |
US3692027A (en) | 1971-04-23 | 1972-09-19 | Everett H Ellinwood Jr | Implanted medication dispensing device and method |
US3783868A (en) * | 1971-05-06 | 1974-01-08 | Gulf Oil Corp | Percutaneous implant |
FR2138333B1 (en) | 1971-05-24 | 1974-03-08 | Rhone Poulenc Sa | |
US3917120A (en) * | 1971-11-11 | 1975-11-04 | Merck Patent Gmbh | Single use container for liquid pharmaceutical compositions |
US3817237A (en) | 1972-08-24 | 1974-06-18 | Medtronic Inc | Regulatory apparatus |
US3818511A (en) * | 1972-11-17 | 1974-06-25 | Medical Prod Corp | Medical prosthesis for ducts or conduits |
US3863622A (en) * | 1973-01-09 | 1975-02-04 | Robert Enno Buuck | Incontinence system and methods of implanting and using same |
US3875928A (en) * | 1973-08-16 | 1975-04-08 | Angelchik Jean P | Method for maintaining the reduction of a sliding esophageal hiatal hernia |
US3906674A (en) | 1973-12-13 | 1975-09-23 | Lowell D Stone | Valve cleaner |
US3900028A (en) * | 1974-02-26 | 1975-08-19 | American Hospital Supply Corp | Injection site for sterile medical liquid container |
US3998222A (en) * | 1974-04-15 | 1976-12-21 | Shihata Alfred A | Subcutaneous arterio-venous shunt with valve |
US4003379A (en) * | 1974-04-23 | 1977-01-18 | Ellinwood Jr Everett H | Apparatus and method for implanted self-powered medication dispensing |
US3923060A (en) * | 1974-04-23 | 1975-12-02 | Jr Everett H Ellinwood | Apparatus and method for implanted self-powered medication dispensing having timing and evaluator means |
US3938520A (en) * | 1974-06-10 | 1976-02-17 | Abbott Laboratories | Transfer unit having a dual channel transfer member |
US3954102A (en) | 1974-07-19 | 1976-05-04 | American Medical Systems, Inc. | Penile erection system and methods of implanting and using same |
US4026305A (en) | 1975-06-26 | 1977-05-31 | Research Corporation | Low current telemetry system for cardiac pacers |
FR2347030A1 (en) | 1975-08-04 | 1977-11-04 | Guiset Jacques | PROTHETIC BLADDER |
US4033345A (en) * | 1975-11-13 | 1977-07-05 | Sorenson Research Co., Inc. | Autologous transfusion filter system and method |
US4009711A (en) * | 1976-03-17 | 1977-03-01 | Uson Aurelio C | Penile prosthesis for the management of erectile impotence |
US4206762A (en) * | 1976-06-21 | 1980-06-10 | Cosman Eric R | Telemetric differential pressure sensing method |
US4281667A (en) * | 1976-06-21 | 1981-08-04 | Cosman Eric R | Single diaphragm telemetric differential pressure sensing system |
US4056116A (en) * | 1976-09-08 | 1977-11-01 | Baxter Travenol Laboratories, Inc. | Valve for interconnecting sterile containers and the like |
US4152269A (en) * | 1977-02-01 | 1979-05-01 | Warner-Lambert Company | Collection and separation device |
US4230582A (en) * | 1978-02-01 | 1980-10-28 | Tuleja Anthony Z | Drain traps with strainer means |
US4190534A (en) * | 1978-05-08 | 1980-02-26 | Armco Steel Corporation | Waste water filtration and sludge removal system |
US4243306A (en) * | 1978-05-30 | 1981-01-06 | Bononi Walter H | Pad device |
US4246893A (en) * | 1978-07-05 | 1981-01-27 | Daniel Berson | Inflatable gastric device for treating obesity |
US4187893A (en) * | 1978-07-19 | 1980-02-12 | Abbott Laboratories | Combined additive and administration port for a container |
US4221219A (en) * | 1978-07-31 | 1980-09-09 | Metal Bellows Corporation | Implantable infusion apparatus and method |
SE412748B (en) | 1978-09-15 | 1980-03-17 | Engwall Sten | sheet winches |
US4201202A (en) | 1978-09-25 | 1980-05-06 | Medical Engineering Corp. | Penile implant |
US4235222A (en) * | 1978-10-19 | 1980-11-25 | Istrate Ionescu | Heat-responsive alignment system and solar collection device |
US4306705A (en) * | 1979-01-22 | 1981-12-22 | Svensson Jan A | Slide valve and coupler assembly |
US4217664A (en) * | 1979-02-02 | 1980-08-19 | Faso Joseph M | Prosthesis and method for creating a stoma |
US4265241A (en) | 1979-02-28 | 1981-05-05 | Andros Incorporated | Implantable infusion device |
US4360019A (en) * | 1979-02-28 | 1982-11-23 | Andros Incorporated | Implantable infusion device |
US4304225A (en) | 1979-04-30 | 1981-12-08 | Lloyd And Associates | Control system for body organs |
US4271827A (en) | 1979-09-13 | 1981-06-09 | Angelchik Jean P | Method for prevention of gastro esophageal reflux |
US4274407A (en) | 1979-11-13 | 1981-06-23 | Med Pump, Inc. | Fluid injection system |
US4381775A (en) * | 1980-02-05 | 1983-05-03 | Takeda Chemical Industries, Ltd. | Method for low pressure filtration of plasma from blood |
US4686085A (en) * | 1980-04-14 | 1987-08-11 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4426893A (en) * | 1980-04-28 | 1984-01-24 | Lear Siegler, Inc. | High production serrator |
US4318396A (en) * | 1980-05-15 | 1982-03-09 | Medical Engineering Corporation | Penile prosthesis |
DE3019996A1 (en) * | 1980-05-24 | 1981-12-03 | Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen | HOHLORGAN |
JPS5935631B2 (en) * | 1980-07-24 | 1984-08-29 | テルモ株式会社 | Body fluid “filtration” device |
US4429693A (en) * | 1980-09-16 | 1984-02-07 | Blake L W | Surgical fluid evacuator |
US4342308A (en) | 1980-10-02 | 1982-08-03 | Medical Engineering Corporation | Penile erectile system |
US4400169A (en) | 1980-10-27 | 1983-08-23 | University Of Utah Research Foundation | Subcutaneous peritoneal injection catheter |
US4441215A (en) * | 1980-11-17 | 1984-04-10 | Kaster Robert L | Vascular graft |
US4424132A (en) * | 1981-02-05 | 1984-01-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Apparatus and method for separating blood components |
EP0378251B1 (en) | 1981-03-18 | 1994-06-01 | Günther Walter Otto Bramm | Magnetically suspended and rotated impellor pump apparatus |
US4405053A (en) * | 1981-04-27 | 1983-09-20 | Abbott Laboratories | Tamperproof closure system for plastic containers |
US4447230A (en) * | 1981-08-05 | 1984-05-08 | Quest Medical, Inc. | Intravenous administration set assembly |
US4412530A (en) * | 1981-09-21 | 1983-11-01 | American Medical Systems, Inc. | Dual-mode valve pressure regulating system |
US4369771A (en) * | 1981-09-24 | 1983-01-25 | Medical Engineering Corporation | Penile erectile system |
JPS5859749U (en) * | 1981-10-16 | 1983-04-22 | オリンパス光学工業株式会社 | container cap |
US4399042A (en) * | 1981-10-19 | 1983-08-16 | The Dehydro Corporation | Filter devices and methods |
US4424807A (en) * | 1981-10-20 | 1984-01-10 | Evans Sr Alvin S | Penile implant |
US4503568A (en) * | 1981-11-25 | 1985-03-12 | New England Deaconess Hospital | Small diameter vascular bypass and method |
US4456175A (en) | 1981-12-03 | 1984-06-26 | Dnepropetrovsky Khimiko-Tekhnologichesky Institut Imeni F. E. Dzerzhinskogo | Nozzle assembly for liquid spraying in coke oven ascension pipe |
US4509947A (en) * | 1982-08-02 | 1985-04-09 | Medtronic, Inc. | Self-cleaning drug delivery catheter and storage bladder |
US4771772A (en) * | 1982-08-09 | 1988-09-20 | Medtronic, Inc. | Robotic implantable medical device and/or component restoration system |
EP0102548B1 (en) | 1982-08-09 | 1988-11-02 | Medtronic, Inc. | Apparatus including an at least partially implantable device and method for maintaining such a device viable |
US4628928A (en) | 1982-08-09 | 1986-12-16 | Medtronic, Inc. | Robotic implantable medical device and/or component restoration system |
US4599081A (en) | 1982-09-30 | 1986-07-08 | Cohen Fred M | Artificial heart valve |
US4542753A (en) * | 1982-12-22 | 1985-09-24 | Biosonics, Inc. | Apparatus and method for stimulating penile erectile tissue |
IL67773A (en) | 1983-01-28 | 1985-02-28 | Antebi E | Tie for tying live tissue and an instrument for performing said tying operation |
US4643718A (en) * | 1983-02-22 | 1987-02-17 | Applied Immunesciences, Inc. | Therapeutic apheresis |
US4505710A (en) * | 1983-05-13 | 1985-03-19 | Collins Earl R | Implantable fluid dispensing system |
US4491461A (en) * | 1983-05-17 | 1985-01-01 | Hoekstra Irenus A | Method of desulfurization of flue gases |
EP0126718A3 (en) * | 1983-05-20 | 1985-10-23 | Bengt Gustavsson | A device for transferring a substance from one vessel to another and further to the intended application |
DE3326250A1 (en) * | 1983-07-21 | 1985-01-31 | Lang Apparatebau GmbH, 8227 Siegsdorf | BELLOW PUMP |
US4595390A (en) * | 1983-07-21 | 1986-06-17 | Salomon Hakim | Magnetically-adjustable cerebrospinal fluid shunt valve |
US4714460A (en) * | 1983-07-29 | 1987-12-22 | Reynaldo Calderon | Methods and systems for retrograde perfusion in the body for curing it of the disease or immume deficiency |
ATE38938T1 (en) | 1983-08-22 | 1988-12-15 | Univ Utah Res Found | PERITONEAL INJECTION CATHETER DEVICE. |
US4584994A (en) | 1983-09-30 | 1986-04-29 | Charles Bamberger | Electromagnetic implant |
US4507114A (en) * | 1983-10-21 | 1985-03-26 | Baxter Travenol Laboratories, Inc. | Multiple chamber container having leak detection compartment |
US4550720A (en) * | 1983-11-15 | 1985-11-05 | Medical Engineering Corporation | Capacitance device for medical implant |
FR2555056B1 (en) * | 1983-11-18 | 1986-02-28 | Aerospatiale | TOTAL HEART PROSTHESIS COMPRISING TWO DECOUPLED PUMPS ASSOCIATED IN A FUNCTIONALLY INDEPENDENT UNIT, AND ELECTRICALLY CONTROLLED VALVES FOR SUCH A PROSTHESIS |
US4563175A (en) * | 1983-12-19 | 1986-01-07 | Lafond Margaret | Multiple syringe pump |
DE3408331C2 (en) * | 1984-03-07 | 1986-06-12 | Fresenius AG, 6380 Bad Homburg | Pumping arrangement for medical purposes |
DE3587885T2 (en) | 1984-03-21 | 1994-11-03 | Mclaughlin William F | Filtration of a liquid suspension. |
FR2561922B1 (en) * | 1984-04-02 | 1987-04-30 | Biomasys | DEVICE FOR ATRAUMATIC ACCESS TO THE BLOOD CIRCUIT |
US4619651A (en) * | 1984-04-16 | 1986-10-28 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
US4556050A (en) | 1984-05-02 | 1985-12-03 | Hodgson Darel E | Artificial sphincter including a shape memory member |
US4559930A (en) | 1984-05-07 | 1985-12-24 | Cobiski John F | Thoracic bench |
US4627832A (en) * | 1984-05-08 | 1986-12-09 | Cordis Corporation | Three stage intracranial pressure relief valve having single-piece valve stem |
US4668222A (en) * | 1984-05-25 | 1987-05-26 | Thermedics Inc. | Percutaneous access device with removable tube |
US4583523A (en) | 1984-07-02 | 1986-04-22 | Lloyd & Associates | Implantable heart assist device and method of implanting same |
EP0192712A1 (en) | 1984-09-05 | 1986-09-03 | Intra Optics Laboratories Pty. Limited | Control of blood flow |
US4568851A (en) * | 1984-09-11 | 1986-02-04 | Raychem Corporation | Piezoelectric coaxial cable having a helical inner conductor |
US4643716A (en) * | 1984-09-26 | 1987-02-17 | The Kendall Company | Multi-size ureteral stent |
US4598579A (en) * | 1984-10-23 | 1986-07-08 | Cordis Corporation | Portable instrument to test pressure/flow of ventricular shunt valves |
US4664100A (en) | 1984-11-19 | 1987-05-12 | Rudloff David A C | Penile implant |
US4756949A (en) | 1984-11-29 | 1988-07-12 | Kimberly-Clark Corporation | Method for producing pad structures with viscoelastic cores and article so made |
US4602621A (en) | 1984-12-18 | 1986-07-29 | Hakky Said I | Manually actuated, self contained penile implant |
JPS63501471A (en) | 1984-12-27 | 1988-06-09 | サントリー株式会社 | Method for purifying interferon |
DE3587090T2 (en) | 1984-12-28 | 1993-06-03 | Toshiba Kawasaki Kk | REGULATED POWER SUPPLY. |
US4610658A (en) * | 1985-02-21 | 1986-09-09 | Henry Buchwald | Automated peritoneovenous shunt |
EP0200286A3 (en) | 1985-02-28 | 1987-01-14 | Quotidian No. 100 Pty. Limited | Control of blood flow |
US4679560A (en) | 1985-04-02 | 1987-07-14 | Board Of Trustees Of The Leland Stanford Junior University | Wide band inductive transdermal power and data link |
US4592339A (en) | 1985-06-12 | 1986-06-03 | Mentor Corporation | Gastric banding device |
US4781677A (en) * | 1985-07-17 | 1988-11-01 | Wilcox Gilbert M | Method of treatment utilizing a double balloon nasobiliary occlusion catheter |
US4696288A (en) * | 1985-08-14 | 1987-09-29 | Kuzmak Lubomyr I | Calibrating apparatus and method of using same for gastric banding surgery |
US4698058A (en) * | 1985-10-15 | 1987-10-06 | Albert R. Greenfeld | Ultrasonic self-cleaning catheter system for indwelling drains and medication supply |
US4676772A (en) * | 1985-12-23 | 1987-06-30 | Cordis Corporation | Adjustable implantable valve having non-invasive position indicator |
US4681570A (en) * | 1985-12-26 | 1987-07-21 | Dalton Michael J | Peritoneal catheter |
US4728430A (en) * | 1986-02-10 | 1988-03-01 | Millipore Corporation | Diafiltration method |
US4828543A (en) * | 1986-04-03 | 1989-05-09 | Weiss Paul I | Extracorporeal circulation apparatus |
US5049129A (en) * | 1986-05-29 | 1991-09-17 | Zdeb Brian D | Adapter for passive drug delivery system |
US4871354A (en) * | 1986-07-24 | 1989-10-03 | The West Company | Wet-dry bag with lyphozation vial |
IE60235B1 (en) * | 1986-09-18 | 1994-06-15 | Kabi Pharmacia Ab | "Connector and disposable assembly utilising said connector" |
US4723538A (en) * | 1986-10-16 | 1988-02-09 | Stewart Edward T | Penile constrictor ring |
US4711231A (en) | 1986-11-03 | 1987-12-08 | Aaron N. Finegold | Implantable prosthesis system |
US4771780A (en) * | 1987-01-15 | 1988-09-20 | Siemens-Pacesetter, Inc. | Rate-responsive pacemaker having digital motion sensor |
GB8701731D0 (en) * | 1987-01-27 | 1987-03-04 | Patcentre Benelux Nv Sa | Pumps |
DE3705637A1 (en) * | 1987-02-21 | 1988-09-29 | Bissendorf Peptide Gmbh | DEVICE FOR REMOVING LOCALLY APPLIED ACTIVE SUBSTANCES AGAINST SOLID TUMORS |
US4925443A (en) | 1987-02-27 | 1990-05-15 | Heilman Marlin S | Biocompatible ventricular assist and arrhythmia control device |
US5098369A (en) * | 1987-02-27 | 1992-03-24 | Vascor, Inc. | Biocompatible ventricular assist and arrhythmia control device including cardiac compression pad and compression assembly |
FR2621248B1 (en) | 1987-03-31 | 1989-08-18 | Sroussi Donald | DEVICE IMPLANTABLE IN THE ORGANISM FOR REPEATED INJECTION OF PRECISE DOSES OF LIQUID MEDICINAL SUBSTANCES |
IT1204717B (en) * | 1987-06-16 | 1989-03-10 | Claber Spa | VASCULAR ACCESS DEVICE, PARTICULARLY FOR BLOOD PURIFICATION TREATMENTS |
US4829990A (en) | 1987-06-25 | 1989-05-16 | Thueroff Joachim | Implantable hydraulic penile erector |
NL8701644A (en) | 1987-07-13 | 1989-02-01 | Cordis Europ | DEVICE FOR DOSING IN THE BODY OF A LIQUID MATERIAL. |
US4846794A (en) | 1987-08-13 | 1989-07-11 | The Cleveland Clinic Foundation | Coiled tubing for intravenous and intra-arterial applications |
US5092849A (en) * | 1987-08-25 | 1992-03-03 | Shiley Infusaid, Inc. | Implantable device |
GB8722854D0 (en) * | 1987-09-29 | 1987-11-04 | Hardy S M | Implantable artificial kidney |
US4863453A (en) * | 1987-12-22 | 1989-09-05 | Sherwood Medical Company | Sterile closure device |
US5062835A (en) * | 1988-01-15 | 1991-11-05 | Maitz Carlos A | Aspirator device for body fluids |
US4981474A (en) * | 1988-02-16 | 1991-01-01 | Baxter Travenol Laboratories, Inc. | Body fluid drainage device |
US5009894A (en) * | 1988-03-07 | 1991-04-23 | Baker Cummins Pharmaceuticals, Inc. | Arrangement for and method of administering a pharmaceutical preparation |
US4883460A (en) * | 1988-04-25 | 1989-11-28 | Zanetti Paul H | Technique for removing deposits from body vessels |
US4942668A (en) | 1988-05-11 | 1990-07-24 | Zircon International, Inc. | Digital inclinometer |
US4979955A (en) | 1988-06-06 | 1990-12-25 | Smith Robert M | Power assisted prosthetic heart valve |
JP2675075B2 (en) * | 1988-06-10 | 1997-11-12 | 株式会社新素材総合研究所 | Container with contents |
US4955857A (en) * | 1988-07-18 | 1990-09-11 | Shettigar Udipi R | Multi-enzyme bioreactor therapy for cancer |
US5152743A (en) * | 1988-08-05 | 1992-10-06 | Healthdyne, Inc. | Apparatus and method for selective separation of blood cholesterol |
US5151082A (en) * | 1988-08-05 | 1992-09-29 | Heathdyne, Inc. | Apparatus and method for kidney dialysis using plasma in lieu of blood |
US5224926A (en) | 1988-08-05 | 1993-07-06 | Healthdyne, Inc. | Transvivo plasma extraction catheter device |
US4950224A (en) * | 1988-08-05 | 1990-08-21 | Healthdyne, Inc. | Apparatus and method for in vivo plasma separation |
AU4191989A (en) * | 1988-08-24 | 1990-03-23 | Marvin J. Slepian | Biodegradable polymeric endoluminal sealing |
US5098377A (en) * | 1988-09-06 | 1992-03-24 | Baxter International Inc. | Multimodal displacement pump and dissolution system for same |
US4902279A (en) * | 1988-10-05 | 1990-02-20 | Autoject Systems Inc. | Liquid medicament safety injector |
US5681275A (en) * | 1988-10-07 | 1997-10-28 | Ahmed; Abdul Mateen | Ophthalmological device with adaptable multiple distribution plates |
US5123428A (en) | 1988-10-11 | 1992-06-23 | Schwarz Gerald R | Laparoscopically implanting bladder control apparatus |
US5012822A (en) | 1988-10-11 | 1991-05-07 | Schwarz Gerald R | Method for controlling urinary incontinence |
US5069662A (en) * | 1988-10-21 | 1991-12-03 | Delcath Systems, Inc. | Cancer treatment |
US4982731A (en) * | 1988-10-26 | 1991-01-08 | The Regents Of The University Of California | Implantable system and method for augmenting penile erection |
US5018646A (en) * | 1988-11-23 | 1991-05-28 | S. C. Johnson & Son, Inc. | Squeezable fluid container |
US5062416A (en) * | 1988-12-01 | 1991-11-05 | Stucks Albert A | Penile erection system |
US5011488A (en) * | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US5765706A (en) * | 1989-02-03 | 1998-06-16 | Senetics, Inc. | Flush mounted indicator device |
JPH02212768A (en) * | 1989-02-13 | 1990-08-23 | Terumo Corp | Blood sampling tube |
US5049146A (en) * | 1989-05-31 | 1991-09-17 | Baxter International, Inc. | Blood/gas separator and flow system |
WO1991000094A1 (en) | 1989-06-28 | 1991-01-10 | Finn Tranberg | A new papaverine injection system |
DE58903472D1 (en) | 1989-08-09 | 1993-03-18 | Siemens Ag | IMPLANTABLE INJECTION BODY. |
US4941461A (en) | 1989-09-05 | 1990-07-17 | Fischell Robert | Electrically actuated inflatable penile erection device |
US5042084A (en) | 1989-09-07 | 1991-08-20 | Cochlear Pty. Limited | Three wire system for Cochlear implant processor |
US5100564A (en) * | 1990-11-06 | 1992-03-31 | Pall Corporation | Blood collection and processing system |
US5876425A (en) * | 1989-09-22 | 1999-03-02 | Advanced Bionics Corporation | Power control loop for implantable tissue stimulator |
US5092839A (en) * | 1989-09-29 | 1992-03-03 | Kipperman Robert M | Coronary thrombectomy |
US5578267A (en) * | 1992-05-11 | 1996-11-26 | Minntech Corporation | Cylindrical blood heater/oxygenator |
US4958630A (en) * | 1989-10-06 | 1990-09-25 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating impotence |
US5048511A (en) * | 1989-10-06 | 1991-09-17 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating impotence |
US5057075A (en) | 1989-12-13 | 1991-10-15 | Moncrief Jack W | Method for implanting a catheter |
US4968296A (en) * | 1989-12-20 | 1990-11-06 | Robert Ritch | Transscleral drainage implant device for the treatment of glaucoma |
US4983177A (en) * | 1990-01-03 | 1991-01-08 | Wolf Gerald L | Method and apparatus for reversibly occluding a biological tube |
US5112202A (en) | 1990-01-31 | 1992-05-12 | Ntn Corporation | Turbo pump with magnetically supported impeller |
US5180362A (en) * | 1990-04-03 | 1993-01-19 | Worst J G F | Gonio seton |
US5147281A (en) * | 1990-04-23 | 1992-09-15 | Advanced Medical Systems, Inc. | Biological fluid pumping means and method |
US5156619A (en) * | 1990-06-15 | 1992-10-20 | Ehrenfeld William K | Flanged end-to-side vascular graft |
US5178603A (en) * | 1990-07-24 | 1993-01-12 | Baxter International, Inc. | Blood extraction and reinfusion flow control system and method |
US5074868A (en) | 1990-08-03 | 1991-12-24 | Inamed Development Company | Reversible stoma-adjustable gastric band |
US5006106A (en) | 1990-10-09 | 1991-04-09 | Angelchik Jean P | Apparatus and method for laparoscopic implantation of anti-reflux prosthesis |
US5316543A (en) | 1990-11-27 | 1994-05-31 | Cook Incorporated | Medical apparatus and methods for treating sliding hiatal hernias |
US5209347A (en) * | 1990-12-05 | 1993-05-11 | Clintec Nutrition Company | Internal tear seal dual bag |
US5167623A (en) * | 1990-12-27 | 1992-12-01 | The Kendall Company | Multilumen catheter |
US5484431A (en) * | 1991-01-29 | 1996-01-16 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | System for creating at a site, remote from a sterile environment, a parenteral solution |
US5314624A (en) * | 1991-03-26 | 1994-05-24 | Otsuka Pharmaceutical Factory, Inc. | Process for filtering plasma and regenerating a secondary filter therefor |
US5226429A (en) | 1991-06-20 | 1993-07-13 | Inamed Development Co. | Laparoscopic gastric band and method |
US5273526A (en) * | 1991-06-21 | 1993-12-28 | Lake Region Manufacturing Company, Inc. | Vascular occulusion removal devices and method |
US5358474A (en) * | 1991-07-02 | 1994-10-25 | Intermed, Inc. | Subcutaneous drug delivery device |
JPH07500023A (en) * | 1991-07-04 | 1995-01-05 | オーエン、アール・ロナルド | tubular surgical implant |
US5769812A (en) * | 1991-07-16 | 1998-06-23 | Heartport, Inc. | System for cardiac procedures |
US5250020A (en) * | 1991-09-12 | 1993-10-05 | Mentor Corporation | Unitary inflatable penile prosthesis |
EP0560984B1 (en) * | 1991-09-27 | 1999-05-26 | Terumo Kabushiki Kaisha | Flexible member for medical use |
US6471872B2 (en) * | 1991-10-11 | 2002-10-29 | Children's Hospital Medical Center | Hemofiltration system and method based on monitored patient parameters |
US5160338A (en) * | 1991-11-13 | 1992-11-03 | Inamed Development Co. | Device for removing implantable articles |
US5636643A (en) * | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5304206A (en) | 1991-11-18 | 1994-04-19 | Cyberonics, Inc. | Activation techniques for implantable medical device |
AU671971B2 (en) * | 1991-11-29 | 1996-09-19 | Chiron Corporation | Anti-cancer immunotherapeutic vector constructs |
US5403273A (en) * | 1991-12-17 | 1995-04-04 | Minnesota Mining And Manufacturing Company | Blood reservoir |
US5730883A (en) * | 1991-12-23 | 1998-03-24 | Baxter International Inc. | Blood processing systems and methods using apparent hematocrit as a process control parameter |
CA2082467A1 (en) * | 1992-01-30 | 1993-07-31 | Wilfred Wilger | Radially locking spray nozzle cap |
JP3146465B2 (en) * | 1992-03-13 | 2001-03-19 | 株式会社ニッショー | Chemical injection device |
FR2688693A1 (en) | 1992-03-19 | 1993-09-24 | Ferriere Xavier | Artificial sphincter, especially urethral (urinary) sphincter |
US5554013A (en) * | 1992-05-01 | 1996-09-10 | Mcgaw, Inc. | Disposable cassette with negative head height fluid supply |
JP2605345Y2 (en) * | 1992-05-01 | 2000-07-10 | 株式会社大塚製薬工場 | Drug container |
US5281198A (en) * | 1992-05-04 | 1994-01-25 | Habley Medical Technology Corporation | Pharmaceutical component-mixing delivery assembly |
FR2692777A1 (en) | 1992-06-26 | 1993-12-31 | Alfieri Patrick | Remote control unit for implant esp. artificial sphincter in human body - uses oscillator, amplifier, and transmitting antenna to send energy to tuned receiving antenna on implant |
JP3231086B2 (en) * | 1992-06-30 | 2001-11-19 | テルモ株式会社 | Liquid separation device |
WO1994003142A1 (en) | 1992-07-30 | 1994-02-17 | Temple University - Of The Commonwealth System Of Higher Education | Direct manual cardiac compression device and method of use thereof |
NZ244796A (en) * | 1992-08-18 | 1995-05-26 | Scherer Corp R P | Capsule shell of soft gelatin contains a medicament and has a removable tab |
US5397354A (en) * | 1992-08-19 | 1995-03-14 | Wilk; Peter J. | Method and device for removing a toxic substance from blood |
US5297536A (en) * | 1992-08-25 | 1994-03-29 | Wilk Peter J | Method for use in intra-abdominal surgery |
EP0591980B1 (en) * | 1992-10-07 | 1999-05-06 | Asahi Medical Co., Ltd. | Leukocyte-removing filter device and system |
US20020095164A1 (en) | 1997-06-26 | 2002-07-18 | Andreas Bernard H. | Device and method for suturing tissue |
US5447526A (en) * | 1992-12-24 | 1995-09-05 | Karsdon; Jeffrey | Transcutaneous electric muscle/nerve controller/feedback unit |
CA2153390A1 (en) * | 1993-01-07 | 1994-07-21 | Michael Richard Williams | Low pressure contactor |
US5439448A (en) * | 1993-01-19 | 1995-08-08 | Datascope Investment Corp. | Bubble-free connector for liquid carrying tubing |
US5910252A (en) * | 1993-02-12 | 1999-06-08 | Cobe Laboratories, Inc. | Technique for extracorporeal treatment of blood |
ES2125310T3 (en) | 1993-02-18 | 1999-03-01 | Lubomyr Ihor Kuzmak | ADJUSTABLE GASTRIC BAND FOR LAPAROSCOPY. |
US5449368A (en) * | 1993-02-18 | 1995-09-12 | Kuzmak; Lubomyr I. | Laparoscopic adjustable gastric banding device and method for implantation and removal thereof |
US5626843A (en) * | 1993-02-26 | 1997-05-06 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS, by removel of interferons, TNFs and receptors therefor |
US5888511A (en) * | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
AU5637094A (en) * | 1993-03-16 | 1994-09-22 | Clintec Nutrition Company | Peelable seal and container having same |
DE4308586C1 (en) * | 1993-03-18 | 1994-05-11 | Fresenius Ag | Haemodialysis appts. with balance chamber - involves inner volume of balance chamber being at most two thirds of that of dialysis fluid chamber |
US5272664A (en) | 1993-04-21 | 1993-12-21 | Silicon Graphics, Inc. | High memory capacity DRAM SIMM |
DE69425966T2 (en) * | 1993-04-27 | 2001-03-29 | Haemonetics Corp., Braintree | Apheresis device |
US5632396A (en) * | 1993-05-06 | 1997-05-27 | Becton, Dickinson And Company | Combination stopper-shield closure |
US5385540A (en) * | 1993-05-26 | 1995-01-31 | Quest Medical, Inc. | Cardioplegia delivery system |
DE4317752C2 (en) | 1993-05-27 | 1997-10-16 | Peter Dr Feindt | Device for supporting cardiac function |
US5437605A (en) | 1993-05-27 | 1995-08-01 | Helmy; Ali M. | Remote controllable penile prosthetic system |
US5601604A (en) | 1993-05-27 | 1997-02-11 | Inamed Development Co. | Universal gastric band |
US5335773A (en) * | 1993-07-02 | 1994-08-09 | Habley Medical Technology Corporation | Multi-pharmaceutical storage, mixing and dispensing vial |
US5753227A (en) * | 1993-07-23 | 1998-05-19 | Strahilevitz; Meir | Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases |
US5445630A (en) * | 1993-07-28 | 1995-08-29 | Richmond; Frank M. | Spike with luer fitting |
US5405339A (en) * | 1993-09-03 | 1995-04-11 | Medtronic, Inc. | Medical connector and method for connecting medical tubing |
US5484612A (en) * | 1993-09-22 | 1996-01-16 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
US5505733A (en) | 1993-10-22 | 1996-04-09 | Justin; Daniel F. | Intramedullary skeletal distractor and method |
DE4338553A1 (en) * | 1993-11-08 | 1995-05-18 | Ferring Arzneimittel Gmbh | Injection syringe for mixing and applying injection substances |
US5997501A (en) | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
US5443497A (en) * | 1993-11-22 | 1995-08-22 | The Johns Hopkins University | Percutaneous prosthetic by-pass graft and method of use |
AU1331595A (en) * | 1993-11-30 | 1995-06-19 | Medex, Inc. | Anti-reflux valve with environmental barrier |
CA2155735A1 (en) * | 1993-12-22 | 1995-06-29 | Richard C. Giesler | Self-priming drip chamber with enhanced visibility |
US5518504A (en) | 1993-12-28 | 1996-05-21 | American Medical Systems, Inc. | Implantable sphincter system utilizing lifting means |
US5415660A (en) | 1994-01-07 | 1995-05-16 | Regents Of The University Of Minnesota | Implantable limb lengthening nail driven by a shape memory alloy |
US5501703A (en) * | 1994-01-24 | 1996-03-26 | Medtronic, Inc. | Multichannel apparatus for epidural spinal cord stimulator |
US5504700A (en) | 1994-02-22 | 1996-04-02 | Sun Microsystems, Inc. | Method and apparatus for high density sixteen and thirty-two megabyte single in-line memory module |
DE4410876A1 (en) * | 1994-03-29 | 1995-10-05 | Fresenius Ag | Medical multi-chamber bag and process for its manufacture |
US5454840A (en) * | 1994-04-05 | 1995-10-03 | Krakovsky; Alexander A. | Potency package |
US6190691B1 (en) * | 1994-04-12 | 2001-02-20 | Adolor Corporation | Methods for treating inflammatory conditions |
IL109499A (en) * | 1994-05-02 | 1998-01-04 | Univ Ramot | Implant device for draining excess intraocular fluid |
US5453079A (en) * | 1994-06-15 | 1995-09-26 | Schwaninger; Claude L. | Blood flow valve for treatment of male sexual impotence |
AU701572B2 (en) * | 1994-07-11 | 1999-02-04 | Dacomed Corporation | Vessel occlusive prosthesis |
US5509888A (en) | 1994-07-26 | 1996-04-23 | Conceptek Corporation | Controller valve device and method |
US5569187A (en) * | 1994-08-16 | 1996-10-29 | Texas Instruments Incorporated | Method and apparatus for wireless chemical supplying |
DK0776297T3 (en) * | 1994-08-19 | 1999-05-10 | Gore & Ass | Ventilated bottle for freeze-drying and method for minimizing contamination of freeze-dried products |
US5743874A (en) * | 1994-08-29 | 1998-04-28 | Fischell; Robert E. | Integrated catheter for balloon angioplasty and stent delivery |
US6071258A (en) * | 1994-09-12 | 2000-06-06 | Cobe Cardiovascular, Inc. | Perfusion control assembly with improved component visibility and accessibility |
US5540731A (en) | 1994-09-21 | 1996-07-30 | Medtronic, Inc. | Method and apparatus for pressure detecting and treating obstructive airway disorders |
US5571116A (en) * | 1994-10-02 | 1996-11-05 | United States Surgical Corporation | Non-invasive treatment of gastroesophageal reflux disease |
DE4435602C2 (en) | 1994-10-05 | 1998-07-16 | Gunter Preis | Method and device for supplying implanted measuring, control and regulating systems with energy and for bidirectional data transfer |
JP2911763B2 (en) * | 1994-10-27 | 1999-06-23 | 三桜子 布川 | Artificial blood vessel |
CA2175720C (en) * | 1996-05-03 | 2011-11-29 | Ian M. Penn | Bifurcated stent and method for the manufacture and delivery of same |
FR2726768A1 (en) * | 1994-11-14 | 1996-05-15 | Debiotech Sa | SYRINGE DEVICE ATTACHABLE TO A VIAL |
US5601094A (en) * | 1994-11-22 | 1997-02-11 | Reiss; George R. | Ophthalmic shunt |
EP0714636B1 (en) * | 1994-11-28 | 2003-04-16 | The Ohio State University | Interventional medicine apparatus |
US5789147A (en) * | 1994-12-05 | 1998-08-04 | New York Blood Center, Inc. | Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood |
US5585007A (en) * | 1994-12-07 | 1996-12-17 | Plasmaseal Corporation | Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant |
US5725493A (en) * | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
US5433701A (en) * | 1994-12-21 | 1995-07-18 | Rubinstein; Mark H. | Apparatus for reducing ocular pressure |
US5591217A (en) | 1995-01-04 | 1997-01-07 | Plexus, Inc. | Implantable stimulator with replenishable, high value capacitive power source and method therefor |
DE19511998A1 (en) | 1995-03-31 | 1996-10-02 | Eska Medical Gmbh & Co | Controller for discharge of urine from urethra |
US5669883A (en) * | 1995-04-12 | 1997-09-23 | Symbiosis Corporation | Veress needle and cannula assembly |
JPH08336069A (en) | 1995-04-13 | 1996-12-17 | Eastman Kodak Co | Electronic still camera |
DE19517699C2 (en) * | 1995-05-13 | 1999-11-04 | Wilhelm Fleischmann | Device for vacuum sealing a wound |
AUPN295995A0 (en) * | 1995-05-15 | 1995-06-08 | Filtration Engineering Pty Ltd | Apparatus & method for backwashing fluid filter systems |
US5665065A (en) * | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US5518499A (en) | 1995-06-06 | 1996-05-21 | Aghr; Arif H. | Intracavernous vasoactive pharmacological pump |
US5702431A (en) | 1995-06-07 | 1997-12-30 | Sulzer Intermedics Inc. | Enhanced transcutaneous recharging system for battery powered implantable medical device |
US5775331A (en) | 1995-06-07 | 1998-07-07 | Uromed Corporation | Apparatus and method for locating a nerve |
US5662711A (en) * | 1995-06-07 | 1997-09-02 | Douglas; William | Flow adjustable artery shunt |
US6176240B1 (en) * | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US5584808A (en) * | 1995-06-20 | 1996-12-17 | Healy; Patrick M. | Valve mechanism |
KR100373772B1 (en) * | 1995-07-31 | 2003-09-13 | 심영택 | Treatment apparatus for erectile disorder |
IE77523B1 (en) * | 1995-09-11 | 1997-12-17 | Elan Med Tech | Medicament delivery device |
US5771903A (en) | 1995-09-22 | 1998-06-30 | Kirk Promotions Limited | Surgical method for reducing the food intake of a patient |
US6102922A (en) | 1995-09-22 | 2000-08-15 | Kirk Promotions Limited | Surgical method and device for reducing the food intake of patient |
US5702019A (en) * | 1995-09-27 | 1997-12-30 | Becton Dickinson France S.A. | Vial having resealable membrane assembly activated by a medical delivery device |
US5704352A (en) * | 1995-11-22 | 1998-01-06 | Tremblay; Gerald F. | Implantable passive bio-sensor |
US5683357A (en) * | 1995-12-01 | 1997-11-04 | Magram; Gary | External cerebrospinal fluid drain apparatus |
US5578069A (en) * | 1995-12-06 | 1996-11-26 | Vnetritex, Inc. | Electrode deployment mechanism and method using artificial muscle |
ZA9610374B (en) * | 1995-12-11 | 1997-06-23 | Elan Med Tech | Cartridge-based drug delivery device |
US6428571B1 (en) * | 1996-01-22 | 2002-08-06 | Scimed Life Systems, Inc. | Self-sealing PTFE vascular graft and manufacturing methods |
AU2260397A (en) | 1996-01-31 | 1997-08-22 | Trustees Of The University Of Pennsylvania, The | Remote control drug delivery device |
US5925054A (en) * | 1996-02-20 | 1999-07-20 | Cardiothoracic Systems, Inc. | Perfusion device for maintaining blood flow in a vessel while isolating an anastomosis |
US5807302A (en) * | 1996-04-01 | 1998-09-15 | Wandel; Thaddeus | Treatment of glaucoma |
US5846251A (en) * | 1996-07-22 | 1998-12-08 | Hart; Charles C. | Access device with expandable containment member |
SE9601348D0 (en) * | 1996-04-10 | 1996-04-10 | Pharmacia Ab | Improved containers for parenteral fluids |
US5707356A (en) * | 1996-04-30 | 1998-01-13 | Medtronic, Inc. | Pressure relief valve |
US5820579A (en) * | 1996-04-30 | 1998-10-13 | Medtronic, Inc. | Method and apparatus for creating pulsatile flow in a cardiopulmonary bypass circuit |
US5976109A (en) * | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
JPH11509457A (en) | 1996-05-05 | 1999-08-24 | インフルーエンス メディカル テクノロジーズ リミテッド | Implantable pumps and prostheses |
US5928213A (en) * | 1996-05-13 | 1999-07-27 | B. Braun Medical, Inc. | Flexible multiple compartment medical container with preferentially rupturable seals |
US5800514A (en) * | 1996-05-24 | 1998-09-01 | Meadox Medicals, Inc. | Shaped woven tubular soft-tissue prostheses and methods of manufacturing |
US5980480A (en) * | 1996-07-11 | 1999-11-09 | Cs Fluids, Inc. | Method and apparatus for treating adult-onset dementia of the alzheimer's type |
US20030004495A1 (en) * | 1996-07-11 | 2003-01-02 | Eunoe, Inc. | Apparatus and methods for volumetric CSF removal |
US6689085B1 (en) * | 1996-07-11 | 2004-02-10 | Eunoe, Inc. | Method and apparatus for treating adult-onset dementia of the Alzheimer's type |
US5741326A (en) * | 1996-07-15 | 1998-04-21 | Cordis Corporation | Low profile thermally set wrapped cover for a percutaneously deployed stent |
US6835207B2 (en) * | 1996-07-22 | 2004-12-28 | Fred Zacouto | Skeletal implant |
FR2751867B1 (en) * | 1996-08-05 | 1999-05-21 | Leriche Rene Ass | PROSTHESIS COLLERETTE |
US5810760A (en) * | 1996-08-08 | 1998-09-22 | Thomas Jefferson University | Cerebral edema solute catheter and method of draining cerebral edema |
CN1140228C (en) | 1996-08-09 | 2004-03-03 | 爱德华兹生命科学公司 | Mechanical prosthetic valve, and methods of its construction and operation |
US5814099A (en) | 1996-08-12 | 1998-09-29 | Bicer; Demetrio | Central opening curved bileaflet heart valve prosthesis |
US5851985A (en) * | 1996-08-16 | 1998-12-22 | Tepic; Slobodan | Treatment of tumors by arginine deprivation |
US5782383A (en) * | 1996-09-04 | 1998-07-21 | Rexan Closures Inc. | Dispensing closure for sealed enteral fluid containers |
CA2214754A1 (en) * | 1996-09-09 | 1998-03-09 | Masataka Narisada | Method and apparatus for treating blood |
US5902336A (en) * | 1996-10-15 | 1999-05-11 | Mirimedical, Inc. | Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure |
EP0846474B1 (en) * | 1996-10-30 | 2003-08-27 | Nihon Kohden Corporation | Stimulating apparatus for preventing urinary incontinence |
DE19646746C2 (en) * | 1996-11-01 | 2003-09-18 | Nanotron Technologies Gmbh | Transmission method for wireless communication with an implanted medical device |
US5845646A (en) | 1996-11-05 | 1998-12-08 | Lemelson; Jerome | System and method for treating select tissue in a living being |
US5749909A (en) | 1996-11-07 | 1998-05-12 | Sulzer Intermedics Inc. | Transcutaneous energy coupling using piezoelectric device |
US6019788A (en) * | 1996-11-08 | 2000-02-01 | Gore Enterprise Holdings, Inc. | Vascular shunt graft and junction for same |
CA2272348C (en) * | 1996-11-22 | 2007-01-23 | Therakos, Inc. | Integrated cassette for controlling fluid having an integral filter |
US5735809A (en) | 1996-12-05 | 1998-04-07 | Matria Healthcare, Inc. | Fiber assembly for in vivo plasma separation |
US5735887A (en) | 1996-12-10 | 1998-04-07 | Exonix Corporation | Closed-loop, RF-coupled implanted medical device |
JP3455040B2 (en) * | 1996-12-16 | 2003-10-06 | 株式会社日立製作所 | Source clock synchronous memory system and memory unit |
GB9626960D0 (en) * | 1996-12-27 | 1997-02-12 | Glaxo Group Ltd | Valve for aerosol container |
JP2001509705A (en) * | 1997-02-04 | 2001-07-24 | フエール,アラン | Screw-in tear tube cap |
US6102884A (en) * | 1997-02-07 | 2000-08-15 | Squitieri; Rafael | Squitieri hemodialysis and vascular access systems |
US5903211A (en) * | 1997-02-07 | 1999-05-11 | Althin Medical, Inc. | Medical treatment device with a user interface adapted for home or limited care environments |
US5827286A (en) * | 1997-02-14 | 1998-10-27 | Incavo; Stephen J. | Incrementally adjustable tibial osteotomy fixation device and method |
WO1998037926A1 (en) * | 1997-02-26 | 1998-09-03 | Alfred E. Mann Foundation For Scientific Research | Battery-powered patient implantable device |
DE19708391C1 (en) * | 1997-03-01 | 1998-10-22 | Fresenius Medical Care De Gmbh | Method and device for ultrafiltration in hemodialysis |
US5800457A (en) * | 1997-03-05 | 1998-09-01 | Gelbfish; Gary A. | Intravascular filter and associated methodology |
US5824054A (en) * | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Coiled sheet graft stent and methods of making and use |
US5814114A (en) * | 1997-03-24 | 1998-09-29 | Ltg Air Engineering, Inc. | Airborne waste filter arrangement |
DE19713747A1 (en) * | 1997-04-04 | 1998-10-08 | Rieter Ingolstadt Spinnerei | Method and device for filtering fibers from an air stream |
US6022333A (en) * | 1997-05-01 | 2000-02-08 | S.L.I.M. Tech, Ltd. | Method and system for removing materials from lymphatic and other fluids |
US5938669A (en) | 1997-05-07 | 1999-08-17 | Klasamed S.A. | Adjustable gastric banding device for contracting a patient's stomach |
US6059745A (en) * | 1997-05-20 | 2000-05-09 | Gelbfish; Gary A. | Thrombectomy device and associated method |
US6213979B1 (en) | 1997-05-29 | 2001-04-10 | Venetec International, Inc. | Medical line anchoring system |
US6061590A (en) * | 1997-06-03 | 2000-05-09 | Transonic Systems, Inc. | Method and apparatus for predicting intradialytic morbid events through the monitoring of a central blood volume |
US5954715A (en) * | 1997-06-05 | 1999-09-21 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US6003736A (en) | 1997-06-09 | 1999-12-21 | Novo Nordisk A/S | Device for controlled dispensing of a dose of a liquid contained in a cartridge |
US5904698A (en) * | 1997-06-10 | 1999-05-18 | Applied Medical Resources Corporation | Surgical shaving device for use within body conduits |
US6332466B1 (en) | 1997-07-08 | 2001-12-25 | Inbae Yoon | Ovarian capsules and methods of surgical contraception by ovarian encapsulation |
US5919163A (en) * | 1997-07-14 | 1999-07-06 | Delcath Systems, Inc. | Catheter with slidable balloon |
ES2283020T3 (en) | 1997-07-16 | 2007-10-16 | Metacure Nv | SMOOTH MUSCLE CONTROLLER. |
CA2302466A1 (en) | 1997-07-31 | 1999-02-11 | Stanford Syncom Inc. | Means and method for a synchronous network communications system |
US6135945A (en) * | 1997-08-04 | 2000-10-24 | Sultan; Hashem | Anti-incontinence device |
US5873889A (en) * | 1997-08-08 | 1999-02-23 | Origin Medsystems, Inc. | Tissue separation cannula with dissection probe and method |
US6017493A (en) * | 1997-09-26 | 2000-01-25 | Baxter International Inc. | Vacuum-assisted venous drainage reservoir for CPB systems |
US5971967A (en) | 1997-08-19 | 1999-10-26 | Abbeymoor Medical, Inc. | Urethral device with anchoring system |
US5991665A (en) * | 1997-09-18 | 1999-11-23 | Sulzer Intermedics Inc. | Self-cooling transcutaneous energy transfer system for battery powered implantable device |
SE510286C2 (en) * | 1997-09-22 | 1999-05-10 | Gambro Med Tech Ab | Method and Device for Monitoring Infusion Pump in a Hemo or Hemodia Filtration Machine |
US6433040B1 (en) * | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US5980478A (en) * | 1997-10-10 | 1999-11-09 | Transvivo, Inc. | Apparatus and method for the treatment of acute and chronic renal disease by continuous passive plasma ultrafiltration |
US6409674B1 (en) | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
EP0909719B1 (en) * | 1997-10-15 | 2002-07-24 | Taisei Kako Co., Ltd., | Closure for vial container |
FR2769491B1 (en) | 1997-10-15 | 2000-01-07 | Patrick Sangouard | ADJUSTABLE ARTIFICIAL SPHINCTER WITH MAGNETIC CONTROL |
US6088608A (en) * | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
US5908435A (en) * | 1997-10-23 | 1999-06-01 | Samuels; Shaun L. W. | Expandable lumen device and method of use |
US6764481B1 (en) * | 1997-10-27 | 2004-07-20 | Otsuka Pharmaceutical Factory, Inc. | Packaged ophthalmic perfusate and cleaning fluid bag |
US5938584A (en) | 1997-11-14 | 1999-08-17 | Cybernetic Medical Systems Corporation | Cavernous nerve stimulation device |
US20040236877A1 (en) | 1997-12-17 | 2004-11-25 | Lee A. Burton | Switch/network adapter port incorporating shared memory resources selectively accessible by a direct execution logic element and one or more dense logic devices in a fully buffered dual in-line memory module format (FB-DIMM) |
US6432050B1 (en) * | 1997-12-30 | 2002-08-13 | Remon Medical Technologies Ltd. | Implantable acoustic bio-sensing system and method |
US6699231B1 (en) * | 1997-12-31 | 2004-03-02 | Heartport, Inc. | Methods and apparatus for perfusion of isolated tissue structure |
US6074366A (en) * | 1998-01-16 | 2000-06-13 | Tandem Medical Inc. | Medication delivery apparatus |
JP3776227B2 (en) * | 1998-01-16 | 2006-05-17 | テルモ株式会社 | Blood collection instrument |
ES2255155T3 (en) | 1998-02-05 | 2006-06-16 | Biosense Webster, Inc. | DEVICE FOR THE INTRACARDIAC ADMINISTRATION OF PHARMACOS. |
US6007576A (en) * | 1998-02-06 | 1999-12-28 | Mcclellan; Scott B. | End to side anastomic implant |
US5995874A (en) * | 1998-02-09 | 1999-11-30 | Dew Engineering And Development Limited | Transcutaneous energy transfer device |
US7468060B2 (en) | 1998-02-19 | 2008-12-23 | Respiratory Diagnostic, Inc. | Systems and methods for treating obesity and other gastrointestinal conditions |
US6630215B1 (en) * | 1998-03-09 | 2003-10-07 | Denki Kagaku Kogyo Kabushiki Kaisha | Medical Device |
ES2149091B1 (en) * | 1998-03-10 | 2001-05-16 | Gil Vernet Vila Jose Maria | DEVICE FOR FIXING AND ADJUSTABLE SUPPORT AT HEIGHT OF INTERNAL ANATOMICAL ORGANS. |
US6638303B1 (en) * | 1998-03-13 | 2003-10-28 | Carbomedics, Inc. | Heart valve prosthesis |
WO1999047190A1 (en) * | 1998-03-16 | 1999-09-23 | Medtronic, Inc. | Hemostatic system and components for extracorporeal circuit |
US6319191B1 (en) | 1998-03-26 | 2001-11-20 | Precision Medical Devices, Inc. | Implantable body fluid flow control device |
US6095968A (en) | 1998-04-10 | 2000-08-01 | Cardio Technologies, Inc. | Reinforcement device |
US6209738B1 (en) * | 1998-04-20 | 2001-04-03 | Becton, Dickinson And Company | Transfer set for vials and medical containers |
US6099460A (en) | 1998-04-28 | 2000-08-08 | Denker; Stephen | Electromagnetic heart assist technique and apparatus |
US5910149A (en) | 1998-04-29 | 1999-06-08 | Kuzmak; Lubomyr I. | Non-slipping gastric band |
US6099495A (en) * | 1998-04-30 | 2000-08-08 | Medtronic, Inc. | Implantable electrical transducer powered from capacitive storage energy source |
US6287765B1 (en) * | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
US6620382B1 (en) * | 1998-05-22 | 2003-09-16 | Biopheresis Technologies, Llc. | Method and compositions for treatment of cancers |
US6074341A (en) | 1998-06-09 | 2000-06-13 | Timm Medical Technologies, Inc. | Vessel occlusive apparatus and method |
US6361559B1 (en) * | 1998-06-10 | 2002-03-26 | Converge Medical, Inc. | Thermal securing anastomosis systems |
US6287516B1 (en) * | 1998-07-10 | 2001-09-11 | Immunocept, L.L.C. | Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease |
US6113574A (en) * | 1998-07-27 | 2000-09-05 | Spinello; Ronald P. | Anesthetic injection apparatus and methods |
US6113782A (en) * | 1998-07-28 | 2000-09-05 | Terumo Cardiovascular Systems Corporation | Potting of tubular bundles in housing |
US7935409B2 (en) | 1998-08-06 | 2011-05-03 | Kimberly-Clark Worldwide, Inc. | Tissue sheets having improved properties |
US6102887A (en) | 1998-08-11 | 2000-08-15 | Biocardia, Inc. | Catheter drug delivery system and method for use |
US6210347B1 (en) | 1998-08-13 | 2001-04-03 | Peter Forsell | Remote control food intake restriction device |
US6460543B1 (en) * | 1998-08-13 | 2002-10-08 | Obtech Medical Ag | Non-injection port food intake restriction device |
US6067991A (en) | 1998-08-13 | 2000-05-30 | Forsell; Peter | Mechanical food intake restriction device |
US6315767B1 (en) * | 1998-08-19 | 2001-11-13 | Gambro, Inc. | Cell storage maintenance and monitoring system |
JP2000070296A (en) * | 1998-08-27 | 2000-03-07 | M L C:Kk | Intra-lacrimal duct intubation appliance |
WO2000012152A1 (en) | 1998-08-28 | 2000-03-09 | Juan Hernandez Herrero | Apparatus aiding physiologic systolic and diastolic dynamics of cardiac cavities |
AU6384699A (en) * | 1998-09-10 | 2000-04-03 | Percardia, Inc. | Tmr shunt |
FR2783153B1 (en) | 1998-09-14 | 2000-12-01 | Jerome Dargent | GASTRIC CONSTRICTION DEVICE |
WO2000015140A1 (en) * | 1998-09-15 | 2000-03-23 | Infinite Biomedical Technologies, Incorporated | Intraurethral continent prothesis |
US7074216B2 (en) * | 1998-09-15 | 2006-07-11 | Baxter International Inc. | Sliding reconstitution device for a diluent container |
US6632189B1 (en) * | 1998-09-18 | 2003-10-14 | Edwards Lifesciences Corporation | Support device for surgical systems |
US6425867B1 (en) * | 1998-09-18 | 2002-07-30 | University Of Washington | Noise-free real time ultrasonic imaging of a treatment site undergoing high intensity focused ultrasound therapy |
US6167765B1 (en) * | 1998-09-25 | 2001-01-02 | The Regents Of The University Of Michigan | System and method for determining the flow rate of blood in a vessel using doppler frequency signals |
US6077215A (en) | 1998-10-08 | 2000-06-20 | Implex Gmbh Spezialhorgerate | Method for coupling an electromechanical transducer of an implantable hearing aid or tinnitus masker to a middle ear ossicle |
US6275737B1 (en) | 1998-10-14 | 2001-08-14 | Advanced Bionics Corporation | Transcutaneous transmission pouch |
US6134470A (en) * | 1998-11-09 | 2000-10-17 | Medtronic, Inc. | Method and apparatus for treating a tachyarrhythmic patient |
JP2000148656A (en) | 1998-11-09 | 2000-05-30 | Mitsubishi Electric Corp | Memory system |
US7189221B2 (en) * | 1998-11-10 | 2007-03-13 | Integra Life Sciences Corporation | Methods for the treatment of a normal pressure hydrocephalus |
US6645181B1 (en) * | 1998-11-13 | 2003-11-11 | Elan Pharma International Limited | Drug delivery systems and methods |
US6964643B2 (en) | 1998-11-18 | 2005-11-15 | Nugyn, Inc. | Devices and methods for treatment of incontinence |
AU760879B2 (en) | 1998-11-25 | 2003-05-22 | United States Surgical Corporation | Biopsy system |
US6097984A (en) | 1998-11-25 | 2000-08-01 | Medtronic, Inc. | System and method of stimulation for treating gastro-esophageal reflux disease |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6309384B1 (en) | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US6132415A (en) * | 1999-02-09 | 2000-10-17 | Vasca, Inc. | Systems and methods for removing retained fluids and infusing therapeutic fluids |
ES2150881B1 (en) | 1999-02-11 | 2002-02-16 | Univ Madrid Complutense | EXTERNAL MAGNETIC OPERATING VALVE FOR AN INTRAURETRAL ARTIFICIAL URINARY SPINTER. |
US6338144B2 (en) * | 1999-02-19 | 2002-01-08 | Sun Microsystems, Inc. | Computer system providing low skew clock signals to a synchronous memory unit |
US6162238A (en) | 1999-02-24 | 2000-12-19 | Aaron V. Kaplan | Apparatus and methods for control of body lumens |
US6254567B1 (en) * | 1999-02-26 | 2001-07-03 | Nxstage Medical, Inc. | Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration |
US6217552B1 (en) * | 1999-03-01 | 2001-04-17 | Coaxia, Inc. | Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma |
US20040167613A1 (en) * | 1999-03-11 | 2004-08-26 | Ofer Yodfat | Implantable stroke prevention device |
US6142980A (en) * | 1999-03-15 | 2000-11-07 | 3-T Medical Products, Llc | Multi-function medical control valve assembly |
ES2259286T3 (en) * | 1999-03-15 | 2006-10-01 | Implant Innovations, Inc. | TROMBOCIT COLLECTION SYSTEM. |
US6464655B1 (en) * | 1999-03-17 | 2002-10-15 | Environmental Robots, Inc. | Electrically-controllable multi-fingered resilient heart compression devices |
US6315752B1 (en) * | 1999-03-26 | 2001-11-13 | Scimed Life Systems, Inc. | Implantable bypass device |
GB2350794A (en) | 1999-04-20 | 2000-12-13 | Nagy Adly Habib | Implantable pump |
US8105258B2 (en) * | 1999-04-26 | 2012-01-31 | Baxter International Inc. | Citrate anticoagulation system for extracorporeal blood treatments |
AU767526B2 (en) * | 1999-04-26 | 2003-11-13 | Gmp Vision Solutions, Inc. | Trabeculotomy device and method for treating glaucoma |
US7395822B1 (en) | 1999-04-30 | 2008-07-08 | Uromedica, Inc. | Method and apparatus for adjustable sling for treatment of urinary stress incontinence |
ATE316391T1 (en) * | 1999-04-30 | 2006-02-15 | Childrens Hosp Medical Center | HEMOFILTRATION SYSTEM |
US6406605B1 (en) * | 1999-06-01 | 2002-06-18 | Ysi Incorporated | Electroosmotic flow controlled microfluidic devices |
US6183450B1 (en) * | 1999-06-04 | 2001-02-06 | William A Lois | Catheter de-clogging device |
AUPQ090499A0 (en) | 1999-06-10 | 1999-07-01 | Peters, William S | Heart assist device and system |
US6835200B2 (en) * | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US7744613B2 (en) | 1999-06-25 | 2010-06-29 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6197055B1 (en) * | 1999-07-06 | 2001-03-06 | Herbert L. Matthews | Single chamber mechanical heart |
US6839393B1 (en) * | 1999-07-14 | 2005-01-04 | Rambus Inc. | Apparatus and method for controlling a master/slave system via master device synchronization |
US6516227B1 (en) | 1999-07-27 | 2003-02-04 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
US6201001B1 (en) * | 1999-08-02 | 2001-03-13 | Abbott Laboratories | Imidazole antiproliferative agents |
AUPQ202699A0 (en) | 1999-08-04 | 1999-08-26 | University Of Melbourne, The | Prosthetic device for incontinence |
FR2797181B1 (en) | 1999-08-05 | 2002-05-03 | Richard Cancel | REMOTE GASTRIC BAND DEVICE FOR FORMING A RESTRICTED STOMA OPENING IN THE ESTOMAC |
US20040102804A1 (en) | 1999-08-10 | 2004-05-27 | Chin Albert K. | Apparatus and methods for endoscopic surgical procedures |
US6454699B1 (en) * | 2000-02-11 | 2002-09-24 | Obtech Medical Ag | Food intake restriction with controlled wireless energy supply |
US6453907B1 (en) * | 1999-08-12 | 2002-09-24 | Obtech Medical Ag | Food intake restriction with energy transfer device |
US6454698B1 (en) * | 1999-08-12 | 2002-09-24 | Obtech Medical Ag | Anal incontinence treatment with energy transfer device |
US6454701B1 (en) * | 1999-08-12 | 2002-09-24 | Obtech Medical Ag | Heartburn and reflux disease treatment apparatus with energy transfer device |
US6471635B1 (en) * | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Anal incontinence disease treatment with controlled wireless energy supply |
NZ516962A (en) | 1999-08-12 | 2003-09-26 | Potencia Medical Ag | Stoma opening forming apparatus |
US6461292B1 (en) * | 1999-08-12 | 2002-10-08 | Obtech Medical Ag | Anal incontinence treatment with wireless energy supply |
US6464628B1 (en) * | 1999-08-12 | 2002-10-15 | Obtech Medical Ag | Mechanical anal incontinence |
US6482145B1 (en) | 2000-02-14 | 2002-11-19 | Obtech Medical Ag | Hydraulic anal incontinence treatment |
US6533733B1 (en) * | 1999-09-24 | 2003-03-18 | Ut-Battelle, Llc | Implantable device for in-vivo intracranial and cerebrospinal fluid pressure monitoring |
FR2799362B1 (en) * | 1999-10-11 | 2002-01-18 | Perouse Implant Lab | COLLAR PROSTHESIS |
US6319279B1 (en) * | 1999-10-15 | 2001-11-20 | Edwards Lifesciences Corp. | Laminated self-sealing vascular access graft |
US6730054B2 (en) * | 1999-10-16 | 2004-05-04 | Baxter International Inc. | Blood collection systems and methods that derive estimated effects upon the donor's blood volume and hematocrit |
US6321282B1 (en) | 1999-10-19 | 2001-11-20 | Rambus Inc. | Apparatus and method for topography dependent signaling |
US6322546B1 (en) * | 1999-10-28 | 2001-11-27 | Jostra Bentley Inc. | Fluid control conduit |
US6579235B1 (en) * | 1999-11-01 | 2003-06-17 | The Johns Hopkins University | Method for monitoring intraocular pressure using a passive intraocular pressure sensor and patient worn monitoring recorder |
US6116193A (en) * | 1999-11-05 | 2000-09-12 | Goeckner; Troy C. | Sow breeding saddle |
US6500809B1 (en) * | 1999-11-12 | 2002-12-31 | Neuron Therapeutics, Inc. | Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
DE19955578C1 (en) * | 1999-11-18 | 2001-09-06 | Fresenius Medical Care De Gmbh | Multi-chamber container, with glucose concentrate compartment and hydrochloric acid concentrate compartment |
US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
FR2802798B1 (en) | 1999-12-22 | 2002-02-01 | Promedon S A | PAD STRAP FOR THE TREATMENT OF URINARY INCONTINENCE |
US6502161B1 (en) | 2000-01-05 | 2002-12-31 | Rambus Inc. | Memory system including a point-to-point linked memory subsystem |
US7131959B2 (en) * | 2003-01-23 | 2006-11-07 | Integrated Vascular Interventional Technologies, L.C., (“IVIT LC”) | Apparatus and methods for occluding an access tube anastomosed to sidewall of an anatomical vessel |
US6764472B1 (en) * | 2000-01-11 | 2004-07-20 | Bard Access Systems, Inc. | Implantable refillable infusion device |
US6447443B1 (en) | 2001-01-13 | 2002-09-10 | Medtronic, Inc. | Method for organ positioning and stabilization |
US6694191B2 (en) | 2000-01-21 | 2004-02-17 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method having telemetry modifiable control software |
US6600953B2 (en) | 2000-12-11 | 2003-07-29 | Impulse Dynamics N.V. | Acute and chronic electrical signal therapy for obesity |
WO2001054615A2 (en) | 2000-01-25 | 2001-08-02 | Harridan Medical | Device for preventing fecal incontinence |
US6311905B1 (en) * | 2000-02-07 | 2001-11-06 | Franklin Miller, Inc. | Screen cleaning and comminuting system |
US20030050591A1 (en) * | 2000-02-08 | 2003-03-13 | Patrick Mchale Anthony | Loading system and method for using the same |
US6454700B1 (en) * | 2000-02-09 | 2002-09-24 | Obtech Medical Ag | Heartburn and reflux disease treatment apparatus with wireless energy supply |
CN1698552B (en) * | 2000-02-10 | 2010-05-12 | 厄罗洛吉卡股份公司 | Controlled urinary incontinence treatment |
BR0108223B1 (en) * | 2000-02-10 | 2009-08-11 | mechanical apparatus for the treatment of impotence. | |
EP1598030B1 (en) | 2000-02-10 | 2008-06-25 | Potencia Medical AG | Controlled urinary incontinence treatment |
US6470892B1 (en) * | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Mechanical heartburn and reflux treatment |
US6463935B1 (en) * | 2000-02-10 | 2002-10-15 | Obtech Medical Ag | Controlled heartburn and reflux disease treatment |
MXPA02007649A (en) * | 2000-02-10 | 2004-08-23 | Potencia Medical Ag | Urinary incontinence treatment with wireless energy supply. |
EP1582175B1 (en) | 2000-02-10 | 2008-08-06 | Potencia Medical AG | Mechanical impotence treatment apparatus |
CA2398326C (en) | 2000-02-10 | 2008-12-16 | Surgical Development Ag | Anal incontinence treatment apparatus with wireless energy supply |
MX340163B (en) * | 2000-02-11 | 2016-06-29 | Potentica Ag | Impotence treatment apparatus with energy transforming means. |
US6450946B1 (en) * | 2000-02-11 | 2002-09-17 | Obtech Medical Ag | Food intake restriction with wireless energy transfer |
EP1792583A1 (en) | 2000-02-11 | 2007-06-06 | Potencia Medical AG | Urinary incontinence treatment apparatus |
WO2001045486A2 (en) * | 2000-02-11 | 2001-06-28 | Potencia Medical Ag | Urinary incontinence treatment apparatus |
ATE380006T1 (en) | 2000-02-11 | 2007-12-15 | Potencia Medical Ag | CONTROLLED IMPOTENCY TREATMENT |
US6604561B2 (en) * | 2000-02-11 | 2003-08-12 | Medical Instill Technologies, Inc. | Medicament vial having a heat-sealable cap, and apparatus and method for filling the vial |
MXPA02007704A (en) | 2000-02-11 | 2002-10-17 | Obtech Medical Ag | Food intake restriction apparatus with controlled wireless energy supply. |
EP1255511B1 (en) * | 2000-02-14 | 2006-01-11 | Potencia Medical AG | Male sexual impotence treatment apparatus |
DE60110392T2 (en) * | 2000-02-14 | 2006-03-09 | Potencia Medical Ag | HYDRAULIC DEVICE FOR THE TREATMENT OF HARNINE CONTINENCE |
US20030100929A1 (en) * | 2000-02-14 | 2003-05-29 | Peter Forsell | Controlled penile prosthesis |
DE60111019T2 (en) * | 2000-02-14 | 2006-05-11 | Potencia Medical Ag | PROSTHESIS |
JP2001218840A (en) * | 2000-02-14 | 2001-08-14 | Kanegafuchi Chem Ind Co Ltd | Adsorbent for transforming growth factor. beta, adsorbing/removing method, and adsorber |
ES2252191T3 (en) | 2000-02-14 | 2006-05-16 | Potencia Medical Ag | PROTESIS FOR CONTROLLED PENIS. |
US6475136B1 (en) | 2000-02-14 | 2002-11-05 | Obtech Medical Ag | Hydraulic heartburn and reflux treatment |
BR0108307B1 (en) * | 2000-02-14 | 2009-12-01 | Prosthesis apparatus for the treatment of male sexual impotence with wireless power supply device. | |
US6471688B1 (en) * | 2000-02-15 | 2002-10-29 | Microsolutions, Inc. | Osmotic pump drug delivery systems and methods |
US6400988B1 (en) | 2000-02-18 | 2002-06-04 | Pacesetter, Inc. | Implantable cardiac device having precision RRT indication |
CA2672076A1 (en) * | 2000-03-01 | 2001-09-07 | Caridianbct, Inc. | Extracorporeal blood processing information management system |
IL138632A (en) | 2000-09-21 | 2008-06-05 | Minelu Zonnenschein | Multiple view endoscopes |
MXPA02008996A (en) | 2000-03-16 | 2004-10-15 | Medigus Ltd | Fundoplication apparatus and method. |
US7713227B2 (en) * | 2000-03-20 | 2010-05-11 | Michael Wholey | Method and apparatus for medical device for aspiration of thromboemobolic debris |
US6215727B1 (en) | 2000-04-04 | 2001-04-10 | Intel Corporation | Method and apparatus for utilizing parallel memory in a serial memory system |
US6650943B1 (en) | 2000-04-07 | 2003-11-18 | Advanced Bionics Corporation | Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction |
US20020143284A1 (en) * | 2001-04-03 | 2002-10-03 | Hosheng Tu | Drug-releasing trabecular implant for glaucoma treatment |
US6638239B1 (en) * | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US7867186B2 (en) * | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
JP2001299875A (en) * | 2000-04-24 | 2001-10-30 | Nipro Corp | Liquid housing bag |
US6456883B1 (en) * | 2000-04-26 | 2002-09-24 | Medtronic, Inc. | Apparatus and method for allowing immediate retrieval for information and identification from an implantable medical device having a depleted power source |
US6447500B1 (en) * | 2000-04-28 | 2002-09-10 | Medtronic, Inc. | Brain fluid ion concentration modification for treating neurological disorders |
US7167756B1 (en) * | 2000-04-28 | 2007-01-23 | Medtronic, Inc. | Battery recharge management for an implantable medical device |
US6773428B2 (en) * | 2000-05-12 | 2004-08-10 | Stephen M. Zappala | Implantable delivery system and method for the pharmacologic management of erectile dysfunction |
JP3757757B2 (en) * | 2000-05-18 | 2006-03-22 | 株式会社日立製作所 | Read priority memory system |
US6459917B1 (en) * | 2000-05-22 | 2002-10-01 | Ashok Gowda | Apparatus for access to interstitial fluid, blood, or blood plasma components |
JP3926968B2 (en) * | 2000-05-29 | 2007-06-06 | 明夫 川村 | Non-puncture blood access for hemodialysis |
US6533759B1 (en) * | 2000-06-01 | 2003-03-18 | Robert Watson | Flash chamber with a self closing valve for use with a catheter |
US7530964B2 (en) | 2000-06-30 | 2009-05-12 | Elan Pharma International Limited | Needle device and method thereof |
US6589229B1 (en) | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
US6746461B2 (en) | 2000-08-15 | 2004-06-08 | William R. Fry | Low-profile, shape-memory surgical occluder |
US6862479B1 (en) * | 2000-08-30 | 2005-03-01 | Advanced Bionics Corporation | Spinal cord stimulation as a therapy for sexual dysfunction |
US6592515B2 (en) * | 2000-09-07 | 2003-07-15 | Ams Research Corporation | Implantable article and method |
US6730056B1 (en) * | 2000-09-21 | 2004-05-04 | Motorola, Inc. | Eye implant for treating glaucoma and method for manufacturing same |
WO2002028454A2 (en) | 2000-10-04 | 2002-04-11 | Insulet Corporation | Data collection assembly for patient infusion system |
US6582463B1 (en) * | 2000-10-11 | 2003-06-24 | Heartstent Corporation | Autoanastomosis |
US6616624B1 (en) * | 2000-10-30 | 2003-09-09 | Cvrx, Inc. | Systems and method for controlling renovascular perfusion |
US6585675B1 (en) * | 2000-11-02 | 2003-07-01 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US6591137B1 (en) | 2000-11-09 | 2003-07-08 | Neuropace, Inc. | Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders |
DK1702635T3 (en) | 2000-11-09 | 2008-05-26 | Insulet Corp | Transcutaneous delivery means |
ATE353682T1 (en) * | 2000-11-30 | 2007-03-15 | Terumo Corp | BLOOD RESERVOIR |
FR2817754B1 (en) * | 2000-12-08 | 2003-09-12 | Hospal Internat Marketing Man | DEVICE FOR PRESSURE MEASUREMENT COMPRISING A MEMBRANE MOLDED IN A CASSETTE |
TW458771B (en) | 2000-12-13 | 2001-10-11 | Jiang R Chung | Structure of blood-propelling cavity of artificial left ventricle |
JP4276834B2 (en) * | 2000-12-27 | 2009-06-10 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Biological information and blood processing apparatus information management system |
US6517526B1 (en) * | 2000-12-29 | 2003-02-11 | Yehuda Tamari | Container for lyophilizing biological products |
US6659973B2 (en) | 2001-01-04 | 2003-12-09 | Transvivo, Inc. | Apparatus and method for in-vivo plasmapheresis using periodic backflush |
US8323228B2 (en) * | 2007-04-12 | 2012-12-04 | Rex Medical L.P. | Dialysis catheter |
US20020095210A1 (en) * | 2001-01-16 | 2002-07-18 | Finnegan Michael T. | Heart pump graft connector and system |
US6612977B2 (en) | 2001-01-23 | 2003-09-02 | American Medical Systems Inc. | Sling delivery system and method of use |
US6730267B2 (en) * | 2001-02-09 | 2004-05-04 | Cardiovention, Inc. | Integrated blood handling system having active gas removal system and methods of use |
US20030060695A1 (en) * | 2001-03-07 | 2003-03-27 | Connelly Patrick R. | Implantable artificial organ devices |
EP1977724A1 (en) * | 2001-04-07 | 2008-10-08 | Glaukos Corporation | System for treating ocular disorders |
US7488303B1 (en) * | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
US20020197252A1 (en) * | 2001-04-10 | 2002-12-26 | Renal Tech International | Selective adsorption devices and systems |
US6605108B2 (en) * | 2001-04-13 | 2003-08-12 | Eagle Vision, Inc. | Monocanalicular stent |
US7330753B2 (en) * | 2001-04-18 | 2008-02-12 | Metacure N.V. | Analysis of eating habits |
US6516282B2 (en) * | 2001-04-19 | 2003-02-04 | Ge Medical Systems Global Technology Company | Predictive thermal control used with a vacuum enclosed coil assembly of a magnetic resonance imaging device |
US8091556B2 (en) * | 2001-04-20 | 2012-01-10 | V-Wave Ltd. | Methods and apparatus for reducing localized circulatory system pressure |
US20050240229A1 (en) * | 2001-04-26 | 2005-10-27 | Whitehurst Tood K | Methods and systems for stimulation as a therapy for erectile dysfunction |
US7756582B2 (en) | 2001-05-01 | 2010-07-13 | Intrapace, Inc. | Gastric stimulation anchor and method |
US6535764B2 (en) * | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
US7020531B1 (en) | 2001-05-01 | 2006-03-28 | Intrapace, Inc. | Gastric device and suction assisted method for implanting a device on a stomach wall |
US6607501B2 (en) * | 2001-05-14 | 2003-08-19 | Reynolds G. Gorsuch | Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications |
DE10123769C1 (en) * | 2001-05-16 | 2002-12-12 | Infineon Technologies Ag | Method for adapting different signal propagation times between a controller and at least two processing units and a computer system |
US6678561B2 (en) * | 2001-05-23 | 2004-01-13 | Surgical Development Ag | Heartburn and reflux disease treatment apparatus |
SE0102313D0 (en) * | 2001-06-28 | 2001-06-28 | Obtech Medical Ag | Intestine dysfunction treatment apparatus |
US6551235B2 (en) * | 2001-06-28 | 2003-04-22 | Potencia Medical Ag | Implantable pump |
SE0102312D0 (en) | 2001-06-28 | 2001-06-28 | Obtech Medical Ag | Urinary dysfunction treatment apparatus |
TWI244919B (en) * | 2001-07-06 | 2005-12-11 | Showa Denko Plastic Product Co | Multiple connected medical container and production method thereof |
US6796963B2 (en) * | 2001-07-10 | 2004-09-28 | Myocardial Therapeutics, Inc. | Flexible tissue injection catheters with controlled depth penetration |
KR100407467B1 (en) | 2001-07-12 | 2003-11-28 | 최수봉 | Insulin pump operated by remote-controller |
US6901295B2 (en) * | 2001-07-14 | 2005-05-31 | Virender K. Sharma | Method and apparatus for electrical stimulation of the lower esophageal sphincter |
US6627206B2 (en) * | 2001-07-25 | 2003-09-30 | Greg A. Lloyd | Method and apparatus for treating obesity and for delivering time-released medicaments |
JP4883852B2 (en) * | 2001-07-30 | 2012-02-22 | 日東電工株式会社 | Heat peeling method of chip cut piece from heat release type adhesive sheet |
US20030078487A1 (en) * | 2001-08-09 | 2003-04-24 | Jeffries Robert E. | Ocular pressure measuring device |
US6928338B1 (en) | 2001-08-10 | 2005-08-09 | Medtronic, Inc. | Decision information system for drug delivery devices |
US20030208247A1 (en) | 2001-09-28 | 2003-11-06 | Michele Spinelli | Implantable stimulation lead with tissue in-growth anchor |
FR2830455B1 (en) | 2001-10-09 | 2004-06-25 | Saphir Medical | CATHETER WITH RETRACTABLE PERFORATING OR STITCHING TOOL |
JP2003116982A (en) * | 2001-10-10 | 2003-04-22 | Medicos Hirata:Kk | System for drainage of gallbladder through duodenum under endoscope |
DE60239282D1 (en) | 2001-10-17 | 2011-04-07 | Transvivo Inc | Plasmapheresis filter device and device for therapeutic apheresis |
US6849183B2 (en) * | 2002-08-13 | 2005-02-01 | Transvivo, Inc. | Method and apparatus for therapeutic apheresis |
US7727219B2 (en) * | 2001-10-22 | 2010-06-01 | Vita 34 Ag | Sterile system and methods for collecting, transporting, storing and cyropreserving body fluids |
US7429258B2 (en) | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040045924A1 (en) * | 2001-11-09 | 2004-03-11 | Masanori Naritomi | Leak stop plug against needle piercing and method of manufacturing the leak stop plug |
US7309323B2 (en) * | 2001-11-16 | 2007-12-18 | National Quality Care, Inc. | Wearable continuous renal replacement therapy device |
US7645253B2 (en) * | 2001-11-16 | 2010-01-12 | National Quality Care, Inc. | Wearable ultrafiltration device |
US7597677B2 (en) * | 2001-11-16 | 2009-10-06 | National Quality Care, Inc. | Wearable ultrafiltration device |
US7837766B2 (en) * | 2001-11-26 | 2010-11-23 | Gillette Thomas D | Systems and methods for reducing off-gassed ozone |
JP2003164508A (en) * | 2001-12-03 | 2003-06-10 | Taisei Kako Co Ltd | Transfusion container |
EP1467678A1 (en) * | 2001-12-21 | 2004-10-20 | Cardiovasc, Inc. | Composite stent with polymeric covering and bioactive coating |
KR100889908B1 (en) * | 2002-02-14 | 2009-03-20 | 가부시키가이샤 오츠카 세이야쿠 코죠 | Medical multi-chamber container |
EP2298370B1 (en) | 2002-02-21 | 2013-10-30 | Design Mentor, Inc. | Fluid pump |
US7311690B2 (en) | 2002-02-25 | 2007-12-25 | Novashunt Ag | Implantable fluid management system for the removal of excess fluid |
AU2003223187B2 (en) * | 2002-02-25 | 2008-05-22 | Sequana Medical Ag | Vesicular shunt for the drainage of excess fluid |
US7186232B1 (en) * | 2002-03-07 | 2007-03-06 | Glaukoa Corporation | Fluid infusion methods for glaucoma treatment |
US7003684B2 (en) * | 2002-03-27 | 2006-02-21 | Via Technologies, Inc. | Memory control chip, control method and control circuit |
US7744581B2 (en) * | 2002-04-08 | 2010-06-29 | Carmel Pharma Ab | Device and method for mixing medical fluids |
AU2003206609B2 (en) * | 2002-04-24 | 2008-12-11 | Ares Trading Sa | Device for preparing a medicinal liquid and method for preserving a solution of medicament for injection |
US6960233B1 (en) | 2002-12-10 | 2005-11-01 | Torax Medical, Inc. | Methods and apparatus for improving the function of biological passages |
US7043295B2 (en) | 2002-04-26 | 2006-05-09 | Medtronic, Inc. | Methods and apparatus for delivering a drug influencing appetite for treatment of eating disorders |
FR2839261B1 (en) * | 2002-05-06 | 2006-04-07 | Ciposa Sa | METHOD FOR CLEANING AND QULAIFYING A DIALYSIS FILTER AND MACHINE FOR CARRYING OUT SAID METHOD |
US6764761B2 (en) * | 2002-05-24 | 2004-07-20 | Baxter International Inc. | Membrane material for automated dialysis system |
DE10224750A1 (en) * | 2002-06-04 | 2003-12-24 | Fresenius Medical Care De Gmbh | Device for the treatment of a medical fluid |
BR0311585A (en) * | 2002-06-05 | 2005-05-10 | Univ Florida | Drug delivery system, method for administering an ophthalmic drug to a patient, kit, use thereof, method for preparing the drug delivery system, and article of manufacture |
JP3866618B2 (en) | 2002-06-13 | 2007-01-10 | エルピーダメモリ株式会社 | Memory system and control method thereof |
US7998190B2 (en) | 2002-06-17 | 2011-08-16 | California Institute Of Technology | Intravascular miniature stent pump |
US20050238506A1 (en) * | 2002-06-21 | 2005-10-27 | The Charles Stark Draper Laboratory, Inc. | Electromagnetically-actuated microfluidic flow regulators and related applications |
US20040024285A1 (en) * | 2002-06-21 | 2004-02-05 | Helmut Muckter | Blood pump with impeller |
US7303553B2 (en) * | 2002-06-24 | 2007-12-04 | Berlin Heart Gmbh | Device for connecting a cannula made of a flexible material with a tube |
US20030236483A1 (en) * | 2002-06-25 | 2003-12-25 | Ren David H | Dual drainage ocular shunt for glaucoma |
US20040015041A1 (en) * | 2002-07-18 | 2004-01-22 | The University Of Cincinnati | Protective sheath apparatus and method for use with a heart wall actuation system for the natural heart |
DK1523355T3 (en) | 2002-07-22 | 2019-04-23 | Becton Dickinson Co | PLASTER-LIKE INFUSION DEVICE |
US20040034275A1 (en) * | 2002-07-29 | 2004-02-19 | Peter Forsell | Multi-material incontinence treatment constriction device |
KR20050043899A (en) | 2002-08-02 | 2005-05-11 | 포텐시아 메디칼 에이쥐 | Apparatus for distributing liquid in a patient's body |
US6772011B2 (en) | 2002-08-20 | 2004-08-03 | Thoratec Corporation | Transmission of information from an implanted medical device |
US7211114B2 (en) * | 2002-08-26 | 2007-05-01 | The Trustees Of Columbia University In The City Of New York | Endoscopic gastric bypass |
US7214233B2 (en) | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
FR2844182B1 (en) * | 2002-09-11 | 2004-12-03 | Humanoptics Ag | CLOSURE PLUG OF A LACRYMAL CANALICLE |
EP1403519A1 (en) * | 2002-09-27 | 2004-03-31 | Novo Nordisk A/S | Membrane pump with stretchable pump membrane |
US20040064110A1 (en) | 2002-10-01 | 2004-04-01 | Peter Forsell | Injection port |
US7103418B2 (en) | 2002-10-02 | 2006-09-05 | Medtronic, Inc. | Active fluid delivery catheter |
EP1581326A2 (en) * | 2002-10-25 | 2005-10-05 | Pall Corporation | Biological fluid filter |
US7335215B2 (en) * | 2002-11-05 | 2008-02-26 | Damage Control Surgical Technologies, Inc. | Method and device for temporary emergency vessel anastomoses |
US20040098545A1 (en) | 2002-11-15 | 2004-05-20 | Pline Steven L. | Transferring data in selectable transfer modes |
US7608114B2 (en) * | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
US6695004B1 (en) * | 2002-12-16 | 2004-02-24 | Alaris Medical Systems, Inc. | Magnetic automatic stop valve |
US7395117B2 (en) * | 2002-12-23 | 2008-07-01 | Cardiac Pacemakers, Inc. | Implantable medical device having long-term wireless capabilities |
US7141071B2 (en) | 2002-12-23 | 2006-11-28 | Python Medical, Inc. | Implantable digestive tract organ |
US7037343B2 (en) | 2002-12-23 | 2006-05-02 | Python, Inc. | Stomach prosthesis |
CA2512013A1 (en) | 2003-01-06 | 2004-07-22 | Atamjit Gill | Surgical instrument for the treatment of female urinary incontinence and methods of use |
US6826663B2 (en) | 2003-01-13 | 2004-11-30 | Rambus Inc. | Coded write masking |
US7124570B2 (en) * | 2003-01-23 | 2006-10-24 | Integrated Vascular Interventional Technologies, L.C. | Apparatus and methods for fluid occlusion of an access tube anastomosed to an anatomical vessel |
AU2003206302A1 (en) | 2003-01-31 | 2004-08-23 | Potencia Medical Ag | Incontinence treatment apparatus with connection device |
EP1587456B1 (en) | 2003-01-31 | 2007-08-29 | Potencia Medical AG | Careful impotence treatment apparatus |
US7407481B2 (en) | 2003-01-31 | 2008-08-05 | Peter Forsell | Impotence treatment apparatus with connection device |
WO2004066885A1 (en) | 2003-01-31 | 2004-08-12 | Potencia Medical Ag | Electrically operable incontinence treatment apparatus |
DE60312563T2 (en) | 2003-01-31 | 2007-11-22 | Instant Communication Ag | ELECTRICALLY OPERATED DEVICE FOR IMPOTENCE TREATMENT |
DE60316035T2 (en) | 2003-01-31 | 2008-05-15 | Potencia Medical Ag | DEVICE FOR SAFE INCONTINENCE TREATMENT |
US7844338B2 (en) * | 2003-02-03 | 2010-11-30 | Enteromedics Inc. | High frequency obesity treatment |
GB0303432D0 (en) * | 2003-02-14 | 2003-03-19 | Council Cent Lab Res Councils | Self-cleaning tube |
WO2004075855A2 (en) * | 2003-02-26 | 2004-09-10 | Biomed Solutions, Llc | Process for in vivo treatment of specific biological targets in bodily fluid |
DE502004005171D1 (en) * | 2003-03-06 | 2007-11-22 | Csl Behring Gmbh | Transfer device, in particular for medical fluids |
US7185790B2 (en) * | 2003-03-20 | 2007-03-06 | Weiler Engineering, Inc. | Hermetically sealed container with non-drip opening |
US20040193095A1 (en) * | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
US20040193262A1 (en) * | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
US7972616B2 (en) * | 2003-04-17 | 2011-07-05 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
US7118525B2 (en) | 2003-04-23 | 2006-10-10 | Coleman Edward J | Implantable cardiac assist device |
US7182744B2 (en) * | 2003-04-25 | 2007-02-27 | Medtronic Vascular | Method and apparatus for aneurismal treatment |
CA2428741A1 (en) | 2003-05-13 | 2004-11-13 | Cardianove Inc. | Dual inlet mixed-flow blood pump |
US20050166006A1 (en) | 2003-05-13 | 2005-07-28 | Advanced Micro Devices, Inc. | System including a host connected serially in a chain to one or more memory modules that include a cache |
US7217236B2 (en) | 2003-05-30 | 2007-05-15 | Innovamedica S.A. De C.V. | Universal pneumatic ventricular assist device |
US7165153B2 (en) * | 2003-06-04 | 2007-01-16 | Intel Corporation | Memory channel with unidirectional links |
WO2005003300A2 (en) * | 2003-06-04 | 2005-01-13 | University Of South Carolina | Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
TW590007U (en) | 2003-06-06 | 2004-06-01 | Univ Tamkang | Tri-leaflet mechanical heart valve |
US6948522B2 (en) * | 2003-06-06 | 2005-09-27 | Baxter International Inc. | Reconstitution device and method of use |
US20040253039A1 (en) * | 2003-06-13 | 2004-12-16 | Stenton Richard J. | Disposable applicator for topical composition |
WO2004110548A1 (en) * | 2003-06-17 | 2004-12-23 | Cube Medical A/S | Closure with passage slit for a haemostatic valve assembly |
US20050027234A1 (en) * | 2003-06-18 | 2005-02-03 | Waggoner Donna Jean | Surgical implant and method of accessing cerebrospinal fluid |
US6798716B1 (en) * | 2003-06-19 | 2004-09-28 | Bc Systems, Inc. | System and method for wireless electrical power transmission |
US7201757B2 (en) | 2003-06-20 | 2007-04-10 | Enteromedics Inc. | Gastro-esophageal reflux disease (GERD) treatment method and apparatus |
US7226441B2 (en) * | 2003-06-23 | 2007-06-05 | Codman & Shurtleff, Inc. | Catheter with block-overriding system |
KR101129516B1 (en) * | 2003-07-18 | 2012-03-29 | 세키스이가가쿠 고교가부시키가이샤 | Hermetically sealed container and vacuum test substance-collecting container |
WO2005018507A2 (en) * | 2003-07-18 | 2005-03-03 | Ev3 Santa Rosa, Inc. | Remotely activated mitral annuloplasty system and methods |
US7736494B2 (en) * | 2003-07-31 | 2010-06-15 | Acquisci, Inc. | Ozone delivery system including a variable pitch gas-fluid contact device |
US7314489B2 (en) * | 2003-08-20 | 2008-01-01 | Ethicon Endo-Surgery, Inc. | Method and apparatus to facilitate nutritional malabsorption |
US7217351B2 (en) * | 2003-08-29 | 2007-05-15 | Beta Micropump Partners Llc | Valve for controlling flow of a fluid |
EP1669051A4 (en) * | 2003-09-30 | 2011-06-15 | Nipro Corp | Medical container and its using method |
US8140168B2 (en) | 2003-10-02 | 2012-03-20 | Medtronic, Inc. | External power source for an implantable medical device having an adjustable carrier frequency and system and method related therefore |
US7762977B2 (en) * | 2003-10-08 | 2010-07-27 | Hemosphere, Inc. | Device and method for vascular access |
EP1680155B2 (en) * | 2003-10-28 | 2015-11-04 | Baxter International Inc. | Dialysis machine with improved integrity test |
US7186290B2 (en) * | 2004-01-08 | 2007-03-06 | Carrier Corporation | Filter system with automatic media refresh |
EP2335751B1 (en) * | 2004-01-22 | 2016-04-06 | Yehuda Tamari | A closed venous-cardiotomy reservoir with improved air handling |
EP1563886A1 (en) | 2004-01-23 | 2005-08-17 | Fuji Photo Film Co., Ltd. | Extraction system |
CN101627938B (en) * | 2004-02-02 | 2011-12-21 | 孕体有限公司 | Contraceptive with permeable and impermeable components |
US8052669B2 (en) * | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US20050256540A1 (en) * | 2004-02-26 | 2005-11-17 | Silver Theodore A | Apparatus and method for movement of electricity or fluid into and out of the body |
US20050209582A1 (en) * | 2004-03-22 | 2005-09-22 | Medtronic Vascular, Inc. | Multi-lumen catheter system |
US7686825B2 (en) * | 2004-03-25 | 2010-03-30 | Hauser David L | Vascular filter device |
US7488302B1 (en) * | 2004-03-29 | 2009-02-10 | Robert Helm | Device allowing serial use of clean and alternative blood filters during blood filtration |
US20060129028A1 (en) | 2004-03-31 | 2006-06-15 | Krakousky Alexander A | Potency package |
US7993397B2 (en) * | 2004-04-05 | 2011-08-09 | Edwards Lifesciences Ag | Remotely adjustable coronary sinus implant |
EP1740132B1 (en) | 2004-04-26 | 2014-12-31 | Synecor, LLC | Restrictive and/or obstructive implant for inducing weight loss |
US20050245957A1 (en) | 2004-04-30 | 2005-11-03 | Medtronic, Inc. | Biasing stretch receptors in stomach wall to treat obesity |
JP4934024B2 (en) | 2004-05-03 | 2012-05-16 | フルフィリウム, インコーポレイテッド | Method and system for controlling stomach volume |
CA2828619C (en) * | 2004-05-05 | 2018-09-25 | Direct Flow Medical, Inc. | Prosthetic valve with an elastic stent and a sealing structure |
US6949067B1 (en) * | 2004-05-11 | 2005-09-27 | Dann Jeffrey A | Device and method for enhancing female sexual stimulation |
US7222224B2 (en) | 2004-05-21 | 2007-05-22 | Rambus Inc. | System and method for improving performance in computer memory systems supporting multiple memory access latencies |
US7534221B2 (en) * | 2004-05-24 | 2009-05-19 | The Trustees Of Columbia University In The City Of New York | Devices and methods for protecting against distal embolisms |
US7524298B2 (en) * | 2004-05-25 | 2009-04-28 | California Institute Of Technology | Device and method for treating hydrocephalus |
US7112186B2 (en) | 2004-05-26 | 2006-09-26 | Shah Tilak M | Gastro-occlusive device |
US7516029B2 (en) | 2004-06-09 | 2009-04-07 | Rambus, Inc. | Communication channel calibration using feedback |
US20060004317A1 (en) * | 2004-06-30 | 2006-01-05 | Christophe Mauge | Hydrocephalus shunt |
WO2006055052A2 (en) * | 2004-07-19 | 2006-05-26 | Michael Gertner | Methods and devices for chronic embolic protection |
US20060015137A1 (en) * | 2004-07-19 | 2006-01-19 | Wasdyke Joel M | Retrievable intravascular filter with bendable anchoring members |
US20060020239A1 (en) * | 2004-07-20 | 2006-01-26 | Geiger Mark A | Cerebral spinal fluid flow sensing device |
KR100643605B1 (en) * | 2004-08-16 | 2006-11-10 | 삼성전자주식회사 | Adaptive preemphasis apparatus, data communication transmitter, data communication receiver, and adaptive preemphasis method |
US8202248B2 (en) * | 2004-08-18 | 2012-06-19 | Sequana Medical Ag | Dialysis implant and methods of use |
WO2006034276A1 (en) * | 2004-09-21 | 2006-03-30 | William A. Cook Austrialia Pty. Ltd. | Side branch stent graft |
EP1805439A1 (en) * | 2004-10-28 | 2007-07-11 | Pall Corporation | Valve |
US7594899B2 (en) * | 2004-12-03 | 2009-09-29 | Innfocus, Llc | Glaucoma implant device |
CN101128171A (en) * | 2004-12-16 | 2008-02-20 | I科学干预公司 | Ophthalmic implant for treatment of glaucoma |
US20060161217A1 (en) | 2004-12-21 | 2006-07-20 | Jaax Kristen N | Methods and systems for treating obesity |
US20060149129A1 (en) | 2005-01-05 | 2006-07-06 | Watts H D | Catheter with multiple visual elements |
US7601162B2 (en) | 2005-01-14 | 2009-10-13 | Ethicon Endo-Surgery, Inc. | Actuator for an implantable band |
US7963989B2 (en) * | 2005-01-24 | 2011-06-21 | Technology Advancement Group, Inc. | Implantable prosthetic device for connection to a fluid flow pathway of a patient |
EP2586386B1 (en) * | 2005-01-25 | 2018-10-31 | Covidien LP | Structure for permanent occlusion of a hollow anatomical structure |
CA2596886C (en) * | 2005-02-04 | 2011-01-04 | Amcol International Corporation | Extended delivery of ingredients from a fabric softener composition |
US8267954B2 (en) * | 2005-02-04 | 2012-09-18 | C. R. Bard, Inc. | Vascular filter with sensing capability |
AU2006214368B2 (en) * | 2005-02-15 | 2011-05-26 | Yale University | Intrauterine fallopian tube occlusion device and method for use |
US7641627B2 (en) * | 2005-02-23 | 2010-01-05 | Camras Carl B | Method and apparatus for reducing intraocular pressure |
US20060212097A1 (en) * | 2005-02-24 | 2006-09-21 | Vijay Varadan | Method and device for treatment of medical conditions and monitoring physical movements |
CA2599965C (en) * | 2005-03-04 | 2014-05-06 | Cardiomems, Inc. | Communicating with an implanted wireless sensor |
US20060224102A1 (en) * | 2005-04-05 | 2006-10-05 | Codman & Shurtleff, Inc | Subarachnoid epidural shunt |
US7801602B2 (en) * | 2005-04-08 | 2010-09-21 | Boston Scientific Neuromodulation Corporation | Controlling stimulation parameters of implanted tissue stimulators |
US20060235269A1 (en) * | 2005-04-15 | 2006-10-19 | The University Of Chicago | Method, apparatus and kit for bile or pancreatic duct endoscopy |
WO2006113394A2 (en) * | 2005-04-15 | 2006-10-26 | Surgisense Corporation | Surgical instruments with sensors for detecting tissue properties, and systems using such instruments |
CA2507142A1 (en) | 2005-04-25 | 2006-10-25 | Mohammad Nadeem Qadir | Apparatus, devices and methods for contraception, conception and pregnancy |
US7984717B2 (en) | 2005-04-29 | 2011-07-26 | Medtronic, Inc. | Devices for augmentation of lumen walls |
KR100588599B1 (en) * | 2005-05-03 | 2006-06-14 | 삼성전자주식회사 | Memory module and memory system |
US7569050B2 (en) | 2005-05-06 | 2009-08-04 | Medtronic Minimed, Inc. | Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portion |
EP2409671B1 (en) | 2005-05-11 | 2014-06-11 | Board Of Regents, The University Of Texas System | Device for treating obesity |
EP1884259A4 (en) | 2005-05-27 | 2011-03-30 | Olympus Corp | Device for introduction into subject |
US8435279B2 (en) * | 2005-06-14 | 2013-05-07 | Advanced Cardiovascular Systems, Inc. | Delivery system for a device such as a stent |
DE102005027809A1 (en) | 2005-06-15 | 2006-12-28 | Q Medial International Ag | Closing device for hollow organs |
JP4848143B2 (en) * | 2005-06-17 | 2011-12-28 | テルモ株式会社 | Blood component collection device |
US8709069B2 (en) * | 2005-07-01 | 2014-04-29 | C. R. Bard, Inc. | Flanged graft with trim lines |
ATE535279T1 (en) * | 2005-07-19 | 2011-12-15 | Shalom Zvi Ben | ORGAN SUPPORT SYSTEM |
JP2009503549A (en) * | 2005-08-02 | 2009-01-29 | バクスター・インターナショナル・インコーポレイテッド | Oxygen indicator for use in medical products |
WO2007017880A2 (en) | 2005-08-11 | 2007-02-15 | Stimplant Ltd. | Implantable device for obesity prevention |
US20070038232A1 (en) * | 2005-08-12 | 2007-02-15 | Kraemer Stefan J M | Apparatus and method for securing the stomach to the diaphragm for use, for example, in treating hiatal hernias and gastroesophageal reflux disease |
US7699769B2 (en) * | 2005-09-01 | 2010-04-20 | Boston Scientific Scimed, Inc. | Adjustable surgical sling |
US8435224B2 (en) * | 2005-09-12 | 2013-05-07 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds |
EP1945150A1 (en) | 2005-10-14 | 2008-07-23 | Continence Control Systems International PTY Ltd. | A method and apparatus for treating fecal incontinence |
US8118750B2 (en) | 2005-10-21 | 2012-02-21 | Medtronic, Inc. | Flow sensors for penile tumescence |
US8366650B2 (en) * | 2005-10-24 | 2013-02-05 | Satiogen Pharmaceuticals, Inc. | Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases |
US8088117B2 (en) * | 2005-10-25 | 2012-01-03 | Nicolon Corporation | Fill port for a flexible container for relieving or distributing stresses at the fill port |
US8543420B2 (en) * | 2007-09-19 | 2013-09-24 | Fresenius Medical Care Holdings, Inc. | Patient-specific content delivery methods and systems |
EP2210632B1 (en) | 2005-11-02 | 2012-01-18 | Injectica AG | Implantable infusion device with advanceable and retractable needle |
EP2545885B1 (en) * | 2005-11-02 | 2022-01-19 | MedicalTree Patents Ltd. | Artificial valve for implantation |
US7368950B2 (en) | 2005-11-16 | 2008-05-06 | Montage Technology Group Limited | High speed transceiver with low power consumption |
US7577039B2 (en) | 2005-11-16 | 2009-08-18 | Montage Technology Group, Ltd. | Memory interface to bridge memory buses |
US7558124B2 (en) | 2005-11-16 | 2009-07-07 | Montage Technology Group, Ltd | Memory interface to bridge memory buses |
US20070167901A1 (en) * | 2005-11-17 | 2007-07-19 | Herrig Judson A | Self-sealing residual compressive stress graft for dialysis |
EP1958608A4 (en) * | 2005-11-29 | 2013-01-23 | Otsuka Pharma Co Ltd | Multichamber bag and gas barrier film |
US7650192B2 (en) * | 2005-12-02 | 2010-01-19 | Medtronic, Inc. | Passive charge of implantable medical device utilizing external power source and method |
US20070150063A1 (en) * | 2005-12-22 | 2007-06-28 | Depuy Spine, Inc. | Devices for intervertebral augmentation and methods of controlling their delivery |
US7720547B2 (en) | 2006-01-04 | 2010-05-18 | Kenergy, Inc. | Extracorporeal power supply with a wireless feedback system for an implanted medical device |
PT2526910E (en) * | 2006-01-17 | 2015-11-18 | Transcend Medical Inc | Glaucoma treatment device |
US8246563B2 (en) * | 2006-02-02 | 2012-08-21 | Cardiac Pacemakers, Inc. | Cardiac rhythm management device and sensor-suite for the optimal control of ultrafiltration and renal replacement therapies |
US20070193632A1 (en) | 2006-02-21 | 2007-08-23 | Jianchao Shu | Artificial heart valve and rotary pressure porting mechanisms |
US8195296B2 (en) | 2006-03-03 | 2012-06-05 | Ams Research Corporation | Apparatus for treating stress and urge incontinence |
WO2007109759A2 (en) | 2006-03-22 | 2007-09-27 | C. R. Bard, Inc. | Female urinary incontinence treatment device and method |
US8070768B2 (en) * | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20090131959A1 (en) | 2006-04-20 | 2009-05-21 | Liquidia Technologies Inc. | Biological Vessel Flow Control Devices and Methods |
JP5566101B2 (en) * | 2006-04-24 | 2014-08-06 | メディカル・インスティル・テクノロジーズ・インコーポレイテッド | Needle penetrable and laser resealable freeze-drying apparatus and related methods |
CA2650570C (en) * | 2006-04-26 | 2017-06-06 | Eastern Virginia Medical School | Systems and methods for monitoring and controlling internal pressure of an eye or body part |
US20070265675A1 (en) | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
US8160709B2 (en) | 2006-05-18 | 2012-04-17 | Endostim, Inc. | Use of electrical stimulation of the lower esophageal sphincter to modulate lower esophageal sphincter pressure |
US7991476B2 (en) | 2006-05-22 | 2011-08-02 | Empire Bio-Medical Devices, Inc. | Method and device for enhanced blood flow |
US8002731B2 (en) * | 2006-05-30 | 2011-08-23 | Boston Scientific Scimed, Inc. | Anti-obesity stent |
EP2049039A2 (en) | 2006-06-22 | 2009-04-22 | AMS Research Corporation | Adjustable tension incontinence sling assemblies |
US7828715B2 (en) * | 2006-06-29 | 2010-11-09 | Ams Research Corporation | Method of treating anal incontinence |
US8075471B2 (en) | 2006-07-12 | 2011-12-13 | Allegheny-Singer Research Institute | Apical torsion device for cardiac assist |
DE102006036073A1 (en) * | 2006-08-02 | 2008-02-07 | Heise, Michael, Dr.med. | Vascular tubular graft |
US20080039768A1 (en) * | 2006-08-10 | 2008-02-14 | Medtronic, Inc. | Implantable devices with photocatalytic surfaces for treating hydrocephalus |
US7455663B2 (en) * | 2006-08-23 | 2008-11-25 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
US9168355B2 (en) * | 2006-09-29 | 2015-10-27 | Covidien Lp | Acute hemodialysis catheter assembly |
US7738961B2 (en) | 2006-10-09 | 2010-06-15 | Endostim, Inc. | Method and apparatus for treatment of the gastrointestinal tract |
JP2010505556A (en) * | 2006-10-09 | 2010-02-25 | ニューロフルーディクス, インコーポレイテッド | Cerebrospinal fluid purification system |
US7749235B2 (en) | 2006-10-20 | 2010-07-06 | Ethicon Endo-Surgery, Inc. | Stomach invagination method and apparatus |
US20080103544A1 (en) | 2006-10-28 | 2008-05-01 | Weiner Richard L | Method of treating female sexual dysfunction |
FR2908979A1 (en) | 2006-11-28 | 2008-05-30 | Saidi Abdelkader | Erectile dysfunction treating device for use during e.g. prostatectomy, has infusing unit for infusing therapeutic solution into cavernous tissue of penis of patient having erectile dysfunction in discontinuous or continuous manner |
US8241621B2 (en) * | 2006-12-18 | 2012-08-14 | Medistem Laboratories | Stem cell mediated treg activation/expansion for therapeutic immune modulation |
US7846160B2 (en) | 2006-12-21 | 2010-12-07 | Cytyc Corporation | Method and apparatus for sterilization |
WO2008097905A1 (en) * | 2007-02-05 | 2008-08-14 | Boston Scientific Scimed, Inc. | Blood access apparatus and method |
US7694570B1 (en) * | 2007-03-30 | 2010-04-13 | Cosense, Inc | Non-invasive dry coupled disposable/reusable ultrasonic sensor |
US8469908B2 (en) * | 2007-04-06 | 2013-06-25 | Wilson T. Asfora | Analgesic implant device and system |
US9259233B2 (en) * | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
US20080262466A1 (en) * | 2007-04-19 | 2008-10-23 | Steve Smith | Storage container |
WO2008134064A1 (en) * | 2007-04-28 | 2008-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Dynamic and adjustable support devices |
US8075472B2 (en) | 2007-05-03 | 2011-12-13 | Leviticus-Cardio Ltd. | Permanent ventricular assist device for treating heart failure |
US7824357B2 (en) * | 2007-06-11 | 2010-11-02 | Ibrahim Rashid Al-Rashdan | Method and system for preventing contrast associated nephropathy |
EP2002855B1 (en) * | 2007-06-14 | 2012-07-11 | RenApta B.V. | Artificial kidney |
GB0713864D0 (en) | 2007-07-17 | 2007-08-29 | Sheppard & Charnley Ltd | Electric motor/generator assembly |
EP2173276A4 (en) * | 2007-08-02 | 2015-07-08 | Bio Connect Systems | Implantable flow connector |
US9234514B2 (en) * | 2007-08-27 | 2016-01-12 | Quest Medical, Inc. | Two-chamber blood pump |
US8002737B2 (en) * | 2007-10-04 | 2011-08-23 | Hyprotek, Inc. | Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers |
US8696543B2 (en) * | 2007-10-11 | 2014-04-15 | Kirk Promotion Ltd. | Method for controlling flow of intestinal contents in a patient's intestines |
EA033368B1 (en) | 2007-10-11 | 2019-10-31 | Implantica Patent Ltd | Apparatus for controlling flow in a bodily organ |
US8795153B2 (en) * | 2007-10-11 | 2014-08-05 | Peter Forsell | Method for treating female sexual dysfunction |
US9555241B2 (en) * | 2007-10-11 | 2017-01-31 | Peter Forsell | Method of obtaining male contraception |
US10307597B2 (en) * | 2007-10-11 | 2019-06-04 | Peter Forsell | Method for controlling flow of urine in a patient's urethra, ureter, renal pelvis or bladder |
US8992409B2 (en) * | 2007-10-11 | 2015-03-31 | Peter Forsell | Method for controlling flow in a bodily organ |
US10195325B2 (en) * | 2007-10-11 | 2019-02-05 | Peter Forsell | Method for controlling flow of sperms in a uterine tube |
US9949871B2 (en) * | 2007-10-11 | 2018-04-24 | Peter Forsell | Method for controlling flow of eggs in a uterine tube |
US20090248033A1 (en) * | 2007-10-11 | 2009-10-01 | Milux Holding S.A. | Method for the treatment of gallstones |
EP2246080B1 (en) * | 2007-10-12 | 2016-02-10 | DEKA Products Limited Partnership | An extracorporeal blood flow system |
JP5363496B2 (en) * | 2007-11-07 | 2013-12-11 | ジャメス ラネ ロドネイ | System, method and apparatus for accessing the circulatory system |
US7887503B2 (en) * | 2007-11-20 | 2011-02-15 | Mark Geiger | Method and apparatus for removing harmful proteins from a mammalian's ventricular cerebrospinal fluid |
TWI407939B (en) * | 2007-11-27 | 2013-09-11 | 財團法人國家實驗研究院 | System and method for wireless physiological signal integration |
BRPI0906467C1 (en) * | 2008-01-25 | 2021-05-25 | Gruenenthal Gmbh | pharmaceutical dosage form with modified tear-resistant outer shape and controlled release |
EP3970664A1 (en) | 2008-01-28 | 2022-03-23 | Implantica Patent Ltd. | A fluid movement device |
US8961448B2 (en) | 2008-01-28 | 2015-02-24 | Peter Forsell | Implantable drainage device |
US9060771B2 (en) * | 2008-01-29 | 2015-06-23 | Peter Forsell | Method and instrument for treating obesity |
US20090198271A1 (en) * | 2008-01-31 | 2009-08-06 | Rainbow Medical Ltd. | Electrode based filter |
US7844342B2 (en) | 2008-02-07 | 2010-11-30 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using light |
EP2096566B1 (en) * | 2008-02-29 | 2018-04-04 | Fresenius Medical Care Holdings, Inc. | Instructional media system for dialysis machine |
FI123247B (en) | 2008-03-19 | 2013-01-15 | Aalto Korkeakoulusaeaetioe | Intracorporeal bone distribution device |
EP2273947B1 (en) * | 2008-04-03 | 2018-05-16 | Cook Medical Technologies LLC | Self cleaning devices and systems |
US7987853B2 (en) * | 2008-04-25 | 2011-08-02 | Conceptus, Inc. | Devices and methods for occluding a fallopian tube |
AU2008357095B2 (en) * | 2008-05-26 | 2014-03-13 | Yeda Research And Development Co. Ltd. | Methods of treating cancer of the central nervous system |
US7988849B2 (en) * | 2008-06-03 | 2011-08-02 | Baxter International Inc. | Customizable personal dialysis device having ease of use and therapy enhancement features |
EP3298995A1 (en) * | 2008-06-25 | 2018-03-28 | Novartis AG | Ocular implant with shape change capabilities |
US8172823B2 (en) * | 2008-07-03 | 2012-05-08 | Baxter International Inc. | Port assembly for use with needleless connector |
US8057679B2 (en) * | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US20100152640A1 (en) * | 2008-09-05 | 2010-06-17 | Imtecbiomedical, Inc. | Methods and apparatus for vascular access |
US10668196B2 (en) | 2008-10-10 | 2020-06-02 | Peter Forsell | Heart assisting device |
US10226329B2 (en) | 2008-10-10 | 2019-03-12 | Peter Forsell | Artificial valve |
US11628053B2 (en) | 2008-10-10 | 2023-04-18 | Peter Forsell | Variable sling for urinary continence |
US20110196484A1 (en) | 2008-10-10 | 2011-08-11 | Milux Holding Sa | Heart help method |
EP3120896A1 (en) * | 2008-10-10 | 2017-01-25 | Kirk Promotion LTD. | A system, an apparatus, and a method for treating a sexual dysfunctional female patient |
EP2349170B1 (en) | 2008-10-10 | 2023-09-27 | Implantica Patent Ltd. | Apparatus for the treatment of female sexual dysfunction |
EP2349106B1 (en) | 2008-10-10 | 2017-01-11 | Kirk Promotion LTD. | System for the treatment of male sexual dysfunction |
US8475355B2 (en) | 2008-10-10 | 2013-07-02 | Milux Holding S.A. | Heart help device, system, and method |
US9839503B2 (en) * | 2008-10-10 | 2017-12-12 | Peter Forsell | Implantable device for internal urinary control |
EP2349096B1 (en) | 2008-10-10 | 2021-01-27 | MedicalTree Patent Ltd. | An improved artificial valve |
CA3126252A1 (en) | 2008-10-10 | 2010-04-15 | Medicaltree Patent Ltd. | Heart help pump, system, and method |
EP2346456B1 (en) | 2008-10-10 | 2021-04-07 | Implantica Patent Ltd. | An apparatus for temporary male contraception |
WO2010042032A1 (en) | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | Fastening means for implantable medcial control assembly |
EP3689318A1 (en) | 2008-10-10 | 2020-08-05 | MedicalTree Patent Ltd. | Heart help device and system |
US9452045B2 (en) | 2008-10-10 | 2016-09-27 | Peter Forsell | Artificial valve |
EP2349076B1 (en) | 2008-10-10 | 2018-06-13 | Kirk Promotion LTD. | A system, an apparatus for treating a sexual dysfunctional female patient |
EP2349083B1 (en) | 2008-10-10 | 2020-06-17 | Implantica Patent Ltd. | Artificial stomach |
BRPI0919860B8 (en) | 2008-10-31 | 2021-06-22 | Implantica Patent Ltd | implantable device and system for bone adjustment, operable with wireless power transmission |
US8523838B2 (en) * | 2008-12-15 | 2013-09-03 | Carmel Pharma Ab | Connector device |
US8679090B2 (en) * | 2008-12-19 | 2014-03-25 | Icu Medical, Inc. | Medical connector with closeable luer connector |
MX365189B (en) * | 2009-01-29 | 2019-05-27 | Implantica Patent Ltd | Obesity treatment. |
EP2218952B1 (en) * | 2009-02-12 | 2013-02-27 | Sophysa | Device for mechanical localisation and reading the setting of an adjustable valve |
WO2010096822A2 (en) * | 2009-02-23 | 2010-08-26 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
US8430831B2 (en) * | 2009-02-25 | 2013-04-30 | The Invention Science Fund I, Llc | Device, system, and method for controllably reducing inflammatory mediators in a subject |
JP5449525B2 (en) * | 2009-04-03 | 2014-03-19 | クック メディカル テクノロジーズ エルエルシー | Delivery system for a magnetic anastomosis device |
US9173760B2 (en) * | 2009-04-03 | 2015-11-03 | Metamodix, Inc. | Delivery devices and methods for gastrointestinal implants |
CN102481450B (en) | 2009-04-07 | 2015-09-16 | 威斯特天主教保健中心 | uterine electrical stimulation system and method |
US9949812B2 (en) * | 2009-07-17 | 2018-04-24 | Peter Forsell | Vaginal operation method for the treatment of anal incontinence in women |
US10952836B2 (en) * | 2009-07-17 | 2021-03-23 | Peter Forsell | Vaginal operation method for the treatment of urinary incontinence in women |
US8632485B2 (en) * | 2009-11-05 | 2014-01-21 | Fresenius Medical Care Holdings, Inc. | Patient treatment and monitoring systems and methods |
US8388566B2 (en) * | 2010-04-29 | 2013-03-05 | Sorin Group Italia, S.r.l. | Oxygenator with integrated arterial filter including filter frame |
JP6058530B2 (en) * | 2010-05-06 | 2017-01-11 | アイシーユー・メディカル・インコーポレーテッド | Medical connectors including sealable luer connectors |
US8545430B2 (en) * | 2010-06-09 | 2013-10-01 | Transcend Medical, Inc. | Expandable ocular devices |
CN103328976B (en) * | 2010-11-01 | 2016-08-10 | B.R.A.H.M.S有限公司 | There is prognosis and the risk assessment of the patient of nonspecific main suit |
IT1403656B1 (en) * | 2011-01-28 | 2013-10-31 | Frattini Paolo Giuseppe Gobbi | HERMETIC CLOSURE CONNECTOR, PERFORTABLE WITHOUT NEEDLE AND AUTOMATICALLY CLOSABLE FOR TIGHTENING, FOR FLEXIBLE PIPES INTENDED FOR THE COLLECTION AND DISTRIBUTION OF LIQUID SOLUTIONS FOR PHARMACOLOGICAL AND / OR NUTRITIONAL USE. |
DE102011010067A1 (en) * | 2011-02-01 | 2012-08-02 | Fresenius Medical Care Deutschland Gmbh | Method and device for controlling an extracorporeal blood treatment device |
US8888732B2 (en) * | 2011-03-11 | 2014-11-18 | Apollo Endosurgery, Inc. | Intraluminal sleeve with active agents |
EP2716310B1 (en) * | 2011-05-27 | 2017-02-01 | Grifols, S.A. | Priming anticoagulant line for blood extraction |
US9295613B2 (en) * | 2011-12-13 | 2016-03-29 | Fenwal, Inc. | Container with pH indicator |
US9270134B2 (en) * | 2012-01-27 | 2016-02-23 | Medtronic, Inc. | Adaptive rate recharging system |
US9225190B2 (en) * | 2012-09-07 | 2015-12-29 | Manufacturers And Traders Trust Company | Implant current controlled battery charging based on temperature |
WO2014052438A1 (en) * | 2012-09-25 | 2014-04-03 | Regents Of The University Of Minnesota | Methods for making and using antimicrobial peptides |
WO2014098810A1 (en) * | 2012-12-18 | 2014-06-26 | Empire Technology Development, Llc | Vascular reinforcement device |
WO2014113483A1 (en) * | 2013-01-15 | 2014-07-24 | Metamodix, Inc. | System and method for affecting intestinal microbial flora |
US9579457B2 (en) * | 2013-03-15 | 2017-02-28 | Flint Hills Scientific, L.L.C. | Method, apparatus and system for automatic treatment of pain |
EP2967927A4 (en) * | 2013-03-15 | 2016-10-12 | Merit Medical Systems Inc | Esophageal stent |
-
2009
- 2009-01-28 US US12/864,714 patent/US8961448B2/en active Active
- 2009-01-28 EP EP09706196.4A patent/EP2244662B1/en active Active
- 2009-01-28 JP JP2010544922A patent/JP5643113B2/en active Active
- 2009-01-28 AU AU2009209515A patent/AU2009209515A1/en not_active Abandoned
- 2009-01-28 CA CA2749771A patent/CA2749771C/en active Active
- 2009-01-28 US US12/864,695 patent/US9789290B2/en active Active
- 2009-01-28 EP EP21168499.8A patent/EP3928809A1/en active Pending
- 2009-01-28 EP EP09705463.9A patent/EP2244759A4/en active Pending
- 2009-01-28 CA CA2749759A patent/CA2749759C/en active Active
- 2009-01-28 CA CA3187608A patent/CA3187608A1/en active Pending
- 2009-01-28 WO PCT/SE2009/000036 patent/WO2009096851A1/en active Application Filing
- 2009-01-28 ES ES09706196T patent/ES2901553T3/en active Active
- 2009-01-28 US US12/864,828 patent/US10729894B2/en not_active Expired - Fee Related
- 2009-01-28 WO PCT/SE2009/000040 patent/WO2009096855A1/en active Application Filing
- 2009-01-28 AU AU2009209514A patent/AU2009209514A1/en not_active Abandoned
- 2009-01-28 US US12/864,724 patent/US9457172B2/en active Active
- 2009-01-28 ES ES09706730T patent/ES2877766T3/en active Active
- 2009-01-28 EP EP21199129.4A patent/EP3964243A1/en active Pending
- 2009-01-28 EP EP22176783.3A patent/EP4088772A1/en active Pending
- 2009-01-28 WO PCT/SE2009/000041 patent/WO2009096856A1/en active Application Filing
- 2009-01-28 CA CA3116266A patent/CA3116266A1/en active Pending
- 2009-01-28 CA CA2749766A patent/CA2749766C/en active Active
- 2009-01-28 AU AU2009209518A patent/AU2009209518A1/en not_active Abandoned
- 2009-01-28 WO PCT/SE2009/000038 patent/WO2009096853A1/en active Application Filing
- 2009-01-28 WO PCT/SE2009/000037 patent/WO2009096852A1/en active Application Filing
- 2009-01-28 EP EP09705127.0A patent/EP2244758A4/en active Pending
- 2009-01-28 EP EP09706078.4A patent/EP2244760B8/en active Active
- 2009-01-28 EP EP09706730.0A patent/EP2244663B1/en active Active
- 2009-01-28 CA CA2999337A patent/CA2999337C/en active Active
- 2009-01-28 US US12/864,706 patent/US10384042B2/en active Active
-
2015
- 2015-02-20 US US14/626,985 patent/US9694165B2/en active Active
-
2016
- 2016-10-04 US US15/284,560 patent/US10463843B2/en active Active
-
2017
- 2017-07-03 US US15/640,714 patent/US11253684B2/en active Active
- 2017-10-12 US US15/730,768 patent/US11045631B2/en active Active
-
2019
- 2019-08-19 US US16/543,656 patent/US11826690B2/en active Active
- 2019-10-14 US US16/600,642 patent/US20200337822A1/en active Pending
- 2019-11-01 US US16/671,266 patent/US11291808B2/en active Active
-
2020
- 2020-08-04 US US16/984,368 patent/US11839848B2/en active Active
-
2021
- 2021-06-16 US US17/348,792 patent/US11660562B2/en active Active
-
2022
- 2022-02-21 US US17/676,324 patent/US20220168550A1/en active Pending
- 2022-04-04 US US17/712,208 patent/US12005386B2/en active Active
-
2023
- 2023-11-01 US US18/499,253 patent/US20240058736A1/en active Pending
- 2023-11-27 US US18/519,208 patent/US20240082776A1/en active Pending
- 2023-12-11 US US18/202,717 patent/US20240091697A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020151922A1 (en) * | 1998-05-13 | 2002-10-17 | Michael Hogendijk | Apparatus and methods for removing emboli during a surgical procedure |
WO2001012108A1 (en) * | 1999-08-12 | 2001-02-22 | Potencia Medical Ag | Medical implant apparatus with wireless energy transmission |
WO2001045590A2 (en) * | 1999-12-23 | 2001-06-28 | Percusurge, Inc. | Strut design for an occlusion device |
US20020165575A1 (en) * | 2001-05-07 | 2002-11-07 | Saleh Fathy M.A. | Vascular filtration device |
WO2005072169A2 (en) * | 2004-01-20 | 2005-08-11 | Massachusetts General Hospital | Permanent thrombus filtering stent |
US20050266042A1 (en) * | 2004-05-27 | 2005-12-01 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
US20060224177A1 (en) * | 2005-04-01 | 2006-10-05 | Stephanos Finitsis | Thrombus removal system and process |
Non-Patent Citations (1)
Title |
---|
See also references of EP2244662A4 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11839848B2 (en) | Blood clot removal device, system, and method | |
AU2021200756B2 (en) | Blood Clot Removal Device, System, And Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09706196 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12864828 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009706196 Country of ref document: EP |